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Pathogens secrete an arsenal of effectors to facilitate infection, however these effectors 
are themselves susceptible to molecular detection by plant immune receptors known as 
NLRs (nucleotide-binding, leucine-rich repeat proteins). Our understanding of how NLRs 
function mechanistically still remains relatively rudimentary. Mechanistic studies of NLRs 
have largely been hampered by difficulties in producing sufficient quantities of soluble NLR 
protein for biochemical and structural investigation. A major goal in the field is to expand 
our structural understanding of how effectors activate NLRs and to increase the variety and 
number of protein structures of these receptors. 
 
Using the example of the Arabidopsis paired TIR-NLRs RRS1 and RPS4, this work aimed to 
evaluate a diverse range of protein expression systems for their suitability for NLR protein 
production. This study investigated the use of classical heterologous expression systems of 
E. coli and insect cells as well as plant-based systems such as cell-free wheat germ, 
transgenic lines of Arabidopsis thaliana and agroinfiltration of Nicotiana benthamiana. 
Soluble full-length RRS1 protein could be purified from plant-based systems, though 
protein yield issues have hampered current efforts to gain structural information on this 
protein. The insights presented in this multi-system screening process should provide a 
valuable foundation for future studies into NLR purification. 
 
In the second part of this work, I set out to examine the structural basis of the recognition 
of Pseudomonas syringae effector AvrRps4 by RRS1 via RRS1’s integrated WRKY 
transcription factor domain. Previous work has shown that binding of the effector AvrRps4 
to RRS1 is required but not sufficient to activate a defence response. I therefore set out to 
gain a structural insight into this NLR-effector interface to help guide and support our 
biological understanding of the inter- and intra-molecular interactions involved in the 
activation of this receptor complex. Through the use of quantitative biochemical techniques 
including surface plasmon resonance and analytical gel filtration, we gained important 
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Approximately 20-40% of global crop yields are lost each year due to damage by pests and 
disease. With a global population set to grow by a further 20% by 2050, combined with 
climatic change, and limited agriculturally viable land, such losses are unsustainable and 
pose a major threat to our global food security. Only through understanding the complex 
interplays between plant hosts and their pathogens will we gain insights to help reduce this 
yield gap and strengthen global food security.  
 
Unlike mammals, plants rely on a multi-layered innate immune system comprised of a 
repertoire of genetically determined intra- and extra-cellular receptors for pathogen 
detection and induction of defences in response to pathogen attack. The work in this 
project focusses on the intracellular receptors involved in plant innate immunity and 
understanding the mechanism through which these receptors perceive pathogens and 
activate plant defences. This introductory chapter will discuss a broad overview of plant 
immunity focussing on the perception of pathogen effectors by intracellular receptors, 
namely the modular nucleotide-binding, leucine-rich repeat proteins (NLRs).  
 
1.1 Overview of Plant-pathogen interactions 
 
1.1.1 Models for plant innate immunity 
 
Plants are constantly exposed to a wide variety of biotic and abiotic challenges to which 
they must be able to adapt and respond appropriately in order to reproduce successfully. 
Challenge by pathogens such as bacteria, fungi, oomycetes, nematodes and viruses has led 
to the evolution of a multi-layered plant innate immune system which is capable of cell 
autonomous detection of the presence of pathogens leading to activation of defence 
responses within the plant tissue. There are a growing number of models to illustrate this 
multi-layered response with the most current describing two interlinked layers of plant 
innate immunity referred to as the ‘zigzagzig model’1,2, Figure 1.1A. In this model, the 
primary layer of immunological response is initiated at the plasma membrane, where plants 





activation of the first layer of the plant immune response, PTI (Pattern-triggered immunity). 
These receptors are responsible for the detection of pathogen-derived conserved 
molecules, PAMPs (Pathogen associated molecular patterns), as well as plant self-derived 
peptides termed DAMPs (Damage associated molecular patterns) which are believed to act 
as markers of pathogen-induced cellular damage within the host tissue3. To attenuate host 
immune responses, pathogens have evolved to secrete an arsenal of effector proteins 
which suppress host defence responses and facilitate pathogen infection through 
manipulation of host proteins and signalling pathways. However, these effector proteins 
are themselves susceptible to molecular detection by the host plant cell through 
intracellular immune NLR receptors, often encoded by Resistance (R) genes4. Activation of 
NLRs through direct or indirect effector perception, leads to induction of ETI (effector 
triggered immunity) often associated with the programmed cell death hypersensitive 
response (HR), Figure 1.1. 
Figure 1.1 The multi-layered model of plant immunity. (A) Zigzagzig model of plant immunity 
presenting the quantitative output of the plant immune system in four phases. Phase 1 involves 









detection of PAMPs via PRRs resulting in activation of PTI. In phase 2 successful pathogens deliver 
effectors (Avr-Rs) into the host cell which act to attenuate PTI, effector triggered susceptibility (ETS). 
Phase 3 involves detection of pathogen effectors by plant NLRs resulting in activation of ETI. In phase 
4 pathogen isolates which have lost recognised effectors are selected for leading to ETS, figure taken 
from Jones and Dangl, 20065. (B) Representation of the zigzagzig multi layered plant immune system 
in plant cellular context. PAMPs (Pathogen associated molecular patterns), DAMPs (Damage 
associated molecular patterns), PRRs (Pattern recognition receptors), NLRs (Nucleotide-binding, 
leucine-rich repeats). Plasma membrane associated PRRs can take the form of receptor kinases or 
receptor like kinases and often function with co receptors (not shown) which bind PAMPs and 
DAMPs via extracellular LRR domains. NLRs are predominantly intracellular proteins based with a 
largely canonical modular structure.  NLRs can recognise effectors by a number of mechanisms 
discussed in 1.2.  
 
Since the ‘zigzagzig model’ was first postulated, other authors have extended or modified 
this original model as more experimental data has been revealed. For example, the 
‘invasion model’6 avoids a strict definition of PAMPs and effectors in favor of a more 
spectrum-based definition of immunogenic molecules. The ‘invasion model’ refers to 
effectors, PAMPs and DAMPs as invasion patterns (IPs) and both PRR and NLR immune 
receptors as invasion pattern receptors (IPRs) which activate an IP-triggered response. This 
more generalized model, argues against the strict separation of PTI and ETI signalling 
pathways in favour of a broad view of a spectrum-based system evolved to detect invasion 
without the constraints of strict definitions on pathogen-derived molecules.  
 
The strict distinction between widely distributed, conserved PAMPs and race, species or 
strain-specific effectors is increasingly becoming blurred as our understanding of plant-
pathogen interactions evolves7. Additionally, some R-genes have been found to encode 
PRRs, for example the Solanum lycopersicum PRR Cf-9 which confers recognition of the 
Cladosporium fulvum effector Avr98,9.  To accommodate this, a new model referred to as 
the ‘spatial immunity model’ has been proposed10. The model argues that the definition of 
a plant immune response should be determined on the basis of where immunogenic 
molecules are perceived. The model suggests the use of the term extracellular 
immunogenic pattern (ExIP) or intracellular immunogenic pattern (InIP). The spatial 
bipartition in the defining immunogenic molecules allows the differentiation of immune 




extracellularly triggered responses (ExTRs), and intracellular InIPs as intracellularly triggered 
immunity (InTI)10.  
 
Whilst our ever-evolving understanding of the complexities of microbe-plant interactions 
means these models are not likely to represent all examples, such models help to 
conceptualise the intricacies of the interactions between these organisms. For the purposes 
of this study I will refer to the players in plant-pathogen interactions using the terms 
described in the ‘zigzagzig model’, Figure 1.1.  
 
1.1.2 Perception of MAMPS and cell surface immunity 
 
PAMPs/MAMPs are highly conserved throughout the lineages of microbes and through 
their detection provide plants with a mechanism for perceiving and defending against the 
vast majority of pathogenic challenges. PAMPs have been identified across the major 
phylogenetic lineages of plant pathogens. Well described bacterial PAMPs include the 
flagellin peptide flg2211, peptidoglycans12 and elf18 a peptide derived from Elongation 
factor Tu13. PAMPs have also been identified in fungi and oomycetes, for example chitin14 
and heptaglucan15 respectively. 
 
Plant self-derived molecules termed DAMPs are also capable of activating PRRs. DAMPs are 
believed to act as a marker for pathogen-induced cellular damage within the host tissue 
providing an alternative mechanism for extracellular pathogen recognition. 
Oligogalacturonides (oligomers of alpha-1,4-linked galacturonosyl residues) are an example 
of a DAMP released via direct damage caused by invading pathogens16. During host invasion 
many fungi species release cell wall degrading enzymes which release oligogalacturonides 
usually embedded in the matrix of the cell wall. Oligogalacturonides are recognised by PRR 
WAK1 (wall-associated kinase 1) which transduce this perception into a PTI defence 
response17. 
 
PAMPs are released by pathogens proliferating in the apoplast of plant tissue following 
invasion and are subsequently vulnerable to detection by PRRs. There are two major classes 
of PRRs: Receptor kinases proteins (RKs) and Receptor-Like proteins (RLPs). It is believed 
that most RLPs, which lack internal kinase domains, function in conjunction with one or 





Upon binding of PAMPs/DAMPs, PRRs activate a PTI response with some PRRs requiring co-
receptors such as BAK1 (Brassinosteroid Insensitive 1-associated receptor kinase 1) or other 
SERK (Somatic embryogenesis receptor kinases) family members to do so3,18. This results in 
an active signalling complex which activates downstream PTI events including the activation 
of MAPK (Mitogen-activated protein kinase) and CDPK (Calcium-dependent protein kinase) 
cascades, reactive oxygen species (ROS) and reactive nitrogen species generation, resulting 
in large scale reprogramming of the cell transcriptome and metabolome. One such 
downstream target of FLS2 (Flagellin Sensitive 2) is the NADPH oxidase RBOHD (Respiratory 
Burst Oxidase Homologue D) which is phosphorylated by BIK119,20(Botrytis Induced Kinase 
1). This enzyme is responsible for a classic hallmark of PTI, the generation of apoplastic ROS 
burst. ROS have direct roles in defence as antimicrobial molecules as well as important 
immune signalling components. The later stages of PTI involve events such as callose 
deposition, thought to help strengthen plant cell walls against pathogen invasion, and 
redistribution or restriction of water and nutrient availability with the aim of restricting 
pathogen growth.  
 
1.1.3 Effectors and effector-triggered immunity 
 
Whilst PTI appears to be remarkably effective at preventing the majority of non-host 
adapted pathogen colonisations, pathogens have evolved host specific adaptation 
mechanisms to overcome these defences through the secretion of an arsenal of effector 
proteins which largely function to attenuate host immunity, Figure 1.1. The delivery 
mechanism of effectors varies amongst pathogens. Many Gram-negative bacteria use a 
specialised needle-like structure which directly delivers effectors into the host cell, called 
the Type III secretion system21. For example, this mechanism is utilised by bacterial speck 
and blight causing bacteria Pseudomonas syringae and Ralstonia solanacearum discussed 
later in this study. Fungi and oomycetes deliver effectors via haustoria 22, a specialized 
feeding structure which extends through the plant cell wall and forms an intimate 
association with the host cell membrane, whilst nematodes utilise a specialized proboscis 
called a stylet for effector delivery23. Alternatively, a subset of pathogens secrete effectors 
into the apoplast of the host, for example C. fulvum 24. 
 
Adapted pathogens deliver an arsenal of effectors into hosts which attenuate host defences 
and support pathogen proliferation, imposing effector-triggered susceptibility. Effectors 




virulence strategy. Yeast two-hybrid interactome network studies have noted a 
convergence of effectors from distinct pathogens targeting an overlapping subset of highly 
interconnected host protein ‘hubs’25. For example, the PRR receptor complex is a common 
target of effectors26–28. In order to detect the presence of effectors, plants have evolved 
intracellular R-protein immune receptors encoded by R genes. R-protein perception of 
effectors leads to induction of ETI. Whether ETI is a distinct signalling mechanism or a 
potentiator of PTI signalling is still debated but the two layers of immune signalling do 
appear to be interlinked. Activation of ETI, in the presence of PTI, leads to induction of a 
form of programmed cell death referred to as the hypersensitive response (HR) which is 
thought to aide immunity by constricting pathogen growth in the plant tissue.  
 
Most R genes encode NLRs. NLRs are capable of recognizing effectors directly or indirectly 
and can function both singly or in a pair, see section 1.2. The canonical structure of NLRs 
consist of: a TIR (Toll/interleukin 1-receptor) or CC (coiled-coil) class defining N-terminal 
domain29; a nucleotide binding NB-ARC (Nucleotide-binding domain found in Apaf1, R 
proteins and CED4 ) domain and a C-terminal LRR (leucine rich repeat) domain4,30,31. Plant 
genomes contain hundreds of NLR proteins likely due to strong selection for novel 
pathogen recognition capabilities. NLRs are believed to be the most rapidly evolving gene 
family in the plants with 126 NLRs presently reported in the Col-0 accession of Arabidopsis  
thaliana alone32. 
 
Animals also utilize NLRs for activation of innate immunity. Animal NLRs share a similar 
modular domain architecture with plant NLRs which is thought to have evolved 
independently but convergently in the two kingdoms33. Many animal NLR domain 
structures comprise; LRRs, a CARD (caspase activation and recruitment domain) or PYD 
(pyrin domain) N-terminal domain which activates downstream signalling and a NACHT 
nucleotide binding which enables activation of the NLR complex33,34. Upon activation by 
detection of pathogen-derived ligands, some mammalian NLR proteins form an oligomeric 
wheel-like structure referred to as an inflammasome. The structure of one inflammasome 
involving the NLR NLRC4 (NLR family CARD domain-containing protein 4) and NAIP2 (NLR 
family, apoptosis inhibitory protein 2) has now been solved using cryo-electron 
microscopy35. Given the modular similarities between the two kingdoms NLRs, advances in 
understanding mammalian NLR structure and function have long been used to make 





1.2 Models for effector perception by NLRs 
 
NLR proteins are involved in the induction of an ETI response upon the detection of 
effectors. This perception can occur through direct binding of an effector to an NLR or 
indirectly through detection of an effector’s perturbations of the host plant cell, for 
example phosphorylation or cleavage of host target protein by an effector Figure 1.2.  
 
1.2.1 Direct recognition of effectors 
 
The direct recognition model for NLR effector perception biochemically expands on Flor’s 
gene-for-gene hypothesis37. The model describes a receptor-ligand mechanism via which 
direct binding of an effector to an NLR activates induction of an ETI response38, Figure 1.2A. 
It is thought this plant-pathogen interaction is largely facilitated through the polymorphic 
NLR LRR domain. The effector-NLR pair of ATR1 and RPP1 is an example of such a 
Figure 1.2 Four models of NLR effector perception mechanisms. NLRs can perceive effectors in a 
variety of ways. Current models include: (A) Direct recognition where NLRs bind effectors directly 
commonly via NLR’s LRR domain; (B) Guard model in which an NLR monitors host proteins for 
effector induced perturbations; (C) Decoy Model in which an NLRS monitors a decoy mimic of 
authentic host targets and (D) The Integrated Domain model where decoy domains can be 
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recognition mechanism by an NLR. A. thaliana NLR RPP1 has been shown to directly bind 
the oomycete Hyaloperonospora arabidopsidis (the causal agent of downy mildew) effector 
ATR1 via RPP1’s LRR domain and activate ETI in a ligand-dependent manner39. Similarly, 
recognition of Melampsora lini effector AvrL567 by the L5 and L6 flax TIR-NLRs occurs 
directly via multiple contact points in the NLR's LRR domain with assistance from the N-
terminal TIR domains40,41.  
 
1.2.2 The Guard model of recognition 
 
In addition to binding effectors directly, NLRs can also survey host proteins in the plant cell 
for perturbations induced by an effector’s virulence activity in a scenario described as the 
‘Guard model’1 e.g. host protein cleavage by an effector, Figure 1.2B. This model also 
describes how one NLR can monitor for the presence of multiple effectors through a 
guarding a common virulence target of several effectors. This allows plants to monitor for a 
range of pathogens via a limited repertoire of NLRs. 
 
A key example of the ‘Guard’ mechanism of NLR recognition is the A. thaliana guardee 
protein RIN4. RIN4 is a small, unstructured protein seen to associate with PRR complexes 
and act as a scaffold in both PTI and ETI signalling. It is the virulence target of multiple 
effectors and monitored by the ‘Guard’ NLRs RPM1 and RPS2. The effector AvrRpt2 from P. 
syringae cleaves RIN4 as part of its virulence strategy. This cleavage event can be detected 
by RPS2 and leads to activation of RPS2-mediated ETI defences42,43. The P. syringae 
effectors AvrB and AvrRpm1 also target RIN4 by up regulating expression of RIPK which 
phosphorylates RIN4 residue T166. Phosphorylation of RIN4 at this residue is perceived by 
RPM1 and leads to activation of ETI44,45. In this way both RPM1 and RPS2 can indirectly 
perceive a pathogen challenge through monitoring a virulence target of effectors for 
perturbations44. Interestingly, the effector HopF2 has evolved to ADP-ribosylate RIN4, 
hypothesised to inhibit accumulation of S141 phosphorylated RIN4 which promotes PTI 
without increasing phosphorylation of RIN4 residue T166 monitored by the NLR RPM1 
thereby evading NLR detection46. This example highlights an on-going evolutionary arms 







1.2.3 The Decoy hypothesis 
 
A variation on the ‘Guard model’ of NLR activation is the ‘Decoy model’47. This model is 
similar to the guard model in that NLRs detect the virulence functions of effectors and the 
host proteins they target as a proxy for effector detection. However, instead on monitoring 
the authentic host effector target protein ‘Decoy model’ NLRs monitor a virulence target 
mimic for effector-induced perturbations, Figure 1.2C.  
 
Through utilisation of this mechanism a single structural decoy or ‘effector bait’ monitored 
by one or more NLRs can protect a whole family of effector target proteins. For example, 
the NLR Prf is kept in an autoinhibited state by the kinase Pto. Pto is cleaved by the effector 
AvrPto releasing Pto’s inhibition of Prf and activating defence48,49.  Pto itself is not known to 
have a direct role in plant resistance but it shows great homology to several other kinase 
domains involved in immunity, namely those of PRR receptors FLS2 and EFR26. Similarly, 
RPS5 guards the decoy PBS1 which negatively regulates the NLR50,51. AvrPphB targets PBS1 
and cleaves the protein allowing RPS5 immune defence response induction28. PBS1 has 
been shown to play no role in immunity but shows structural similarity to several other 
virulence targets of AvrPphB which do play important roles in immune signalling including 
BIK126,28.  
 
1.2.4 Integrated domain NLRs 
 
Whilst direct effector perception within the canonical NLR structure is classically associated 
with effector interactions with the LRR domain39,40, it is estimated that between 3-10% of 
plant NLRs utilize non-canonical domains termed ‘integrated domains’52,53 to perceive 
effectors. Integrated domains are believed to have evolved from the host targets of 
effectors and facilitate direct binding of effectors to NLRs by acting as bait for pathogen 
effectors54,55, Figure 1.2D. 
 
Whether these integrated domains are actually true ‘decoys’ retaining none of their 
template host protein’s biological function themselves is still controversial56. The 
‘integrated decoy’ model54 implies the non-canonical domain integrated into the structure 
of the NLR has lost its original biochemical function and acts solely as a structural mimic in 
effector sensing. However, this is not the case for all integrated domain NLRs as the 




like the WRKY transcription factors the domain mimics57,58. Subsequent authors proposed 
that the term ‘integrated decoy’ should be replaced with ‘sensor domain’ in order to fully 
incorporate the possibility that at least some of these integrated domains may retain their 
ancestral biochemical function, perhaps even for only a short time in their evolutionary 
history59. The authors argue that as the identity or biochemical function of many of the 
ancestral effector targets or integrated domain NLRs have yet to be identified it is not 
possible to label these domains simply as biochemically inactive decoys. Furthermore, the 
evolution of these integrated domain NLRs still remains unclear and it is entirely possible 
that fully functioning effector target domains may become fused into the structure of NLRs 
before subsequently losing the ancient biochemical function. This would suggest that more 
recent NLR atypical domain fusions may not have yet evolved to lose this function and 
become a true ‘decoy’ 56. Some have argued however against the use of the term ‘sensor 
domain’ noting the term ‘sensor’ does not fully convey the principle that these domains are 
mimicking functional host target template of the integrated domains60. It has therefore 
been suggested that ‘integrated domains’ may be a more appropriate term as this 
incorporates the concept of an atypical domain fusion into the NLR structure without 
assigning a function to the domain 52 and is the term utilised in this study.  
 
Several bioinformatics studies have highlighted the diversity of NLR integrated domains 
with evidence of such integration events occurring in phylogenetically unrelated monocot 
and dicot lineages as well as at least one moss species (Physcomitrella patens)52,53. 
Bioinformatic studies predict that the most common atypical domains to be structurally 
integrated into NLRs are Pkinase domains as well as the DNA binding WRKY and Zf-BED 
domains52,53. Pkinase and WRKY domains have classically been associated with plant 
immunity signalling and increasing evidence is emerging for the role BED domain-
containing proteins play as well53,61–63. This finding strongly supports the concept postulated 
by the ‘integrated domain’ model that domains integrated into NLRs would be linked to 
playing important roles in plant immunity and hence targeted by effectors. Several NLRs 
containing these atypical domains have already been cloned. For example: the wheat stem 
rust resistance (Puccinia graminis) NLR RPG5 cloned from Barley (Hordeum vulgare) 
contains an integrated protein kinase domain64; Integrated WRKY domains have been 
identified in the NLR RRS1 which functions in a pair with RPS4 to recognise effector from P. 
syringae, R. solanacearum and Colletotrichum higginsianum65,66 and ZfBED domains were 
found in the cloned Oryza sativa resistance NLR Xa1 which recognises an unknown bacterial 





Integration of these domains appears to commonly occur in pairs of genetically linked NLRs 
which function together to elicit an immune response. For example, in the A. thaliana NLR 
pair utilised in this thesis (RRS1 and RPS4) the sensor NLR RRS1 contains an integrated 
WRKY domain65,66 and in the well-studied Oryza sativa NLR pair Pikp-1 and PikP-2, PikP-1 
contains an integrated Heavy-metal associated (HMA) domain68,69. As demonstrated in 
these two integrated NLR pairs, the location of the integrated domain in the structure of an 
NLR is not consistent, with the HMA domain of PikP1 found between the CC and NB-ARC 
domain and WRKY of RRS1 at the C-terminus of the protein, Figure 1.3. This may reflect 
different intra- and inter-domain interactions involved in the activation mechanisms for 
NLRs of this variety. It is likely given the variation in modular domain layout that binding of 
an effector to the integrated domain of an NLR may have a different effect on the intra and 
inter molecular interactions with other NLR domains. This suggests that there will not be a 
single step-by-step activation mechanism of all integrated domain NLRs rather a variety of 
paths utilised by different NLRs to transduce effector signalling into defence activation. 
Such differences in activation and inter-domain interactions can even be demonstrated 




Figure 1.3 Variations in modular domain structure of integrated domain NLRs. Modular structure of 
NLRs RRS1, PikP1 and RGA5 that contain an integrated WRKY and HMA (Heavy metal associated) 
integrated domain respectively demonstrating that the site of integrated domains (highlighted in 
yellow) can vary between NLRs. Size of domains is not to scale.  
 
Understanding the structural basis of NLR integrated domains recognition of effectors is a 
key step in enabling the future engineering of synthetic NLRs with expanded recognition 
capabilities. The structures of several NLR integrated domain-effector complexes have now 
been solved including the Magnaporthe oryzae effector Avr-PikD bound to the HMA 
domain of PikP170 and R. solanacearum PopP2 bound to the integrated WRKY domain of 
TIR NB-ARC LRR Dom4 WRKY Dom6SRRS1
CC NB-ARC LRRHMAPikP1




RRS171, the latter of which interactions are further discussed in 1.5.2 and 5.1. 
Understanding effector-integrated domain binding events at the structural level allows us 
to begin to understand the constraints and requirements of effector recognition by 
integrated domain NLRs which can then be used to guide future engineering of synthetic 
NLRs. There is also evidence that integrated domain NLRs can interact with pathogen 
effectors via domains outside of their defined integrated domain. This is demonstrated by 
the ability of the M. oryzae effector AVR-Pia to interact with O. sativa NLR RGA5 at sites 
both within and outside of RGA5’s integrated HMA domain72. The mechanistic relevance in 
terms of effector perception and NLR regulation of these non-integrated domain 
interactions is not yet understood72 but successful engineering of synthetic NLRs with 
expanded effector recognition capability will likely rely on a comprehensive understanding 
of the entire interaction surface between NLRs and effectors.  
 
1.3 The domain structure of NLR proteins 
 
NLRs are modular proteins largely consisting of three classical domains73: a N-terminal CC 
or TIR domain74; a central NB-ARC ATPase domain75 and a C-terminal LRR. Many NLRs show 
structural variations to this domain pattern including domain duplications and deletions as 
well as integration of non-canonical domains such as integrated domain NLRs, discussed in 
section 1.2.4, which contain a variety of non-canonical domains such as WRKY, BED and 
HMA domains. Truncated NLRs have also been identified such as the TIR only Arabidopsis 
NLR RBA176.  
 
1.3.1 Class defining N-terminal domains 
 
NLRs can be categorized into one of two monophyletic groups based upon the nature of 
their N-terminal domains: TIR domain NLRs (TNLs) found only in dicots and CC domains 
NLRs (CNLs) present in both monocots and dicots74,77. There is a second small subclass of 
the CNLs which do not possess the negatively charged ‘EDVID’ motif found in the rest of the 
CNLs class. Instead this group shows strong homology for the non NLR R protein RPW8 
(Resistance To Powdery Mildew 8) and are therefore categorised as CCRPw8 NLRs78,79. This 
CCRPw8  class of NLRs also shows difference to the rest of the CNLs in their NB-ARC domains 
and are thought to form a monophyletic anciently diverged clade within the NLRs29,80. The 




expression of only the N-terminal domains from a variety of NLRs capable of inducing an HR 
in planta78,81,82.   
 
Through the solving of multiple NLR TIR domain structures two putative dimerization 
interfaces have been identified in this domain. These two interfaces are clearly highlighted 
in the crystal structure of A. thaliana NLR SNC1’s TIRs: the DE interface and AE interface 
83,84, see Figure 1.4 . Mutations in either of these TIR dimerization interfaces were found to 
disrupt the cell death instigating abilities of the SNC1, L6 and RPS4 TIR domains as well as 
full-length L6 and RPS4 highlighting the importance of these interfaces in the ability of the 
NLR to invoke an immune response84. It was subsequently postulated that dimerization of 
the TIR domains may allow the TIR domains to signal for an immune response via signalling 
through cooperative assembly formation (SCAF)85. 
  
It appears these AE and DE interfaces can be widely found throughout TNLs with similar 
interfaces also being identified in the Arabidopsis NLR RPP184. Identification of these two 
dimerization interfaces has led to the development of the hypothesis that these interfaces 
may allow TNLs to oligomerise via their TIR domains forming oligomeric structures similar 
to those seen in mammalian NLRs85. It should be noted however that these observations 
Figure 1.4 Multiple self-association interfaces of the TIR domain. The SNC1 TIR crystal structure 
reveals two self-association interfaces, the DE interface αD and αE regions of the protein and AE 
interface involving the αA and αE regions. In the SNC1 TIR structure, Molecule A and B were 
observed in the asymmetric unit and interact through the AE interface; and molecules A and C 
interact with a crystallographic symmetry-related molecule through the DE interface.Figure taken 




are purely based of models of the TIR domains alone and do not include the effects that 
other NLR domains may have on the formation of this oligomer in terms of domain 
arrangement or stoichiometry. Though several NLRs have been observed to self-associate 
upon activation in planta82,86, the downstream signalling importance of dimerization or 
oligomerisation of plant NLRs upon activation has yet to be fully understood33.  
What has been observed for several NLRs is that transient over-expression of the N-
terminal domains of NLRs alone can result in a cell death response in cells. This has been 
demonstrated for both TNLs (RPS4, N, RPP1, L10, L6)30,39,87–91 and a subset of CNLs (MLA, 
NRG1, ADR1)78 demonstrating this domains’ role in at least some NLRs as activators of 
downstream signalling pathways. This is not observed however in the case of all NLRs. 
Overexpression of the potato NLR Rx NB-ARC domain alone is sufficient to induce cell death 
in N. tobacum90. Conversely, the expression of the CC or NB-ARC domain of RPS5 was 
observed to not be capable of inducing HR. However, when expressed together these two 
domains did induce an HR response in the plant tissue suggesting the CC and NB-ARC39 
work together in RPS5 to activate downstream defences91. Whether these findings however 
are due to variations in method of NLR activation or experimental procedure (e.g epitope 
tags or expression levels) still needs to be assessed30. 
 
Recent observations have also suggested that plant TIR domains may possess NADase 
activity92,93. For example, the TIR domains of RUN1 and L6 were observed to cleave NAD+ 
into Nicatinamide and ADPR. What role this possible NADase activity plays in downstream 
signalling however is not yet understood92. Notably, NADase biochemical activity was not 
observed for all NLR TIR domains including RPS4, SNC1, RPP1 and ROQ1.  
 
Several structures of CC domains have been published and are hypothesised the capture 
the different activation state conformations of NLR CC domains. The structure of Sr33’s CC 
domain (four helix bundles) shows close similarities to unrelated CC domain of Rx and is 
thought to capture the inactive monomeric state of a CC domain. Conversely the dimer of 
two elongated antiparallel helix-turn-helix monomers of MLA10 CC domain is thought to 








Structurally related to the nematode Caenorhabditis elegans cell death regulator CED497
 
and Homo sapien Apaf-1 domain98, the plant NLR NB-ARC domain consists of three 
subdomains: NB (Nucleotide-binding), ARC1 and ARC2. Interestingly plant NLR NB-ARC 
domains have lost the fourth ARC3 domain found in the H. sapien protein Apaf-1.  The NB 
domain is comprised of five-stranded parallel β sheets surrounded by seven α helices. The 
ARC1 domain consists of four α helix bundles whilst the ARC2 domain adopts a winged helix 
fold. Plant NLR NB-ARC domains have ATPase activity and contain a number of conserved 
motifs including: hhGRExE, P-loop (Walker A), Walker B, GxP, RNBS-A to D, and MHD 
motifs99,100. Through structure-informed mutagenesis the roles of a number of these motifs 
has been investigated. The NB subdomain P-loop motif contains a conserved lysine residue 
in the consensus sequence GxxxxGKS/T which is key for nucleotide interactions binding α 
and γ phosphates. In mammalian APAF-1 the MHD motif in the ARC2 subdomain has been 
found to interact with β phosphate of the bound nucleotide whilst the NB Walker B motif is 
thought to be responsible for nucleotide hydrolysis. The RNBS-C motif marks the distinction 
between the NB and ARC1 domain whilst the hhGRExE links the NB to the N-terminal 
domain and is involved in conformation changes of the protein in APAF-1100, see Figure 1.6.  
 
the CC domain of the potato NLR Rx (resistance to potato virus X),
had a much more compact shape: a monomer of four helices
folded back on themselves (13). One important difference be-
tween the structures is that Rx was crystalized as a heterodimer
with an interacting partner, Ran GTPase-activating protein 2 (Ran-
GAP2). At the time, it was unclear if the major differences between
MLA10 and Rx were due to differences in sequences or if the
presence of the interacting protein promoted a different confor-
mation for Rx (potentially the off-state, unperturbed by a patho-
gen trigger). Now, Casey et al. (2) have provided a third option by
generating an NMR solution structure for the CC domain of Sr33.
Sr33, an ortholog of MLA10, confers resistance to the Ug99 strain
of wheat stem rust, a rapidly emerging threat to global wheat
production (14).
Unexpectedly, the structure of the Sr33 CC looks much more
like the distantly related Rx than its true ortholog MLA10 (Fig.
1A). Like the Rx CC, the Sr33 CC also adopts a compact bundle
of four α-helices packed back upon themselves. The Sr33 CC
structure is also monomeric, indicating that CC domains, as pu-
rified proteins, can form this tetracoil fold in the absence of
associated proteins like RanGAP2. Casey et al. (2) verified that
the MLA10 structure is robust to the vagaries of protein purifi-
cation and crystallization. They were able to reproduce a very
similar elongated dimer structure, albeit with slightly different
contacts between the monomers. However, the story in solution
was different. In solution, when assayed by light scattering as-
says [size exclusion chromatography (SEC)-coupled multiangle
light scattering and SEC-coupled small-angle X-ray scattering],
the CCdomains of Sr33, Rx, andMLA10 all behaved likemonomeric
proteins of the compact Rx/Sr33-like fold. The authors used equiv-
alent constructs (MLA105–120 and Sr336–120), so the length of the
construct itself is not generating the structural difference. Then, why
is the MLA10 crystal structure so different?
One possibility is that the elongated MLA10 structure is
merely an artifact of crystallization. Perhaps MLA101–120 is in-
trinsically less likely to form a monomer than Sr331–120. If unable
to form the monomer, the MLA10 CC could pack itself in the
crystal to bury its exposed hydrophobic surfaces as a dimer. This
hypothesis could explain how an incorrect structure identified
hydrophobic residues that are both conserved and required
for function in MLA10. The fact that the new MLA10 dimer
structure generated by Casey et al. (2) is packed slightly offset
from the original is perhaps consistent with a hypothesis of
expediency.
An intriguing second hypothesis is that the elongated MLA10
structure, rather than being incorrect, just reflects a different
functional state for the CC domain. This hypothesis is supported
by discrepancies between what we know about the dimerization
state in the crystal and the multimerization state in planta. MLA10
CC crystalizes as a dimer. However, this CC truncation is inactive
in planta. The longer MLA101–160 form is autoactive, and muta-
tional analysis shows that dimerization is required for function. The
longer Sr33 CC in vitro is a monomer; however, in planta, it is also
a dimer. Hydrophobic residues equivalent to those residues de-
fined in MLA10 are required for both Sr33 function and dimeriza-
tion. One way to square these results is if the Rx/Sr33 four-helix
structure represents the monomeric off-state for the CC domain
and the MLA10 structure is revealing the dimeric on-state. The
central two helices of the Sr33 structure and oneMLA10monomer
overlap reasonably well, with similar positioning of important hy-
drophobic residues (Fig. 1B, teal). To switch from one state to
another requires straightening turn 1 and turn 3 to reposition helix
1 and helix 4, respectively. These structures present a hypothesis
for how CC domains could flip back and forth between inactive
monomers and active dimers. The surfaces that are stabilized by
helix–helix interactions in the compact monomer are protected in
the dimer by a helix from the partner molecule. One caveat to this
hypothesis is that the MLA10 dimer defined by the crystal struc-
ture is nonfunctional in planta, so this hypothetically “active”
dimer structure is incomplete.
While analyzing the function of the structurally determined CC
domains (i.e., truncations at amino acid 120), Cesari et al. (1) found
that CC domain length is critically important. They provide func-
tional data showing that short MLA101–120 or Sr331–120 constructs
are unable to trigger autoactive cell death, whereas longer 160-aa
constructs are functional (1). The longer forms also had a higher
Fig. 1. (A) MLA10 (P otein Data Bank ID cod 3QFL; blue an white)
was the first plant NLR CC domain crystalized. It crystalized as an
elongated dimer, stabilized by hydrophobic residues. The second
plant CC domain structure is the Rx protein (Protein Data Bank ID
code 4M70; yellow). Rx crystalized as a compact monomer, with a
four-helix bundle. Th NMR structure of the Sr33 CC (Protein Data
Bank ID code 2NCG; green) indicates that it is folded similar to Rx,
despite being more closely related to the MLA10 CC [∼78% identical
(Id.) to MLA10, ∼20% identical to Rx]. S veral hydr phobic residues
shown to be important for MLA dimerization are conserved in Sr33,
likely stabilizing the monomer fold (shown in cyan). (B) Hypothetical
CC conformation switch between an inactive off monomer and an
active on dimer. Helices are labeled from the N terminus to C terminus
(red, orange, yel ow, a d green). Approx mately 180° straightening of
turns attached to helix 1 (red) and helix 4 (green) might allow an
Rx/Sr33-type CC fold to switch into a MLA10-like dimer. Conserved
hydrophobic residues are shown in cyan. The top structure is the Sr33
NMR structure, and the bottom structure is the Sr33 CC domain
modeled onto one-half of the MLA10 dimer (other monomer in white).
MLA10 dimer helices are color-coded as in the Sr33 monomer.





















Figure 1.5 The activation structures of plant NLR coiled-coil domains. Elongated dimer of 
MLA10 CC domain (Purple/white-PDB 3QFL) is thought to represent an active state whilst the 
compact monomer structure of Sr33 CC (Green-PDB 2NCG) and Rx CC (Yellow-PDB 4M70) are 
predicted to represent the inactive state. Amino acid sequence identity of protein’s CC domains 








Plant NLR LRR domains are highly polymorphic and contain varying number of repeats 
based around the consensus motif of hydrophobic leucines interspersed with hydrophilic 
residues (LxxLxLxxN/CxL) as well as non-canonical LRR motifs. The repeating leucine motifs 
form a parallel β-sheet at the concave side of an arc shaped structure with the leucine 
residues forming the hydrophobic core, see Figure 1.7. Classically associated as the effector 
binding domain of direct recognition ligand-receptor NLRs, the hyper variability of this 
region and the highly adaptable exposed surface utilised in LRR protein-protein interactions 
mean this domain is primed for rapid evolution of new recognition specificities39.  
 
Classically associated with being a protein-protein interaction domain, the role LRRs play in 
NLR activation appears to vary, largely facilitated by the domain’s large exposed adaptable 
surface. Co-immunoprecipitation experiments suggest that in addition to playing a crucial 
role in the perception of effectors in the case of direct recognition NLRs39,40 the LRR domain 
also has a pivotal role in maintaining the NLR in an auto-inhibited state in the absence of 
effectors51. For example, the LRR domain of RPS5 has been observed to associate with the 




Structurally related to the C. elegan cell death regulator CED471 and Homo sapien  Apaf-1 
domain72, the NLR NB-ARC domains consist of three subdomains: NB, ARC1 (Apaf-1, 
Resistance protein, CED4 1) and ARC2. Interestingly NLR NB-ARC domains have lost the 
fourth ARC3 domain found in Apaf-1. The NB-ARC domain and therefore NLRs 
themselves belong to the STAND (Signal Transduction Adenosine Triphosphatases) family 
of NTPases. It is hypothesised that the NB-ARC domain acts as a hydrolysing switch in 
NLR regulation, coupling nucleotide binding with conformational changes within the NLR 
and transduction of defence signalling downstream (See section 1.4)73.   
 
Plant NLR NB-ARC domains have ATPase activity and contain a number of 
conserved motifs including: hhGRExE, P-loop (Walker A), Walker B, GxP, RNBS-A to D, 
and MHD motifs74,75. Through structured informed mutagenesis the roles of a number of 
these motifs have been hypothesised. The NB subdomain P-loop motif contains a 
conserved lysine residue in the consensus sequence GxxxxGKS/T which is key for binding 
α and γ phosphates. In mammalian Apaf-1 the MHD motif in the ARC2 subdomain has 
been found to interact with β phosphate of the bound nucleotide whilst the NB Walker B 
motif is thought to be responsible for nucleotide hydrolysis. The RNBS-C motif marks the 
distinction between the NB and ARC1 domain whilst the hhGRExE links the NB to the N-
terminal domain and is involved in conformation changes of the protein in Apaf-175. As 
there are currently no resolved crystal structures of plant NLR NB-ARC domains, the 
crystal structures of Apaf1, CED4 and other STAND ATPases can be used for homology 
modelling purposes of this domain (Fig. 9).  
 
Figure 9 (A) Structural model for NB-ARC domain of NLR I-2 based on structural template 
of ADP bound human Apaf-1116, (B) General topology of NB-ARC1-ARC2 domain based on 
crystal structure of Apaf-1, The NB domain is comprised of five-stranded parallel β sheet 
surrounded by seven α helicies. The ARC1 domain consists of four α helix bundles whilst the 
ARC2 domain adopts a winged helix fold cylinder represent α helices and arrows β sheets75 
In an ADP-bound conformation, the MHD aspartate
may contact the so-called sensor I arginine through a salt
bridge (as predicted by the WHAT-IF server). This
conserved arginine (APAF-1 R265, corresponding to
R313 in I-2; Fig. 7) in the sensor I motif senses the
presence of a c-phosphate on the bound nucleotide in
related AAA+ proteins and relays this information to other
domains of the protein (Ogura and Wilkinson, 2001).
Because only the ADP-bound structure has been solved
for APAF-1, it is not known how it sen es a c-phosphate,
but the corresponding arginine directly interacts with the
c-phosphate in the crystal structure of ATP-bound CED-4
(Yan et al., 2005). The sensor I maps to the NB
subdomain and is hallmarked by the hhhhToR signature,
which is referred to as the RNBS-B motif in plant R
proteins (Meyers et al., 1998) (Fig. 6). The importance of
this motif was suggested by loss-of-function mutations of
the two neighbouring threonine amino acids in Rpm1 and
Prf (Salmeron et al., 1996; Tornero et al., 2002) (Fig. 6),
which could result in a side chain dislocation of the
adjacent sensor I arginine. Direct proof for functional
importance of the sensor I arginine was shown here by its
substitution for an al ine. As shown in Fig. 8A, thi
mutation results in a loss-of-function phenotype. In light
of this mutation of he MHD, aspartate might not only
directly affect ADP binding through a delocalization of
the preceding histidine, but could also lead by itself to
a more open conformation of the NB-ARC as it can no
longer interact with sensor I. An open conf r ation
would result in weaker binding of ADP, allowing
exchange for ATP and resulting in R-protein activation.
To conclude, the MHD histidine may be in direct
contact with the ADP, and its mutation could directly
destabilize the inactive ADP-bound protein complex,
allowing nucleotide excha e and activation of the pro-
tein. Mutation of the aspartate could dislocate the histidine
making it less effective in repressing the R protein and/or
negatively influence the interaction between the NB and
ARC2 subdomains, thereby destabilizing the closed,
inactive protein conformation.
Implications of the I-2 structural model on residues
outside the MHD motif
The availability of a structural model of the NB-ARC
domain of R proteins allows the formation of hypotheses
on the molecular mechanism underlying autoactivation
phenotypes induced by mutation of residues outside the
MHD motif. Most autoactiva ing muta io s in R protein
map to the interface of the NB and the ARC2 subdomains,
such as I-2S233F, I-2D283E, Rps5D266E, RxD399V, and
Fig. 7. Structural model of the NB-ARC domain of I-2. Computationally derived 3D structure model of the NB-ARC domain of the resistance
protein I-2. The model was created using the ADP-bound structure of human APAF-1 (PDB code 1z6t, chain A) as structural template for I-2. The
locations of R-protein motifs are marked with arrows. Amino acids of the MHD motif as well as the sensor I arginine are shown in stick
representation. ADP atoms are depicted as balls and sticks. Subdomain colouring: NB, red; ARC1, green; ARC2, blue. Atom colouring: oxygen, red;
nitrogen, blue; phosphorus, orange.
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(NB)-ARC because it is shared between R proteins and
the apoptotic regulators human apoptotic protease-acti-
vating factor 1 (APAF-1) and its Caenorhabditis elegans
homolog CED-4 [15]. Proteins that have an NB-ARC
domain are evolutionary related to the mammalian
NACHT-LRR (NAIP, CIITA, HET-E, TP1) proteins
(NLRs), many of which also function in innate immunity
[16,17,18!]. Both NB-ARC and NLR proteins belong to
the STAND (signal transduction ATPases with numer-
ous domains) family of NTPases [18!]. The nucleotide-
binding domain of these proteins is proposed to work as
an NTP-hydrolyzing switch, regulating signal transduc-
tion by conformational changes [18!].
In this review, we focus on the regulatory role of the NB-
ARC domain in NBS-LRR proteins and its proposed
function as a molecular switch. Since no three-dimen-
sional (3D) structures are available for NBS-LRR pro-
teins, comparisons are made with two metazoan NB-ARC
proteins whose crystal structures have recently been
solved, APAF-1 and CED-4 [19!!,20!]. To provide a link
between structure and function, known autoactivating
and loss-of-function mutations in the NB-ARC domain
of NBS-LRR proteins (Figure 1 and Supplementary
table) are mapped onto the 3D structures of APAF-1
and CED-4 (Figure 2). In agreement with recent models
[21], NBS-LRR proteins are proposed to work as dynamic
signalling molecules, performing reversible intra- and
intermolecular interactions. The outcome of these inter-
actions determines whether a plant activates its defence
responses.
Structural features of the NB-ARC domain
As suggested previously, the APAF-1 and CED-4 crystal
structures [19!!,20!] are highly similar to that of AAA+
384 Biotic interactions
Figure 1
Architecture of the NB-ARC1-ARC2 domains. (a) General protein
topology of the NB-ARC1-ARC2 domains as derived from the APAF-1
crystal structure (cylinders and arrows represent a-helices and b-
strands, respectively) [19!!]. The central b-sheet in the NB domain is
formed by five b-strands (cyan), which adopt a 2-3-4-1-5 topology, and
is surrounded by seven a-helices (red). The b-strands b1 and b3
encompass the Walker A (orange line) and Walker B motifs, respectively.
The ARC1 and ARC2 domains are shown in purple and dark blue,
respectively. (b) Mutations of the R proteins I-2, N, L6, Prf, RPM1, RPS2,
Rx, SSI4 are mapped onto the aligned NB-ARC1-ARC2 domain
structures (red, purple and blue boxes) of APAF-1 and CED-4. Sequence
motifs that have been described in other publications are annotated (see
also Table 1). Autoactivating mutations are highlighted in green, loss-of-
function mutations in yellow. Mutations and the corresponding sequence
positions of APAF-1 (CED-4) are linked by horizontal lines. Black-
coloured text in orange boxes indicates nucleotide-binding amino acids
in APAF-1/CED-4 [19!!,20!]. Orange-coloured sequence positions of
APAF-1/CED-4 represent amino acids that form part of the active site
and thus might affect nucleotide binding and hydrolysis, even though
they have not been reported to be involved directly in nucleotide binding.
The locations of a-helices and b-strands (red cylinders and blue arrows,
respectively) are derived from the crystal structure of APAF-1 [19!!]. All
mutations together with literature references are listed in the
Supplementary table, which additionally maps RPM1 loss-of-function
mutations that were not found in specific sequence motifs.
Current Opinion in Plant Biology 2006, 9:383–390 www.sciencedirect.com
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Figure 1.6 Model of plant NB-ARC doma n structure and motifs. Structural model for NB-ARC 
domain of NLR I-2 based on structural template of ADP bound human Apaf-1. Subdomains are 







effector. This interaction is reliant on the first four LRRs of RPS5. A similar mechanism has 
been predicted for the mouse NLR NLRC4 based of the crystal structure of the protein. In 
the case of NLRC4 suppression of the NLR signalling activity is thought to be dependent on 
the LRRs domain negative suppression of NLRC4’s NB-ARC domain101,102. 
 
 
1.4 NLR activation and signalling 
 
1.4.1 Inter- and intra-molecular interactions of NLR activation 
 
Until the recent publishing of the Arabidopsis NLR ZAR1 structure, models of NLR activation 
were largely based on biochemical data, single domain structures and inference from 
mammalian NLRs. Now, utilising the information from the structure of CC-NLR ZAR1 and 
previous biochemical observations, a model has been put forward for NLR activation. 
However, it should be noted that whilst the broad principles of this model might apply to 
most NLRs it is not likely to represent all NLRs universally given the diversity of plant NLRs 
and effector perception strategies, see section 1.2.  
 
The ATPase function and nucleotide binding status of NB-ARC domains has long been 
proposed to be the regulator of NLR activation acting as a form of molecular switch 103,104. 
In this model,  nucleotide binding and exchange is coupled with conformational changes 
























1.3.1 N-terminal domains 
 
Based upon the sequence of the N-terminal stretch of NLRs prior to the NB-ARC domain, 
NLRs can be categorised into two monophyletic groups: the TIR-NLRs (TNLs) found only 
in dicots and CC-NLRs (CNLs) present in both monocots and dicots (Fig. 6)59,60. This 
nomenclature is based around the presence of a TIR (Toll/interleukin 1-receptor) or coiled-
coil (CC) domain in the NLR’s N-terminal region. The N-terminal region has been shown to 
play an important role in defence signalling in many NLRs with transient expression of 
these domains in isolation capable of inducing an HR immune response in plants (See 
section 1.4).  
2 Biotic interactions
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Current Opinion in Plant Biology
Structural models of domains found in NB-LRR proteins. (a) Structural domains of TNLs and CNLs and their estimated dimensions (Å). The 3D model
of CCMla10 and TIRL6 are based on a crystal structure, whereas the 3D structure of the NB-ARCMla10 and LRRLr10 are prediction models [3
!!,4!!,6!]. NB-
ARCMla10 was modelled after ADP-bound Apaf1 (1z6tA [10]). (b) Hypothetical models for the folding of CNLs and TNLs to illustrate the relative
distances between domains and their possible orientations in a closed conformation (resting state). (c) Remote homology models of the NB-ARC
domain of Rx1 built after ADP-bound Apaf1 (left panel) and ATP-bound CED4 (2a5y) (right panel). Models show major differences between the ‘open’
and ‘closed’ conformations of the nucleotide-binding pocket. The change in conformation is due to a rotation of the NB/ARC1 with respect to the
ARC2 domain around an ARC1–2 hinge (in yellow). Arrows indicate the swing between open and closed conformation.
Current Opinion in Plant Biology 2012, 15:1–10 www.sciencedirect.com
Figure 5) Structural models of d ma s found in NLR proteins. (a) Structural domains of TNLs and 
CNLs and their estimated dimensions (A˚). The 3D model of CCMla10 and TI L6 are based on a crystal 
structure, whereas the 3D structure of the NB-ARC Mla10 and LRR Lr10 are prediction models (b) 
Hypothetical models for the folding of CNLs and TNLs (c) Remote homology models of the NB-ARC 
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Structural models of domains found in NB-LRR proteins. (a) Structural domains of T Ls and CNLs and their es imated dimensions (Å). The 3D mo el
of CCMla10 and TIRL6 are based on a crystal structure, whereas the 3D structure of the NB-ARCMla10 and LRRLr10 are p ediction models [3
!!,4!!,6!]. NB-
ARCMla10 was modelled after ADP-bound Apaf1 (1z6tA [10]). (b) Hypoth tical models for the folding of CNLs and TNLs to illustrate the relative
distances between domains and their possible orientations in a cl sed conformation (resting state). (c) Remote homology odels of he NB-ARC
domain of Rx1 built after ADP-bound Apaf1 (left p el) and ATP-bound CED4 (2a5y) (right panel). Models show major differences between the ‘open’
and ‘closed’ conformations of the nucleotide-binding pocket. The change in co formation is ue to a ro ation of the NB/ARC1 with respect to the
ARC2 domain around an ARC1–2 hinge (in yellow). Arrows indicate the swing betw en open and cl sed conformation.
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Figure 5) Structural models of d ma  foun  n NLR prot ins. ( ) Structural d m ins of TNLs an  
CNLs and their estimated dime sions (A˚). Th  3D odel of CCMla10 and TI L6 are based on a crystal
structure, whereas the 3D str cture of the NB-ARC Mla10 and LRR Lr10 are prediction models (b) 
Hypothetical models for the folding of CNL and TNLs (c) Remote homology models of the NB-ARC 
domain of Rx1 in ATP and ADP bound conformation, Taken from Takken & Goverse, 201260 
LRR (Lr10) 
Figure 1.7 Composite Model of Lr10 LRR domain. Composite model of the LRR domain of Lr10 
revealed a compact horseshoe-like structure divided into an N-terminal part containing a cluster 
of positively charged residues and a C-terminal part enriched in aromatic amino acids possibly 




nucleotide binding P-loop of several NLRs including RPS4, N and Rx render the NLR inactive 
highlighting the critical role of the NB-ARC domain in ETI induction87,103,105. The NB-ARC 
domain is also the focus of the ‘equilibrium model’ of NLR activation which describes a 
scenario in which an NLR adopts an ‘off’ state conformation when the NB-ARC domain 
binds ADP changing to an ‘on’ state of defence signalling when ATP is bound106. This model 
hypothesizes that though an NLR is capable of binding ATP or ADP in the absence of an 
effector, effector binding helps to stabilize the ATP-bound form of the NLR. Stabilization of 
the ATP bound form of NLR shifts the equilibrium between the two states and allows the 
ATP bound form to accumulate in the plant cell potentially beyond a threshold upon which 
defence is activated. However, ADP/ATP exchange has been demonstrated not to be key 
for the activation of all NLRs. For example the O. sativa CC-NLR PBL1 confers broad 
resistance to blast fungus M. oryzae whilst lacking a P-loop motif for ADP/ATP binding107. 
This highlights a key theme to NLR mechanistic work in that it is likely there are multiple 
mechanism through which different NLRs are activated. 
 
Autoinhibition of NLRs largely involves intramolecular interaction of multiple NLR domains 
with the LRR domain74,90. For example both the N-terminal CC/TIR domains and NB-ARC is 
predicted to be in close proximity of the LRR in the autoinhibited state with simple models 
suggesting the LRR and CC/TIR sequester away the NB-ARC preventing nucleotide 
exchange74,75,100. The LRR domain was found to play a key autoinhibited role in the case of 
the ZAR1 structure, in which the authors found that in the absence of Xanthomonas 
campestris effector AvrAC, ZAR1 precomplexed with pseudokinase RKS1, resides in an 
autoinhibited conformation with ADP bound in ZAR1’s nucleotide binding pocket. 
Intramolecular interactions involving the LRR domain of ZAR are thought to sequester the 
NLR in an inactive conformation 108,109, Figure 1.8. 
 
The ZAR1 structure has now provided key insights into how activation upon ADP to ATP 
exchange occurs in this NLR example. The virulence target of AvrAC is BIK1, a key kinase 
involved in PTI, which the effector uridylylates to prevent activation of PTI. ZAR1-RKS1 
guards PBL2, a kinase decoy of BIK1 which is then uridylylated by AvrAC leading to 
activation of ZAR1110. Uridylylated PBL2 interacts exclusively with RKS1 which interacts with 
ZAR1’s LRR domain. Perception of uridylylated PBL2 by RKS1 stabilizes the activation 
segment of RKS1 which allosterically evicts ADP from ZAR1’s nucleotide binding pocket and 
causes ZAR1’s nucleotide binding domain to become more flexible108. Upon provision and 




oligomerises into a multimeric structure observed by cryo-EM to be a pentamer referred to 
as a resistosome109. This pentameric structure is composed of a central α-helical barrel of 
ZAR1 CC domains109, Figure 1.8. The authors postulate that this α-helical funnel may be 
inserted into the membrane leading to the formation of pores which directly lead to HR, 
though more evidence is needed to support the last step of this model. Such hypothesised 
membrane pore formation is not thought to be the outcome of all activated NLRs given the 
non-cell membrane associated sub-cellular localisation of some active NLRs and the known 
reliance on downstream signalling partners such as NRG1, discussed in 1.4.2.  
 
Whilst oligomerisation had long be observed upon activation of mammalian NLRs, 
exemplified in the structure of 11-mer NLRC4-NAIP2 inflammasome, similar oligomerisation 
of plant NLRs was not observed until the publishing of the ZAR1 pentameric structure 
referred to as a resistosome. Interestingly oligomerization of both plant NLR N-terminal TIR 
and CC domains, discussed in 1.3.1 , and animal N-terminal CARD and PYDs has been 
demonstrated to be integral for downstream signalling87,111–114. In animal NLRs the 
formation of the inflammasome brings the N-terminal domains of the NLRs into close 
proximity providing a platform for the recruitment of active signalling components like 
procaspases35,102,115.  Conversely the function of multimeric plant NLR structures for 
facilitating downstream signalling is still widely debated.  
  
Figure 1.8 Structural remodelling of ZAR1 during activations. The inactive and active states are 
shown on the left and right respectively with the N-terminal α-helix 1 shown in red. Figure adapted 
from Wang et al, 2019108. 
After 3D classification, a subset of 196,707 par-
ticles was used for reconstruction, yielding a
final overall resolution of 3.4 Å on the basis of
the gold Fourier shell correlation standard
(fig. S4D).
The 3D reconstruction reveals that the ZAR1
resistosome contains five protomers of the ZAR1-
RKS1-PBL2UMP complex, forming a wheel-like
structure measuring ~240 Å in diameter and
~120 Å in height (Fig. 1B, movie S1, and table S1).
This structure is reminiscent of those of the NLR
inflammasomes (18–20) and apoptosomes (17).
The ZAR1 resistosome is composed of a central
a-helical barrel that is formed by the CC domains
of ZAR1 (ZAR1CCs). A small fraction of the barrel
protrudes out of the wheel-defined plane and
points toward the solvent region (Fig. 1C). The
NB-ARC domains, which can be further divided
into the NBD (ZAR1NBD), HD1 (ZAR1HD1), and
WHD (ZAR1WHD), form an outer ring structure
(Fig. 1C). The bottom and the top of the ring are
generated by lateral packing of ZAR1NBDs and al-
ternating contacts between ZAR1HD1 and ZAR1WHD
in adjacent subunits, respectively. The pentag-
onal chamber formed on the top is lined with
most of the ZAR1CC-made barrel (Fig. 1C). The
LRRs do not pack against each other but make
lateral contacts with ZAR1HD1, thus contributing
to the pentamerization of the ZAR1 resistosome.
RKS1 and PBL2UMP extend radially to form the
spokes of the wheel-like structure, and neither of
them is involved in the oligomerization of the
resistosome (Fig. 1C). Structural comparison
showed that the interaction of ZAR1LRR with
RKS1-PBL2UMP remains unchanged during acti-
vation (figs. S5 and S6). For this reason, we limit
our discussions below to ZAR1.
Release of the very N-terminal a helix
during ZAR1 activation
The NBD, HD1, and WHD in the ZAR1 resisto-
some are organized similarly to those in active
Apaf-1 and NLRC4 (fig. S7), indicating that ZAR1
adopts an active conformation. By contrast to the
active NLRC4 and Apaf-1, which have an ex-
tended conformation, the active ZAR1 is largely
spherical (fig. S7). Comparison with the structure
of inactive ZAR1 (34) showed that ZAR1WHD and
ZAR1LRR undergo little change relative to each
other during activation (Fig. 2A and fig. S8). By
contrast, structural remodeling occurs between
these two structural domains and ZAR1NBD-
ZAR1HD1, with the former two rotating ~180
degrees around the hinge (residues 393 to 395)
linking ZAR1HD1 and ZAR1WHD (Fig. 2A). Sim-
ilar conformational changes were also observed
for the activation of Apaf-1 (17) and NLRC4
(18–20). Structural superposition of the inactive
ZAR1with one protomer of a lateral ZAR1 dimer
revealed that ZAR1CC, ZAR1WHD, and ZAR1LRR
from the inactive ZAR1 overlap with the other
ZAR1 protomer (Fig. 2B), suggesting that the
three domains have a role in sequestering ZAR1
in a monomeric state and explaining why struc-
tural reorganization is required for ZAR1 activation.
In addition to the structural reorganization
of ZAR1NB-ARC, conformational changes also take
place in ZAR1CC (residues 4 to 138) during acti-
vation. In the inactive ZAR1, the N-terminal
amphipathic helix a1 is largely buried by the
formation of a four-helix bundle and contacts
with ZAR1WHD and ZAR1LRR (Fig. 2A, left). In
the active ZAR1, this a helix detaches from the
original four-helix bundle, rotating about 130
degrees around residue Asp25 and becoming fully
solvent-exposed (Fig. 2A, right). The original a4A
(residues 89 to 111) in the inactive ZAR1 becomes
completely disordered in the active ZAR1, where-
as the flexible fragment (residues 112 to 138) C
terminal to the molten a helix folds into a long
helix (a4B) during activation (Fig. 2C and fig. S9).
Together with a2 and a3, this newly formed a
helix forms a twisted three-helix bundle with its
hydrophobic core partially buried. These struc-
tural observations indicate that ZAR1CC (residues
1 to 138) can adopt two different fold topologies
and that large structural rearrangement of other
domains of ZAR1 during activation switches from
one fold to the alternate one, a phenomenon
called proteinmetamorphosis (38). The structure
of ZAR1CC in the resistosome is different from
those of the CC domains of the CC-NLRs Sr33
(39), Rx (40), and MLA10 (26, 39) (fig. S10).
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Fig. 2. Structural remodeling and fold switching of ZAR1 during activation. (A) Structural
remodeling of ZAR1 during activation. Shown on the left and right are the inactive and
active forms of ZAR1, respectively. The very N-terminal a helix (a1) is shown in red. The
software Coot was used to align the two structures, with the inactive ZAR1NBD-ZAR1HD1 as the
template. (B) The CC, winged-helix, and LRR domains from the inactive ZAR1 overlap with
one protomer of ZAR1 from a lateral dimer. ZAR1NBD-ZAR1HD1 from the inactive ZAR1 (in
cartoon representation) was used as the template to superimpose with the left protomer of
the ZAR1 lateral dimer (in surface representation). (C) Structural comparison of the CC domain
from the inactive (top) and active (bottom) forms of ZAR1. Secondary structural elements are
labeled, and the boundaries for some of them are indicated by the numbers. Broken lines
represent flexible structural elements.
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As ZAR1 only represents one type of NLR as a CC-NLR with indirect-decoy effector 
recognition, it is likely its activation mechanism is not representative of all plant NLRs. The 
model proposed alongside the structure of ZAR1 still leaves several unanswered questions. 
For example, the role of nucleotide hydrolysis, as the structure reveals that binding of both 
the effector-dependent activator and ATP leads to the protein being locked in the ATP-
bound state. It is only through attaining further structures of full-length and multidomain 
NLRs representing a diverse array of effector perception mechanisms and NLR N-terminal 
domains that we will be able to gain robust insights into how the wider family of NLR 
receptors are activated.  
1.4.2 Downstream signalling of NLRs 
 
The signalling steps which link activation of NLRs to ETI and HR are still not 
comprehensively understood and remain a black box in our understanding of plant innate 
immunity. Current thinking suggests that there are two key regulators which work 
downstream of the different NLR classes: EDS1 (Enhanced disease susceptibility 1) for TNLs 
and NPR1 (Nonexpresser of PR Genes 1) for CNLs116.  
 
Nucleo-cytoplasmic EDS1 is a lipase like protein that works in conjunction with PAD4 
(Phytoalexin Deficient 4) or structurally related SAG101 (Senescence-Associated Gene 101) 
as a heterodimer. EDS1 and its interactors PAD4 or SAG101 have been shown to play crucial 
roles in downstream ETI responses such as generation of ROS, salicylic acid and induction of 
a HR117. For example, induction of paired NLRs RRS1/RPS4 ETI responses have been shown 
to be  dependent on EDS1 and SAG101118. Consequently, overexpression of EDS1 and PAD4 
proteins leads to a dose dependent enhancement of resistance against bacterial pathogens 
whilst eds1 and pad4 mutants are highly susceptible to virulent P. syringae strains whose 
effector AvrRps4 activates RRS1/RPS4119.  Whether EDS1 constitutively interacts with TNLs 
is highly debated. Whilst EDS1 has been reported to directly interact with various TIR-NLRs 
such as RPS4, RPS6 and SNC120,121 others have found issues replicating this interaction 
(unpublished data and correspondence). Additionally, it has been hypothesised that upon 
effector perception the interaction between EDS1 and TNLs may be disrupted which then 
allows unbound EDS1 to function downstream121 though more evidence is required to 
support this model. The ability of EDS1/PAD4/SAG101 to form both nuclear and 
cytoplasmic complexes has also been hypothesized to play an important role in transducing 





The importance of helper NLRs in NLR functioning is an exciting emerging field of study in 
plant immunity. The CNLRPW8 NRG1(N Requirement Gene 1) 122 for example, has been 
recently hypothesized to function as a helper NLR for TNLs. This is exemplified in the 
evolution of NRG1 whose presence correlates with the presence of TNLs in different plant 
clades123. Studies have shown the requirement of NRG1 for the functioning of TNLs WRR4, 
Roq1, RPP1 and paired RRS1/RPS4 but not two CNLs tested in N. benthamiana123,124. 
Interestingly, whilst NRG1 was not required for CNLs RPS5 and MLA function, nrg1 loss of 
function mutants showed slightly compromised RPM1 and RPS2 resistance. Interestingly, 
ADR1 which is thought to work downstream of CNLs is also a RPW8-like NLR and is 
phylogenetically related to the NRG1 clade78. The exact mechanistic role that helper 
CNLRPW8 such as ADR1 and NRG1 play is still unknown but presents an exciting evolving 
facet of plant innate immunity research. Taken together this could suggest that RPW8-like 
NLRs are helper NLRs with ADR1 functioning downstream of CNLs and NRG1 downstream 
of TNLs whilst potentially contributing to a subset of CNLs functions123  
 
Additionally the presence of an immune receptor signalling network has recently been 
revealed in initially N. benthamiana and now the wider Solanaceae family125.The ‘NRC’ 
superclade of NLRs in Solanaceae consists of several distinct subclades of helper NLRs, 
NRC1-4, which function together with a highly diversified and expanded range of sensor 
NLRs including Rx, R8, Prf and Rpi-blb2 to perceive a broad range of pathogen effectors126. 
In this way, these NLRs form a signalling network with expanded sensor members relative 
to helpers and high levels of redundancy amongst helpers to form a robust and highly 
evolvable NLR signalling network.  
 
Several NLRs have also been reported to directly interact with transcription factors 
or DNA upon pathogen recognition. For example, two TNLs SNC1 and RPS4 have 
been shown to directly interact with the positive immune regulator transcriptional activator 
bHLH84127  whilst NLR N has been observed to interact with transcription factor  SPL6128. A 
recent study also identified the ability of potato CNL Rx1 to interact with and melt DNA 
following effector recognition via the NLR’s NB-ARC domain, however specificity of the 
target DNA region, for example via a binding partner, has not yet been clarified129. This has 
led to the hypothesis that nuclear NLR proteins may interact directly with transcriptional 
regulators to instigate an immune responses and transcriptional reprogramming upon 





The exact downstream outputs of ETI and how these feed into plant immunity are not fully 
understood. However, a common downstream phenotype of NLR/ETI activation which is 
often but not always observed in induction of HR (Hypersensitive Response)130,131. The exact 
mechanism which leads to HR induction is not yet understood but this defence output is 
associated with the shrinkage of the cell cytoplasm, condensing of chromatin, swelling of 
mitochondria, chloroplast disruption and vacuolization132. This leads to a localised area of 
cell death at the point of pathogen infection thought to help constrict pathogen 
colonization of the host. New evidence is also now emerging about the requirements of 
both PTI and ETI in order to establish an ETI-induced HR. This has been demonstrated via 
unpublished data from the Jones lab showing lack of HR induction when recognised 
effectors are delivered without activation of PTI in Arabidopsis. Additionally, it has been 
recently demonstrated that MAPK3 and MAPK6 activation is required for ETI-induced HR133.  
This suggests that there may be a strong interplay between ETI and PTI. The signalling 
components controlling this output are yet to be defined but these findings present a 
fascinating challenge to the classical association of HR and ETI.  
 
1.5 Investigating paired NLRs with RRS1/RPS4 
 
The A. thaliana TIR-NLRs RRS1 (Resistance to Ralstonia solanacearum 1) and RPS4 
(Resistance to Pseudomonas syringae 4) are a well-studied example of genetically linked 
paired NLRs. This divergently transcribed nuclear-localised NLR pair provide race specific 
resistance to a number of bacteria and fungi134. The roles of effector perception and 
activation of downstream signalling are split between these two NLRs. The ‘sensor’ NLR 
RRS1 is responsible for effector binding, which is facilitated through an integrated WRKY 
domain found towards the C-terminus of the NLR, whilst the ‘executor’ NLR RPS4 is 
responsible for activation of downstream ETI signalling. This spilt allocation of functional 
roles between two NLRs is seen in many genetically linked NLR pairs where one NLR 
contains an integrated domain for effector perception and the other facilitating 
downstream signalling68,135,136.  Understanding the functional mechanism of the RRS1/RPS4 
immune complex will therefore bring key insights to many paired NLRs. 
 
1.5.1 The genomic and protein domain structure of RRS1 & RPS4 
 
Divergently transcribed RRS1 and RPS4 are found in the A. thaliana genome in a head-to-




bidirectional promoter137, Figure 1.9A. This type of genomic arrangement is also found with 
other paired NLRs for example Pikp1/Pikp2 and RGA4/RGA5 and may reflect the need for 
transcriptional co-regulation of the NLR pair members68,69,134,138. Additional RPS4 homologs 
are situated in the genome paired with other divergently transcribed NLRs carrying 
integrated domains, suggesting these linked pairs also co-evolved 137. 
 
RRS1 and RPS4 both possess the canonical TIR, NB-ARC and LRR NLR domains. However, 
each NLR also both possesses additional non-canonical domains which reflect their split 
roles of ‘sensor’ and ‘executor’, Figure 1.9B. RRS1 has an integrated C-terminal WRKY 
domain which allows RRS1 to bind and perceive effectors which target WRKY transcription 
factors. More than 70% of Arabidopsis WRKY transcription factors are involved in defence, 
rendering these proteins as likely plant hubs for effector targeting to attenuate host 
immunity61,62. Given the strong involvement of WRKY proteins in defence signalling it is not 
surprising that bioinformatic studies have predicted that WRKY domains are amongst the 
most common non-canonical domains to be integrated into an NLR structure52,53. The WRKY 
domain integrated into RRS1 is a group III WRKY and contains the conserved DNA binding 
motif ‘WRKYGQK’65.  
 
Beyond the WRKY domain, RRS1 possess a C-terminal extension with little homology to any 
other proteins. This extension, referred to as Domain 6 (Dom6), varies between alleles of 
RRS1. The RRS1 alleles investigated in this study are RRS1-R, found in A. thaliana accession 
Ws-2 and RRS1-S found in the Col-0 accession, Figure 1.9B. These NLRs are near-identical in 
their amino acid sequence except for their C-terminal Dom6 regions. RRS1-S’s C-terminal 
extension, referred to as Dom6S, contains a premature stop codon relative to RRS1-R 
leading to a C-terminal extension of only 21 amino acids. Dom6 of the RRS1-R allele 
(Dom6R) however contains a further 83 amino acids beyond the end of Dom6S, with a total 
C-terminal extension of 104 amino acids. This extension is vital for supporting extended 
effector recognition capabilities compared to RRS1-S as discussed in 1.5.2. RRS1 also 
contains a region of 322 amino acids between the LRR and WRKY domains referred to as 
Domain 4 (Dom4). This domain shows little homology to other known protein domains and 
has no assigned biochemical function. Reports have suggested that Dom4 contains a 
leucine-zipper motif which appears to be conserved in RRS1 alleles from many accessions of 
A. thaliana139. Putative leucine zippers have also been found in WRKY 18, WRKY 40 and 
WRKY 60 and play a role in facilitating physical interactions between WRKY proteins140, 














Figure 1.9 Gene pair and protein modular domain structure of RRS1/RPS4 and paralogous  
RRS1B/RPS4B.  (A) Schematic representation of RRS1/RPS4 and RRS1B/RPS4B gene pairs. 
Exons are depicted as boxes and domains references above relevant regions. Black arrows 
indicate reading frame direction, NLS (nuclear localisation signal), figure adapted from 
Saucet et al, 2015141. (B) Protein domain structure of RRS1 alleles, RPS4 and paralogous 
RRS1B/RPS4B. Amino acid sequence identity is listed as a percentage between the 
comparable domains. 
 
In addition to the canonical NLR domains, RPS4 contains a non-canonical 338 amino acid C-
terminal domain (CTD) extension which is thought to play an important role in mediating 
interactions with RRS1. RPS4’s CTD shows little homology with any other known protein 
domains, limiting protein-protein interaction modelling work that can be done with this 
NLR. Unlike RRS1, the alleles of RPS4 found in Col-0 and Ws-2 which function with RRS1-R 
and RRS1-S are identical.  
A 
B 
At5g45050 and At5g45060 are both required for RRIR. To
investigate whether the At5g45050/At5g45060 gene pair is the
RRIR locus, we tested T-DNA insertion mutants At5g45050-1
(050-1) in Col-0, At5g45060-1 (060-1) in Ws-2 and At5g45060-2
(060-2) in Col-0 (Fig. 2b and Supplementary Table 2), for loss of
AvrRps4 recognition. These were crossed to rrs1 or rps4 mutants
(rrs1-1 in Ws-2; rrs1-3 in Col-0; rps4-21 in Ws-2; rps4-2 in Col-0)
in order to recover the following double mutants after PCR
screening F2 and F3 progenies: Ws-2 rps4-21/060-1, Ws-2 rrs1-1/
060-1, Col-0 rrs1-3/050-1, Col-0 rps4-2/050-1 and Col-0 rps4-2/
060-2. Using reverse transcription–PCR (RT–PCR), we confirmed
the presence of RPS4, RRS1, At5g45060 and At5g45050 transcripts
in Ws-2, Col-0, RLD and eds1 mutants; we also confirmed the
absence of corresponding transcripts in each single and double
T-DNA insertion mutants (Supplementary Figs 2 and 3 and
Supplementary Table 3). In rps4-21, which carries a 5-bp deletion
in RPS4, the transcript was still detected15. We then tested
AvrRps4 recognition in these single and double mutants. As
expected, Ws-2 060-1 mutant showed similar HR to Ws-2 after Pf
Pf0-1 (AvrRps4) infiltration, and retained PopP2 recognition and
HR due to the presence of RRS1/RPS4 (Fig. 2c). The Ws-2 rrs1-1
and rps4-21 mutants, on the other hand, showed the loss of HR to
PopP2, but maintained HR to AvrRps4 (Fig. 2c). This residual
AvrRps4 recognition and HR was completely abolished in Ws-2
rrs1-1/060-1 or rps4-21/060-1 double mutants (Fig. 2c), suggesting
that At5g45060 is required for the RRIR in Ws-2. In addition,
rrs1-1/060-1 and rps4-21/060-1 double mutants showed HR to
HopA1 (recognized by the TNL RPS6)28, suggesting that HR
signalling is still effective in these double mutants. None of the
mutants or accessions showed HR to Pf Pf0-1 carrying a mutated
AvrRps4 (AvrRps4 KRVYAAAA), confirming all HR phenotypes
resulted from specific effector recognition (Fig. 2c)29.
To test whether loss of HR to AvrRps4 correlates with loss of
disease resistance, we assessed the growth of Pst DC3000
(AvrRps4) compared with Pst DC3000 (EV) in wild-type (WT)
and Arabidopsis mutants 3 days post infiltration (d.p.i.). AvrRps4
is recognized in Col-0, restricting Pst DC3000 (AvrRps4) growth
compared with Pst DC3000 (EV), whereas in Col-0 eds1-2, Pst
DC3000 (AvrRps4) grew as much as Pst DC3000 (EV) (Fig. 2d).
In Col-0 050-1 and Col-0 060-2, with the presence of functional
RRS1/RPS4, Pst DC3000 (AvrRps4) growth was restricted
compared with Pst DC3000 (EV) (Fig. 2d). Similarly, restricted
growth of Pst DC3000 (AvrRps4) was observed in Col-0 rrs1-3
and Col-0 rps4-2 due to RRIR (Fig. 2d). However, Col-0 rrs1-3/
050-1, rps4-2/050-1 and rps4-2/060-2 double mutants supported
as much Pst DC3000 (AvrRps4) growth as Pst DC3000 (EV),
8



























































































































Figure 2 | At5g45050 and At5g45060 confer RRS1/RPS4-independent AvrRps4 recognition (RRIR). (a) Diagram showing the candidate RRIR locus
(grey arrows) on Arabidopsis chromosome 5. Genetic molecular markers used are shown in uppercase letters with corresponding genetic distance (cM)
to the RRIR locus (based on 48 F2 plants showing no HR to AvrRps4). Arrows represent TNL-encoding genes. Orientation of arrows indicates reading
frame direction. The physical distance on the map is indicated in kb or Mb. (b) Schematic representation of RRS1/RPS4 and At5g45050/At5g45060 gene
pairs. Positions of the T-DNA insertion for mutant lines used in this study are indicated by white triangles. At5g45050 and At5g45060 re abbreviated as
050 and 060, respectively. The mutants rps4-21 (that carries a 5-bp deletion), rrs1-1 and rps4-2 were reported previously14,15,31. Exons are depicted as boxes,
and the different domains are highlighted on the top (APAF1, R proteins and CED4; LRR, leucine-rich repeat; NB-ARC, nucleotide binding, NLS, nuclear
localization signal; TIR, Toll/interleukin-1 receptor/R protein; WRKY, WRKY DNA-binding domain). Black arrows indicate the reading frame direction.
(c) HR assay in Ws-2 and Ws-2 single and double mutants using leaf infiltration with Pf Pf0-1 secreting AvrRps4 KRVYAAAA, AvrRps4, PopP2 or HopA1.
Pictures were taken 24h.p.i. Magenta arrows indicate leaves showing HR. (d) Bacterial growth of Pst DC3000 carrying empty vector (EV) or secreting
AvrRps4 in Col-0 WT, single and double mutants. Bacterial growth was measured 3 days post infiltration (d.p.i.). Means±standard error (s.e.) of four
replicates per sample are given. Samples with different letters are statistically different at the 5% confidence level based on Tukey’s test. These experiments
were repeated at least three times with similar results.
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At5g45050 and At5g45060 are both required for RRIR. To
investigate whether the At5g45050/At5g45060 gene pair is the
RRIR locus, we tested T-DNA insertion mutants At5g45050-1
(050-1) in Col-0, At5g45060-1 (060-1) in s-2 and At5g45060-2
(060-2) in Col-0 (Fig. 2b and Supplementary Table 2), for loss of
AvrRps4 recognition. These were crossed to rrs1 or rps4 mutants
(rrs1-1 in Ws-2; rrs1-3 in Col-0; rps4-21 in s-2; rps4-2 in Col-0)
in order to recover the following double mutants after PCR
screening F2 and F3 progenies: s-2 rps4-21/060-1, s-2 rrs1-1/
060-1, Col-0 rrs1-3/050-1, Col-0 rps4-2/050-1 and Col-0 rps4-2/
060-2. Using reverse transcription–PCR (RT–PCR), we confirmed
the presence of RPS4, RRS1, At5g45060 and At5g45050 transcripts
in Ws-2, Col-0, RLD and eds1 mutants; we also confirmed the
absence of corresponding transcripts in each single and double
T-DNA insertion mutants (Supplementary Figs 2 and 3 and
Supplementary Table 3). In rps4-21, which carries a 5-bp deletion
in RPS4, the transcript was still detected15. e then tested
AvrRps4 recognition in these single and double mutants. As
expected, Ws-2 060-1 mutant showed similar HR to s-2 after Pf
Pf0-1 (AvrRps4) infiltration, and retained PopP2 recognition and
HR due to the presence of RRS1/RPS4 (Fig. 2c). The s-2 rrs1-1
and rps4-21 mutants, on the other hand, showed the loss of HR to
PopP2, but maintained HR to AvrRps4 (Fig. 2c). This residual
AvrRps4 recognition and HR was co pletely abolished in s-2
rrs1-1/060-1 or rps4-21/060-1 double utants (Fig. 2c), suggesting
that At5g45060 is required for the RRIR in s-2. In addition,
rrs1-1/060-1 and rps4-21/060-1 double utants showed HR to
HopA1 (recognized by the TNL RPS6)28, suggesting that HR
signalling is still effective in these double utants. None of the
mutants or accessions showed HR to Pf Pf0-1 carrying a utated
AvrRps4 (AvrRps4 KRVYAAAA), confir ing all HR phenotypes
resulted from specific effector recognition (Fig. 2c)29.
To test whether loss of HR to AvrRps4 correlates with loss of
disease resistance, we assessed the growth of Pst DC3000
(AvrRps4) compared with Pst DC3000 (EV) in wild-type ( T)
and Arabidopsis mutants 3 days post infiltration (d.p.i.). AvrRps4
is recognized in Col-0, restricting Pst DC3000 (AvrRps4) growth
compared with Pst DC3000 (EV), whereas in Col-0 eds1-2, Pst
DC3000 (AvrRps4) grew as much as Pst DC3000 (EV) (Fig. 2d).
In Col-0 050-1 and Col-0 060-2, with the presence of functional
RRS1/RPS4, Pst DC3000 (AvrRps4) growth was restricted
compared with Pst DC3000 (EV) (Fig. 2d). Similarly, restricted
growth of Pst DC3000 (AvrRps4) was observed in Col-0 rrs1-3
and Col-0 rps4-2 due to RRIR (Fig. 2d). However, Col-0 rrs1-3/
050-1, rps4-2/050-1 and rps4-2/060-2 double mutants supported
as much Pst DC3000 (AvrRps4) growth as Pst DC3000 (EV),
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Figure 2 | At5g45050 and At5g45060 confer RRS1/RPS4-independent AvrRps4 recognition (RRIR). (a) Diagr m showing the candidate RRIR locus
(grey arrows) on Arabidopsis chromosome 5. Genetic molecular markers used are shown in uppercase letters with corresponding g etic dista ce (cM)
to the RRIR locus (based on 48 F2 plants showing no HR to AvrRps4). Arrows represent TNL-encoding genes. Orientation of arrows indicates reading
frame direction. The physical distance on the map is indicated in kb or Mb. (b) Schematic representation of RRS1/RPS4 and At5g45050/At5g45060 gene
pairs. Positions of the T-DNA insertion for mutant lines used in this study are indicated by white triangles. At5g45050 and At5g45060 are abbreviated as
050 and 060, respectively. The mutants rps4-21 (that carries a 5-bp deletion), rrs1-1 and rps4-2 were reported previously14,15,31. Exons are depicted as boxes,
and the different domains are highlighted on the top (APAF1, R proteins and CED4; LRR, leucine-rich repeat; NB-ARC, nucleotide binding, NLS, nuclear
localization signal; TIR, Toll/interleukin-1 receptor/R protein; WRKY, WRKY DNA-binding domain). Black arrows indicate the reading frame direction.
(c) HR assay in Ws-2 and Ws-2 single and double mutants using leaf infiltration with Pf Pf0-1 secreting AvrRps4 KRVYAAAA, AvrRps4, PopP2 or HopA1.
Pictures were taken 24h.p.i. Magenta arrows indicate leaves showing HR. (d) Bacterial growth of Pst DC3000 carrying empty vector (EV) or secreting
AvrRps4 in Col-0 WT, single and double mutants. Bacterial growth was measured 3 days post infiltration (d.p.i.). Means standard error (s.e.) of four
replicates per sample are given. Samples with different letters are statistically different at the 5% confidence level based on Tukey’s test. These experiments
were repeated at least three times with similar results.
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1.5.2 Effector recognition capabilities of RRS1 & RPS4  
 
Different allelic variations of RRS1 provide RPS4-dependent recognition of a variety 
pathogens including P. syringae, R. solanacearum and C. higginsianum, Figure 1.10. Widely 
distributed Gram-negative R. solanacearum is a soil borne bacteria which causes bacterial 
wilt disease in a variety of Solanaceae crop species including potato, tomato and aubergine 
as well as soy bean and banana142. P. syringae is an epiphytic Gram-negative bacterium 
which can infect a wide range of herbaceous and woody crops such as tomato causing 
bacterial speck disease. P. syringae pathovar DC3000 is also widely used to study plant-
pathogen interactions on model species A. thaliana143. C. higginsianum is an ascomycete 
pathogen which causes anthracnose disease on many economically important cruciferous 
plants such as Brassica and Raphanus species as well as model species A. thaliana144.  
 
 
Figure 1.10 The RRS1/RPS4 NLR complex system. Effectors PopP2 (purple circle) from R. 
solanacearum and AvrRps4 (pink circle) from P. syringae target WRKY transcription factors involved 
in plant immunity signalling to trigger effector susceptibility. PopP2 and AvrRps4 are susceptible to 
molecular detection by the NLR pairs RRS1/RPS4 and RRS1B/RPS4B which bind the effectors via 
RRS1’s or RRS1B’s integrated WRKY domain. Activation of these immune complexes leads to  
induction of effector triggered immunity (ETI). RRS1 alleles can recognise AvrRps4 and PopP2 but 



















































In the presence of RPS4, RRS1-R is capable of perceiving the effectors AvrRps4 from P. 
syringae137, PopP2 from R. solanacearum145 and an unknown effector from the fungus C. 
higginsianum134,146, Figure 1.10. AvrRps4 is a type III secreted effector deployed by P. 
syringae f. sp. pisi. Upon secretion into the plant cell AvrRps4 is cleaved between Gly133 
and Gly134 to release a C-terminal anti-parallel coiled coil truncation of residues Gly134-
Gly221 referred to as  AvrRPS4c147. AvrRps4c is capable of inducing resistance though in 
planta processing is not necessary for perception of AvrRps4 as the un-cleaved AvrRps4 
R112L is still recognised147. Processing of AvrRps4 may take place in the chloroplast to 
which AvrRps4 is targeted via a predicted chloroplast transit peptide also utilised by P. 
syringae effector HopK1148. This might suggest that whilst AvrRps4c recognition by RRS1 is 
thought to occur in the nucleus, AvrRps4 may have an additional virulence function in the 
chloroplast. Whether the N- and C-terminal regions of AvrRps4 have distinct virulence 
activities is not known but the N-terminal fragment of AvrRps4 has been shown to interact 
with EDS1 indicating it may play a role beyond acting as a chloroplast localization transit 
peptide149. 
 
The exact virulence mechanism of this effector is not fully understood as the crystal 
structure of AvrRps4c revealed no obvious catalytic sites or biochemical activity150. It is 
therefore hypothesised that AvrRps4c interferes with host immune signalling by direct 
interactions with WRKY transcription factors. Coimmunoprecipitation data has shown that 
AvrRps4 can interact with a variety of WRKY proteins including WRKY41/70/60/33 but 
EMSA studies showed the effector did not disrupt the ability of WRKY proteins to bind their 
W-box DNA element. As discussed in Chapter 5, the inability to detect WRKY-DNA binding 
interaction disruption upon AvrRps4 treatment may be due to insensitivity of the EMSA 
technique. There are two important potential AvrRps4-RRS1 interaction surfaces which 
have been highlighted in the structure of AvrRps4c. Firstly, residues E175 and E187 are 
found in an electrostatic negative patch positioned both on the helices on either side of 
AvrRps4’s β-turn and on the β-turn itself and are predicted in protein-protein interaction 
modelling studies, to directly interact with lysine residues in RRS1’s ‘WRKYGQK’ motif150, 
Figure 5.2. Secondly, a region at the N-terminus of truncated AvrRps4c referred to as the 
KRVY motif (AvrRps4 K135-Y138) is essential for RRS1’s recognition of AvrRps4c but not 
binding. As the ‘KRVY’ motif is not in the electron dense region of the structure of AvrRps4c 
protein-protein interaction modelling of this region with RRS1’s WRKY has not been 
possible. Interestingly mutating the KRVY motif to alanine residues (KRVY/AAAA) results in 




RRS1 but not activating defence. This suggests that whilst binding of AvrRps4c is required 
for RRS1 recognition it is not sufficient to activate defence. The reason for this is not known 
and will likely not be fully understood until we understand the structural basis of RRS1’s 
recognition of AvrRps4. The structure of AvrRps4 and interactions with RRS1’s WRKY 
domain is discussed in further detail in 5.1. 
 
PopP2 is as an acetyltransferase enzyme of the YopJ family151. PopP2 acetylates conserved 
lysine residues in the ‘WRKYGQK’ motif of defence-related WRKY transcription factors and 
RRS1 abolishing the DNA binding capabilities of these proteins65,66. Similarly to AvrRps4, 
coimmunoprecipitation assays have demonstrated that PopP2 can bind of WRKY 
transcription factors including WRKY41/70/60/33. As an acetyltransferase the catalytic core 
residue of C321 is key for virulence function and recognition by RRS1. PopP2 C321A 
mutants are both incapable of acetylating WRKY transcription factors and RRS1 WRKY. The 
recently published crystal structure of the RRS1 WRKYE1195-T1273-PopP2 complex revealed 
that a core lysine residue in RRS1’S WRKY motif, K1221, inserts directly into the active site 
of PopP2 containing residue C321. The interaction surface between RRS1 WRKY and PopP2 
is discussed further in 5.1.  
 
Whilst RRS1-R confers recognition of AvrRps4, PopP2 and an unknown effector from the 
fungus C. higginsianum134,146, RRS1-S is only capable of perceiving AvrRps4. Experiments 
truncating Dom6R of RRS1-R back to the Dom6S boundary have shown that RRS1-R’s 
extended recognition capabilities are facilitated by the Dom6R extension. Whilst RRS1-S is 
still capable of binding and being acetylated by PopP2 this is not transduced into an ETI 
output as observed in RRS1-R. How Dom6R confers such expanded recognition capabilities 
is not fully understood. Interestingly acetyl-lysine mimic substitutions of the lysine residues 
in RRS1-R’s WRKY motif to ‘WRQYGQQ’ activates RPS4-dependent defence activation in the 
absence of an effector but not RRS1-S. This indicates that Dom6R must be involved in 
specific intra- and inter-domain interactions which integrate this acetylation event into ETI 
induction which Dom6S cannot facilitate. 
 
1.5.3 RRS1B/RPS4B: The paralogous B pair 
 
RRS1 and RPS4 (A pair) are linked to second pair of similar divergently transcribed NLRs 
called RRS1B/RPS4B which are found in both Col-0 and Ws-2 A. thaliana accessions141. 




higginsianum, Figure 1.10. RRS1B and RPS4B have the same overall modular domain 
structure as the A pair but only share 64.7% and 65.3% amino acid sequence identity with 
RRS1-R and RPS4 respectively. This similarity goes down to 56% and 58% sequence identity 
when comparing the WRKY and Dom6 regions of RRS1 and RRS1B respectively, Figure 1.9B. 
The possible activation mechanism of RRS1/RPS4 will be discussed in 1.5.4 but domain 
swapping experiments between the B pair and A pair of RRS1/RPS4 suggests these 
paralogous pairs function in mechanistically distinct ways. For example, unlike RRS1 the 
Dom6 region of RRS1B, termed Dom6B, is required for RRS1B’s perception of AvrRps4. 
Additionally, truncation of the WRKY Dom6 region results in RPS4-dependent autoactivity 
in the case of RRS1 but not RRS1B152 (and unpublished data from Dr Yan Ma). This implies 
the two NLR pairs are perceiving effectors and activating ETI in a distinct manner. 
Comparing the activation mechanisms of A and B pair RRS1/RPS4 therefore provides an 
intriguing tool set for understanding how one effector, AvrRps4, is recognised and activates 
different NLRs.  
 
1.5.4 Activation mechanism of the RRS1/RPS4 complex 
 
Qualitative biochemical investigations, HR assays and microscopy studies have begun to 
reveal the activation mechanism of RRS1/RPS4. However, structural insights into the 
functioning of this complex are now required to further our understanding. 
 
In the absence of RRS1, RPS4 can induce a weak autoimmune response upon transient 
expression in N. tabacum. In order to prevent autoimmunity, RRS1 negatively regulates 
RPS4 in the absence of effectors. RRS1 itself is kept in the inactive state by RRS1’s WRKY 
domain negative regulation of Dom4. This can be demonstrated by the RPS4-dependent 
autoactive phenotype observed when RRS1 ΔWRKYDom6 truncations are transiently 
expressed in Nicotiana tabacum152. This autoactivity is dependent on RRS1’s Dom4 as 
further deletion of Dom4 (RRS1 ΔDom4-WRKY-Dom6) abolishes this autoactive phenotype.  
Suppression of Dom4 appears to be specific to RRS1’s coevolved integrated WRKY, as 
substitution of the RRS1 WRKY with similar DNA binding domains such as the bacterial DNA 
binding domain LexA, AtWRKY41 or the WRKY domain of RRS1B result in generation of an 
autoactive complex153. Bimolecular fluorescence complementation (BiFC) studies have 
shown that in the absence of effectors the N- and C-termini of RRS1 Dom4-WRKY-Dom6 are 
in close proximity. Binding of AvrRps4 to RRS1’s WRKY domain is observed to disrupt this 




activation of the complex in the presence of AvrRps4 cannot be explained by this inter 
domain interaction disruption alone as mutant AvrRps4KRVY/AAAA is also observed to disrupt 
this interaction but not activate defence152. What these additional interaction changes are 
is still not understood and likely will require structural information to decipher. What has 
been observed however is the ability of Dom4 to associate with RPS4’s CTD. It is therefore 
predicted that derepressed RRS1 Dom4 activates RPS4 via its CTD. The changes in 
intramolecular interactions within RPS4 which occur upon activation by RRS1 are not fully 
understood. What has been demonstrated however, is the ability of the RPS4 TIR domain to 
activate a cell death response when transiently overexpressed in isolation. This has led to 
the proposed model that upon effector binding by RRS1, suppression of RPS4 TIR is 
released allowing the formation of a signalling-competent RPS4 TIR domain homodimer114. 
 
The mechanism by which AvrRps4 activates the RRS1/RPS4 complex appears to differ from 
PopP2. For example, PopP2 was not observed to disrupt interactions between RRS1 Dom4 
and WRKY-Dom6R in BiFC or coimmunoprecipitation assays. It is likely therefore that 
distinct changes are occurring upon binding of AvrRps4 and PopP2. These distinctions likely 
involve Dom6R which has been shown to be specifically required for PopP2 perception. 
Further evidence for distinct AvrRps4 and PopP2 RRS1 activation mechanisms comes from 
the identification of mutants S983F and E1070K in RRS1-R Dom4, and C887Y in RPS4 CTD 
which impair PopP2 triggered HR but not AvrRps4152. This indicates the requirement of 
distinct residues within RRS1 and RPS4 for PopP2 recognition implying the mechanism of 
intra and inter-molecular changes occurring within the RRS1/RPS4 complex differs between 
effectors. The role these residues play in the activation of RRS1/RPS4 is still not understood 
and will likely require gaining structural information on these domains to assign precise 
functional roles.  
 
The AvrRps4 activation mechanism of the A pair and B pair of RRS1/RPS4 also appears to 
differ. For example, whilst RRS1B required Dom6B for AvrRps4 induced activation truncated 
RRS1 ΔDom6 is still capable of inducing AvrRps4-dependent HR in the presence of RPS4 
(unpublished data Dr Yan Ma). Additionally, whilst Dom4 and Dom6 of RRS1 were observed 
to interact in BiFC studies and coimmunoprecipitation assay no such interaction was 
observed between RRS1B Dom4 and Dom6B152. This suggests that RRS1B Dom4-WRKY-
Dom6B has a different conformation from this region in RRS1 suggesting different inter- 





What intra- and inter-domain interactions changes occur within RPS4 once RRS1 
suppression of RPS4 is released is not understood. RPS4’s NB-ARC domain is thought to play 
an important role in induction of ETI as mutations in RPS4’s nucleotide binding P-loop 
render the RRS1/RPS4 complex non-functional114. Conversely a functioning RRS1 P-loop is 
not required for complex activation highlighting RPS4’s role as the ‘executor’ NLR in the 
pair114. In addition to the functioning RPS4 NB-ARC domain, heterodimerization of the 
RRS1/RPS4 TIR domains has been shown to be crucial in the maintenance of a functioning 
effector recognition complex. The TIR domain of RPS4 can activate defence in an effector 
independent manner whilst RRS1 TIR does not, and can inhibit RPS4 constitutive action of 
defence via its heterodimerization interface114. This interface involves the residues within 
the αA and αE helices and EE loops of RPS4 and RRS1 TIR and the DD loops of RRS1 TIR, 
Figure 11. At the core of this interface resides a stabilising stacking interface of Histidine 
residues (RPS4 H34 and RRS1 H26) as well as interactions between the serines in each TIR 
which precede this histidine residue (SH motif) which together stabilise the heterodimer, 
Figure 11.B. Mutation of this SH motif also prevented homodimerization of RPS4 TIR and 
induction of RPS4-dependent cell death highlighting the importance dimerization of TIRs 
plays in induction of RRS1/RPS4 dependant ETI114.  
 
It is predicted that upon effector perception, RRS1 TIR’s inhibition of RPS4 is released 
enabling the formation of signalling competent RPS4 TIR homodimer. The exact role the TIR 
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Figure 1.11 Heterodimerization interface of RRS1 and RPS4 TIR domains. (A) Crystal structure of 
RRS1 TIR (orange) and RPS4 TIR (teal) heterodimer interface shown in cartoon representation. 
Residues contributing to interface are highlighted in the amino acid and secondary structure below. 
(B) The position of serine and histidine residues within the SH motif heterodimerization interface. 





domains play in instigating ETI upon activation by effector perception is not fully 
understood. It has recently been hypothesised that TIR domains may possess NADase 
activity. These investigations came following the identification that mammalian 
SARM1(sterile alpha and Toll/interleukin-1 receptor motif-containing 1) TIR domain shows 
intrinsic NADase activity cleaving NAD+ (nicotinamide adenine dinucleotide) into ADPR (ADP 
ribose), cyclic ADPR and nicotinamide154. Whilst an ability to cleave NAD+ into nicotinamide 
and ADPR has now been demonstrated for the TIR domains of NLRs RUN1 and L6, albeit at 
distinctly lower enzymatic levels than observed with SARM TIR domain, RPS4 TIR domains 
were not found to have such biochemical activity92,93. Conceivably the correct substrate for 
RPS4 TIR domain cleavage may have not yet been identified or RPS4 TIR may function in a 
disparate manner that L6 and RUN1 potentially via signalling through cooperative assembly 
formation (SCAF)85acting a structural platform. 
 
1.6 Project aims and objectives 
 
If we are to be in a position to engineer synthetic NLRs with the ability to perceive currently 
unrecognised effectors we need to gain a comprehensive understanding of how NLR 
receptors function mechanistically.  Our mechanistic understanding of plant NLRs is still 
hindered by a lack of structural information of these receptors. The structures we do have 
of plant NLRs are largely of single domains in isolation and predominantly limited to the N-
terminal CC or TIR domains. Though the publishing of the ZAR1 structure provided a 
significant leap forward in our understanding of plant NLR activation108,109, this structure 
only represents one type of NLR as a CC-NLR with indirect-decoy effector recognition. Given 
the great diversity of known plant NLRs and effector perception strategies it is highly 
unlikely ZAR1 will provide a universal mechanism through which all NLRs function. This is 
important to recognise as only in attaining a comprehensive understanding of NLR receptor 
mechanisms will the field have the foundation to enable effective engineering or NLRs with 
expanded effector recognition capability. It is therefore vital for the progress of the plant 
NLR field that we gain structural and quantitative biochemical insights of other NLRs in 
order to understand the structural basis through which NLRs function and validate and 
challenge our current models of thinking.  
 
The lack of multidomain structures of NLRs beyond ZAR1 is likely not the result of a lack of 
effort in the field. Instead this reflects the notorious difficulties of expressing these proteins 




NLRs in various expression systems with breakthroughs of full-length NLR expression for 
structural studies only achieved in 2013 and 2019 respectively101,108,109. 
 
The primary aim of this study is to gain biochemical and structural insights into the 
mechanistic functioning of the RRS1/RPS4 NLR pair.  
 
Within this aim, the first objective of this study is to evaluate a diverse range of 
heterologous protein expression systems for the ability to produce RRS1 and RPS4 protein, 
both full-length and domain truncations. By completing a comprehensive study of 
prokaryotic and eukaryotic systems including plant-based expression systems, this study 
aims to evaluate the expression requirements of RRS1 and RPS4. In addition to providing a 
pipeline for RRS1/RPS4 protein production, the insights this work will bring will also provide 
a valuable foundation for other studies of a similar nature looking to express plant 
NLRs.Through completing this first objective, the study would establish a pipeline for 
expressing soluble RRS1 and RPS4 protein to utilise in downstream structural and 
quantitative biochemical studies. As such, the second objective of this work is to begin to 
utilise these identified pipelines to produce RRS1 and RPS4 protein to begin to dissect the 
mechanism through which these NLRs recognise effectors and activate defence responses 
utilising techniques such as analytical gel filtration and Blue Native PAGE. 
 
The third objective of this study focusses on understanding the structural basis of RRS1 
WRKY domain’s recognition of effectors. Given the diversity of RRS1 variations we have in 
both the A and B pair of the protein, this system provides a unique opportunity to 
understand the inherent flexibilities in effector recognition and activation of integrated 
domain NLRs. This study looks to gain a further understanding of this plant/NLR interface 
than biological work has previously provided through utilising structural biology and 
quantitative and qualitative biochemical techniques. These techniques include SPR (Surface 
plasmon resonance) and analytical gel filtration.  
 
Drawing information together from work looking at evaluating the biochemistry of multi 
domain RRS1 and RPS4 protein with a deeper understanding of how effectors are perceived 
by RRS1 will bring fresh insights into the mechanistic behavior of this NLR pair. In this way 
this study will provide an expanded understanding of plant-pathogen interactions at the 
molecular level and contribute towards a growing body of the work in the field which can 
be utilised to strengthen global food security. 
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2 Materials & Methods 
2.1 Materials 
 
2.1.1 Chemicals and Reagents 
Chemicals used in this study were purchased from Sigma-Aldrich, Melford Laboratories, 
Honeywell Fluka, Avantor or Thermo Fisher Scientific unless otherwise stated.  
 
2.1.2 Antibiotics 
Stock and selective media working concentrations for Escherichia coli as well as solutes are 
as listed in Table 2.1. Stock solutions of Chloramphenicol and Gentamycin were stored at -
200C whilst all other antibiotic stocks were stored at 40C. Stock solutions were filter 
sterilised using a 0.3 μm Ministart® filters prior to storage. 
 
Table 2.1 Antibiotics used in this study 
Antibiotic Stock concentration Working Concentration 
Carbenicillin 100 mg/ml in H20 100 μg/mL 
Chloramphenicol 34 mg/ml in ethanol 34 μg/mL 
Gentamycin 10 mg/ml in H20 20 μg/mL 
Kanamycin 30 mg/ml in H20 30 μg/mL 
Rifampicin 10 mg/ml in methanol 50 μg/mL 
 
2.1.3 Bacterial Media: Lysogeny Broth (LB) 
Lysogeny broth media (LB) (LB broth Miller, Formedium) consisting of 1.0% (w/v) tryptone, 
0.5% (w/v) yeast extract and 1.0% (w/v) sodium chloride at pH 7.0, was made up in de-
ionised water prior to autoclaving. Solid LB media plates were prepared with 1% (w/v) 
microbiology grade agar before autoclaving. During transformation electro-transformed or 
chemically transformed cells were rescued with L media, which has a lower salt content of 
0.5% (w/v) compared to 1.0% (w/v) of LB broth.  
 
2.1.4 Bacterial Media: Autoinduction media (AIM) 
AIM (Auto-induction media) was prepared with 1% (w/v) Yeast extract, 0.5% w/v Tryptone, 
0.035% (w/v) auto induction medium micro element mix (Formedium), 0.33% (w/v) 
2 
Materials & Methods 
 49 
ammonium sulphate, 0.68% potassium dihydrogen phosphate, 0.71% (w/v) Disodium 
hydrogen phosphate, 0.05% (w/v) glucose, 0.2% (w/v) α-lactose, 0.015% (w/v) magnesium, 
trace elements. Media was prepared in de-ionised water and autoclaved prior to use. 
 
2.1.5 Bacterial Media: Power Broth 
PowerBroth™ media powder was purchased from Molecular Dimensions and prepared as 
5.2% (w/v) PowerBroth™ powder with 0.4% (v/v) glycerol.  
 
2.1.6 Sf9 Baculovirus media 
Spodoptera frugiperda clonal isolate Sf9 insect cells were grown in Sf-900™ II medium 
purchased from Invitrogen. Sf-900™ II medium is a serum-free and protein-free insect cell 
culture medium which has been optimised for the growth and maintenance of Sf9 and Sf21 
S. frugiperda cells as per OPPF’s standard operating procedure for ‘Insect Expression’ 
produced by Joanne Nettleship (https://www.oppf.rc-harwell.ac.uk/OPPF/protocols/). 
 
2.1.7 Bacterial strains: Escherichia coli 
For plasmid preparation and storage cloning purposes bacterial strains DH10B, DH5α and 
ElectroMAX™Stbl4™ were used. High-throughput protein expression screening at OPPF 
(Oxford Protein Production Facility) was conducted in Lemo21(DE3) and Rosetta™(DE3) 
pLyS E. coli cells. Rosetta™(DE3) pLyS and Rosetta™ 2(DE3) strains were grown in media 
supplemented with chloramphenicol in order to maintain the pRARE2LysS and pRARE2 
plasmids respectively. Sequential protein expression experiments extended to included 
SHuffle®T7, BL21(DE3) and Rosetta™ 2(DE3) E. coli strains. The genotypes and suppliers of 
all E. coli cell strains used in the study can be found in Table 2.2. 
 
Table 2.2 E. coli strains and genotypes used in this study 
E. coli strain Genotype 
BL21(DE3) 
(NEB) 




F– mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139 Δ(ara-leu)7697 galU galK 
λ– rpsL(StrR) nupG 





F– φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
ElectroMAX™Stbl4™ 
(Invitrogen) 
mcrA Δ(mcrBC-hsdRMS-mrr) recA1 endA1 gyrA96 gal-thi-1 supE44 λ-




fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS/ pLemo(CamR) λ DE3 = λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
pLemo = pACYC184-PrhaBAD-lysY 
 
Rosetta™ 2 (DE3) 
(Merck Millipore) 
 









F´ lac, pro, lacIq / Δ(ara-leu)7697 araD139 fhuA2 lacZ::T7 gene1 
Δ(phoA)PvuII phoR ahpC* galE (or U) galK λatt::pNEB3-r1-
cDsbC(SpecR, lacIq) ΔtrxB rpsL150(StrR) Δgor Δ(malF)3 
 
 
2.1.8 Bacterial Strains: Agrobacterium tumefaciens 
Two strains, GV3101 and AgL1, of Agrobacterium tumefaciens strains were used for 
transient transformation of both Nicotiana benthamiana and Nicotiana tabacum. Both 
strains carried rifampicin resistance with GV3101 carrying additional gentamycin resistance 
for maintenance of pMP90 helper plasmid. 
 
2.1.9 DNA Oligonucleotides 
Oligonucleotides were synthesised by Merck Millipore on 0.025 mg scale unless otherwise 
stated using a desalting purification method to remove small-molecule impurities. 
Lyophilised primers were resuspended in ddH2O to a final concentration of 100 μM and 
stored at -200C.  100 μM stocks were diluted to a working concentration of 20 μM and also 
stored at -200C.  A full list of oligonucleotide primers used in this study can be found in 
Appendix 1. 
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2.1.10 DNA fragment synthesis 
DNA fragments used in this project were synthesised from Twist Biosciences. 
 
2.1.11 Plant material: Nicotiana spp 
Nicotiana benthamiana and Nicotiana tabacum cultivar ‘Petit Gerard’ were grown in long 
days (16 hours light, 8 hours dark) under controlled conditions at 240C prior to A. 
tumefaciens-mediated transient transformation of leaf tissue.   
 
2.1.12 Plant material: Arabidopsis thaliana 
Approximately 50mg of transgenic Arabidopsis thaliana seed was sterilised in 1ml of 
sterilisation liquid (1% NaClO, 0.1% Tween20) for 5 mins with periodic agitation. Seeds were 
spun down at 1000 rpm for 30 seconds and the sterilisation liquid supernatant discarded. 
The sterilised seeds were then washed twice with ELGA water spinning down seeds in 
between each wash at 1000 rpm for 30 seconds. In a flow hood seeds were then sowed in 
100 ml of 1% Murashige and Skoog (MS) media155 in 250 ml conical flasks. Seeds was grown 
in shaking liquid culture at 100 rpm for ~2 weeks in a controlled growth room at 220C under 
long day conditions (16 hours light, 8 hours dark) before tissue was harvested and snap 
frozen in liquid nitrogen and stored at -800C or used fresh. 
 
2.2 Molecular Biology 
 
2.2.1 Expression Vectors 
Vectors used for expression in E. coli, Sf9 Insect cell, N. benthamiana, N. tabacum and 
wheat germ cell free heterologous systems in this study can be found in Table 2.3. Maps of 
all protein expression vectors used in this study can be found in Appendix 2. A list of all 
cloned plasmids used in this study can be found in Appendix 4. 
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2.2.2 Polymerase Chain Reaction (PCR) 
Polymerase chain reactions (PCRs) were carried out to amplify regions of DNA for cloning 
purposes and to confirm the presence of target plasmids in transformed bacterial colonies 
referred to as colony PCRs. For colony PCRs, TAQ DNA polymerase (NEB) was used whilst 
cloning PCR products were generated using high fidelity Phusion DNA polymerase (NEB) or 
KAPA HiFi DNA Polymerase (Roche). Reaction mixes were setup as per manufactures 
instructions and reactions performed in a C1000 Touch thermocycler (Bio-Rad). Plasmid 
DNA or cDNA was used for PCR template for cloning PCR product purposes whilst for colony 
PCRs single transformed colonies were diluted in 30 µl of water and 1 µl of this solution 
added to each 15 µl PCR reaction. Annealing temperatures and elongation times were 
optimised based on the properties of the primers and the amplification fragment. PCR 
program parameters for colony PCRs and Phusion PCRs can be found in Table 2.4. 
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In the case of full-length cDNA of RRS1-R it was found that a significantly longer than 
predicted elongation time of 6 minutes was optimal for amplification of fragment.  
 












2.2.3 Gel Electrophoresis 
1% (w/v) agarose gels in TAE (40 mM Tris pH 7.6, 20 mM acetic acid, 1 mM EDTA, 0.5 µg/ml 
ethidium bromide) were used to separate DNA fragments according to size following PCR or 
restriction enzyme digest. DNA samples were mixed with 10x loading dye (40% v/v glycerol, 
0.5% (w/v) SDS, 10 mM EDTA, Orange G) prior to gel loading with an accompanying well 
loaded with DNA ladder. Ladders used in this study were Quick-Load Purple 100bp DNA 
ladder (NEB) or Quick-Load Purple 2-Log DNA ladder (NEB). Samples were run using 
horizontal electrophoresis at 90-130V for 15-20 min before imaging using a UV 
transilluminator (Bio-Rad). DNA bands for cloning purposes were then excised using a razor 
and purified from the agarose gel using QIAquick DNA Gel extraction kits (QIAGEN) 
according to the kit protocol.  
 
2.2.4 Golden Gate Cloning 
Golden Gate cloning utilises Type IIS endonucleases and T4 DNA ligase for the simplified 
assembly of multiple DNA fragments and standard parts into a destination vector in a few 
reactions159,160. Golden Gate cloning was used in this study to generate constructs for in 
planta expression and wheat germ expression. This study used the Type IIS endonuclease 
BsaI which cleaves outside of its 5’GGTCTC3’ recognition site to leave a 4 bp overhangs 
after digestion. Constructs were assembled using the TSL Synbio long protocol using a 












 Priming 95 120 1   Priming 98 300 1 
Denaturing 95 30   Denaturing 98 10  
Annealing 55 15        Annealing 57-60 30       
Extension 72 30s/1KB   Extension 72 15s/1KB  
Final 
extension 
68 300 1  Final 
extension 
72 600 1 
Hold 16 ∞ 1  Hold 16 ∞ 1 
29 30 
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reaction mix consisting of; 100 ng of acceptor vector, 1x T4 Ligase buffer (NEB), 0.1 mg/ml 
Bovine Serum Albumin, 20 U/µl T4 DNA ligase (NEB), 1 U/µl BsaI-HF (NEB) and insert 
fragments in 2:1 insert:acceptor vector go through the digestion-ligation reaction protocol 
shown in Table 2.5 Following the digestion-ligation protocol, the reactions were desalted 
using a sepharose column before transformation into E. coli.  
 
Table 2.5 Long Protocol Digestion-Ligation reaction protocol 
Time Temperature Number 
of Cycles 
20 sec 370C 1 
3 min 370C  
4 min 160C 26 
5 min 500C 1 
5 min 800C 1 
∞ 160C  
 
2.2.5 Infusion Cloning 
Infusion (Clontech) cloning was used for the generation of the E. coli and insect cell 
expression pOPIN vector constructs developed by Oxford Protein Production Facility 
(OPPF), vector maps of heterologous protein expression vectors found in Appendix 2. 
Infusion cloning is a ligation-independent method based on the annealing on 
complementary ends of a PCR insert fragment and linearized cloning acceptor vector70. 
Firstly, PCR products with specific primer extensions are generated to allow for the direct 
cloning of these PCR fragments into pOPIN vectors. Prior to cloning, pOPIN acceptor vectors 
must be linearized with restriction enzymes to allow for insertion of PCR fragment. 
Acceptor pOPINF/S3C/M vectors were linearized by digestion with KpnI and HindIII, pOPINE 
with NcoI and PmeI and pOPINA with NcoI and DraI for 2 hours at 370C before gel 
purification (see section 2.2.3). Infusion reactions were setup with 100 ng of linearized 
destination pOPIN vector, 50-100 ng purified PCR product (Section 2.2.3), 1 µl Infusion 
enzyme pre-mix (Clontech) and made up to 5 µl with ddH2O following the manufacturer’s 
instructions. Reactions were incubated for 30 mins at 420C followed by 15 mins at 500C 
before cooling on ice prior transformation of reactions into DH10B E. coli and plating onto 
IPTG and X-gal supplemented plates for blue-white selection. All RRS1 pOPIN constructs 
were cloned from a RRS1-R cDNA construct generated from N. benthamiana cDNA 
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transiently overexpressing 35s::RRS1-R:HF generated by myself. RPS4 constructs were 
cloned from various cDNA fragments cloned by myself and Dr Zane Duxbury from 
reassembling the exons of a RPS4 gDNA construct. 
 
2.2.6 Plasmid purification & confirmation 
Once colony PCRs (section 2.2.2) were carried out to identify colonies carrying correct 
predicted construct each colony was inoculated into 5 ml of L medium and grown overnight 
370C shaking at 200 rpm. Cells were harvested and plasmid purified using QIAquick Spin 
Miniprep kit (QIAGEN) as per manufacturer’s instruction. Each plasmid prep was eluted in 
35 µl of warmed ddH2O. Non-pOPIN vector construct plasmids were then checked for 
correct assembly using restriction enzyme digest analysis. All plasmids sequences were 
then verified by sanger sequencing using Eurofins Genomics LightRun sequencing services 
(previously GATC Biotech). Verified plasmids were retransformed into DH10B cells and 
cultured to make glycerols by mixing cultures with 20% glycerol prior to freezing in liquid 
nitrogen and storage at -800C. 
 
2.2.7 Transformation of competent bacterial cells 
Transformation of plasmids and ligation reactions into electrocompetent E. coli DH10B and 
ElectroMAX Stbl4 or A. tumefaciens GV3101 were conducted by electroporation. 50 µl 
aliquots of electrocompetent were thawed on ice before adding 100-400 ng of plasmid or a 
5 µl desalted ligation reaction. The cell-DNA mix was then placed in a 0.1 cm cooled 
electroporation cuvette and electroporation conducted using a MicroPulser (Bio-Rad). 
MicroPulser conditions for E. coli were: 1800 V, 25 µF capacitance, 200 Ω resistance and for 
A. tumefaciens were 2400 V, 25 µF capacitance, 200 Ω resistance. All other cells, unless 
otherwise stated, used in this study were transformed using heat shock treatment of 
chemically competent cells. For heat shock treatment, aliquots of chemically transformed 
cells were thawed on ice and mixed with 100-400 ng of plasmid before being incubated on 
ice for 20 minutes. Cells were then heat shock treated for 42 second at 420C followed by a 5 
minute incubation on ice.  
 
Following electroporation or heat shock treatment, cells were diluted with 250 µl of L 
media and left shaking at 200 rpm for 1 hour at 370C or 280C for E. coli and A. tumefaciens 
respectively to allow cells to recover before plating. 50-250 µl of cells were then plated on 
appropriate antibiotic selection LB plates and left to grow overnight at 370C or 280C for E. 
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coli and A. tumefaciens respectively. Blue/white selection plates were generated by 
spreading 10 µl of 1 M IPTG and 40 µl of 40 µg/ml on plates prior to plating of cells.  
 
2.2.8 Isolation of total RNA & cDNA from N. benthamiana 
N. benthamiana tissue harvested 2 dpi was ground to a fine powder using precooled pestle 
and mortar. ~150 mg of ground tissue was then transferred to a precooled 2ml Eppendorf 
and the tissue vortexed with 1 ml TRI reagent (Sigma) and incubated for 5 minutes on ice. 
The sample was then centrifuged at 40C 12,000 x g for 5 minutes. 150 µl of BCP (1-bromo 3-
chloropropane, Sigma) was then added and the sample vortexed before incubation at room 
temperature for 10 minutes. Samples were then centrifuged for 10 minutes at 12,000 x g 
40C. The aqueous upper phase, ~800 µl was then transferred to a fresh 2 ml Eppendorf and 
mixed with 400 µl Isopropanol and 400 µl high salt precipitation solution (0.8 M sodium 
citrate, 1.2M NaCl) to precipitate the RNA. Samples were mixed well by turning before 
incubating for 5 minutes at room temperature. Samples were then centrifuged for 15 
minutes at 12,000 x g at 40C and the supernatant discarded. The RNA pellet was then 
washed with 1.5 ml 75% ethanol then centrifuged for 5 minutes at 7,500 x g at 40C. The 
resulting pellet was air dried and then resuspended in 30 µl DEPC treated H2O. To remove 
any contaminating DNA, the RNA samples were treated with a DNAse treatment using 
RNAse free DNAseI (Roche) as per manufacturer’s instructions. In order to deactivate the 
DNAse, samples were then treated with proteinase K for 15 minutes at 420C. RNA was then 
purified from the sample using QIAGEN RNeasy clean-up kits according to the kit protocol. 
RNA was eluted from RNeasy columns in 50 µl RNAse-free water. The concentration of RNA 
was quantified using a nanodrop and integrity of the RNA observed by gel electrophoresis 
running 1 µl of sample.  
 
cDNA was generated through reverse transcription of 2-5 µg RNA using SuperScript II 
Reverse Transcriptase (Invitrogen). A reaction mixture of purified RNA, Oligo(dT)12-18 and 
dNTPs was incubated at 700C for 5 mins before placing back on ice to disrupt the secondary 
structures of RNA and primers. DTT, SuperScript II buffer, RNAseOUT and SuperScript II 
Reverse transcriptase were then added to the mix and incubated at 420C for 75 mins 
followed by 700C for 15 mins to deactivate the enzymes before being transferred back to 
ice. The cDNA volume was then adjusted to 60-100 µl and stored at -800C.  
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2.3 Transient expression in Nicotiana spp (Agroinfiltration) 
 
Agrobacterium strains were streaked on to solid LB media plates supplemented with the 
appropriate antibiotics from glycerols stored at -800C 3 days prior to the infiltration date 
and grown at 280C for ~2 days. 10 ml overnight cultures of agrobacterium strains were then 
set up from these plates in LB media supplemented with the appropriate antibiotics and 
grown shaking overnight at 280C. Cells were then pelleted by centrifugation at 3500 x g for 
10 mins. Pelleted cultures were resuspended in 2 ml of infiltration buffer (10 mM MgCl2, 10 
mM MES, pH 5.6). Cultures were then diluted in infiltration buffer to OD600= 0.5 to make 
the final mix for infiltration. For co-expression of multiple agrobacterium strains, each 
strain was adjusted to be OD600= 0.5 in the final mixture to ensure the same quantity of 
each expression in the infiltration mix. The agrobacterium mixtures were then incubated at 
room temperature for ~1 hour prior to infiltration. The abaxial leaf surface of N. 
benthamiana or N. tabacum leaves were infiltrated ~5 weeks after sowing with a blunt 
ended 1 ml syringe. N. tabacum leaves were pricked with a sterile needle prior to 
infiltration to aid the delivery of agrobacterium to the leaf apoplast. For protein expression, 
N. benthamiana leaves were harvested and the mid-vein removed before being frozen in 
liquid nitrogen and stored at -800C 2 dpi (days post inoculation). For hypersensitive 
response (HR) assays, N. tabacum leaf images were taken 3-5 dpi. This method is based on 
that described in Sarris et al, 201558. 
 
2.4 Biochemical Techniques 
 
2.4.1 Total protein extraction from plant tissue 
Harvested frozen plant tissue was ground to a fine powder in liquid nitrogen with a 
precooled pestle and mortar. ~0.5 ml of powder (~0.15 g of powdered tissue) was then 
transferred to a pre-cooled 2 ml Eppendorf and mixed thoroughly with 1 ml of extraction 
GTEN buffer (150 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 % v/v glycerol) 
supplemented with 10 mM DTT, 0.2%Nodinet-40 (NP40), anti-protease tablet (cOmplete™ 
EDTA-free, Sigma Aldrich). For N. benthamiana tissue, the extraction buffer also contained 
2% (w/v) PVPP (Polyvinylpolypyrrolidone). Samples were then incubated in the extraction 
buffer at 40C on a rotor. Incubated samples were then centrifuged at 5000 x g for 20 
minutes at 40C and the supernatant collected. To check for protein expression in the total 
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extract, 100 µl of supernatant was then heated with SDS-PAGE loading buffer to 950C for 10 
mins. This method was adapted from Sohn et al, 2014 161. 
 
2.4.2 SDS-PAGE 
This project used two different SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) systems. 
 
Method 1: SDS-PAGE gels were prepared in the lab with a resolving gel layer of 12% or 17% 
w/v polyacrylamide diluted in 375 mM Tris-HCl pH 8.8 and 0.1% w/v SDS. Immediately prior 
to pouring into Mini-PROTEAN 1 mm casting glass plates (Bio-Rad) 0.1 % (w/v) ammonium 
persulfate and 0.04 % (v/v) N,N,N’,N’-tetraacetylethylenediamine was added to the 
polyacrylamide SDS solution. Water saturated butanol was then applied to the top of the 
resolving gel layer whilst setting to ensure a level boundary between the stacking and 
resolving gel layers. This butanol solution was removed once the resolving gel layer had set 
and stacking gel mixture poured on top (5 % w/v polyacrylamide, 63 mM Tris-HCl, pH 6.8 
with 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium persulfate and 0.1 % (v/v) N,N,N’,N’- 
tetramethylethylenediamine). Plastic gel casting combs were then added and the gels left 
to set. Gels were subsequently wrapped in clingfilm and stored at 40C prior to use. Protein 
samples were heated at 950C for 10 mins in 4x SDS-loading buffer (final concentrations: 50 
mM Tris-HCl, pH 6.8, 100 mM dithiothreitol (DTT), 2.0 % (w/v) SDS, 0.1 % bromophenol 
blue, 10 % glycerol). Gel combs were removed prior to loading denatured protein samples 
and gels run in a Bio-Rad miniPOTEAN tetra cell system in SDS-running buffer (25 mM Tris-
HCl, 250 mM NaCl, 0.1 % w/v SDS). Protein samples were loaded along with a pre-stained 
protein standard (RunBlue™ Prestained Molecular Weight Marker, Expedeon or Plus2 Pre-
stained Protein Standard, Invitrogen) and run at 140-180V for 60-75 minutes. 
 
Method 2: Pre-cast 16%, 12% or gradient 4-20% (w/v) polyacrylamide Teo-Tricine SDS gels 
were purchased from Expedeon. Gels were run in RunBlue™ tanks with 1x RunBlue™ Teo-
Tricine SDS running buffer. Prior to loading, protein samples were heated at 950C for 10 
mins in 4x LDS Sample Buffer (Expedeon) supplemented with 100 mM DTT. Gel wells were 
flushed with buffer prior to sample loading and protein samples loaded alongside a pre-
stained protein standard (RunBlue™ Prestained Molecular Weight Marker (Expedeon) or 
Precision Protein™ Dual Xtra Prestained Protein Standard (Bio-Rad). Gels were run at 120-
180V until the dye front reached the bottom of the gel. 
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For visualising proteins, gels prepared by either method were stained overnight shaking at 
room temperature in InstantBlue™ Coomassie Protein Stain (Expedeon) before rising in 
deionised water and imaging using a G:BOX gel doc system (Syngene) and GeneSys 
software.  
 
2.4.3 Immunoblotting (Western blotting) 
SDS-PAGE gels were run as described in 2.4.2. Proteins in the gel were then transferred to a 
PVDF (polyvinylidene difluoride, Merck Millipore) membrane using semi-dry transfer 
apparatus Trans-Blot® TurboTM Transfer System (Bio-Rad) using the ‘High-Molecular 
Weight’ programme according to the manufactures instructions. Following protein transfer, 
gels were blocked for 1 hour in TBST (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1 % Tween®-
20) supplemented with 5% (w/v) non-fat dried milk powder with gentle agitation. Following 
blocking, membranes were incubated with the appropriate antibody in a solution of TBST 
with 5% (w/v) non-fat dried milk powder overnight at 40C with gentle agitation. Antibody 
concentrations can be found in Table 2.6. If a secondary HRP-conjugated antibody was 
required membranes were then washed 3 times with TBST for 10 minutes. Following 
antibody incubation, membranes were washed 3 times in TBST for 5 minutes then in TBS 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl) for 10 minutes. Chemiluminescence visualisation of 
blots was then carried out by thinly covering membranes in 500 µl of HRP substrate 
developing reagent (SuperSignal West Pico Plus or Femto solution, Thermo Scientific). Blots 
were imaged using an ImageQuant LAS 4000 (Life Sciences) or X-ray film exposure 
(Fujifilm). This method is based on that described in Sarris et al, 201558. 
 




α-FLAG HRP M2 1: 10000 Sigma Aldrich  
α-HA HRP  1: 3000 Sigma Aldrich  
α-mCherry  1:3000 Abcam  
α-mNeon 1:2000 Chromotek  
α-rabbit IgG HRP 1:10000 Sigma Aldrich  
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2.4.4 Native-PAGE  
Following protein extraction, protein samples were mixed with 10x Native loading buffer 
and loaded onto a precast 3-12% Native PAGE Bis-Tris Gel (Life Technologies) alongside 
NativeMark Unstained Protein Standard (Thermo Scientific) ladder.  The NativePAGE gel 
was run at 150 V for 60 minutes followed by 250 V for 30-60 minutes at 40C until the dye 
front had reached the base of the gel as per the manufacturer’s protocol. Following gel 
electrophoresis, proteins were transferred to a PVDF membrane in 1x Novex transfer 
buffer. Proteins were transferred as per manufactures instructions using the ‘High-
Molecular Weight’ programme on the semi-dry transfer Trans-Blot® TurboTM Transfer 
System apparatus (Bio-Rad). Following transfer membranes were immediately fixed by 
washing in a solution of 25% methanol and 10% acetic acid for 10 minutes. Membranes 
were then twice washed with distilled water and left to air dry overnight. Once dried 
membranes were reactivated in methanol for 30 seconds and then blocked, probed and 
imaged as described in section 2.4.3.  This method is based on that described in Sarris et al, 
201558. 
 
2.5 High-throughput protein expression screening 
 
Constructs for high-throughput protein expression screening in E. coli and Sf9 Baculovirus 
transfected insect cells were generated using Infusion cloning in pOPIN vectors according to 
section 2.2.5. A list of constructs generated for this expression screen can be found in Table 
3.2. 
 
2.5.1 Rational Design of Protein constructs 
RRS1 and RPS4 domain boundaries on which protein expression boundaries were based 
were defined on the basis of homology to other NLRs. Protein disorder prediction analysis 
was conducted using RONN protein disorder prediction analysis162 
(https://www.strubi.ox.ac.uk/RONN) or IUPred2A163 (https://iupred2a.elte.hu/). Secondary 
structure prediction analysis was conducted using PHYRE2164 
(www.sbg.bio.ic.ac.uk/phyre2/).  
 
2.5.2 E. coli expression screening 
High-throughput screening of RRS1 and RPS4 constructs in E. coli was conducted at the 
OPPF. All constructs except for constructs 39-43 listed in Table 3.2 were screened by myself 
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with the supervision of Heather Rada at OPPF. Each pOPIN construct was screened in two E. 
coli strains, Lemo21(DE3) and Rosetta (DE3) pLysS, grown in two different medias, Power 
Broth and AIM (Overnight Express™ Instant TB medium) at 200C and 250C respectively. This 
meant that each construct was tested in four different expression conditions. Alongside the 
RRS1 and RPS4 pOPIN constructs an eGFP construct was also transformed as a control. The 
protocol described below follows OPPF’s standard operating procedure for ‘small-scale 
cloning and expression’ for E. coli produced by Joanne Nettleship (https://www.oppf.rc-
harwell.ac.uk/OPPF/protocols/). 
 
Expression screening cell growth: 
Sequence verified pOPIN vector constructs were transformed into Lemo21(DE3) and 
Rosetta (DE3) LysS but conducting a heat shock treatment. ~300 ng of pOPIN plasmid was 
added to aliquots of chemically competent E. coli cells and incubated on ice for 30 mins 
before heating at 420C for 30 seconds in a water bath. Cells were then returned to ice for 2 
minutes before 300 µl of Power broth with no antibiotic selection was added to each tube 
and tubes incubated at 370C for 1 hour. Following incubation cells were plated on solid LB 
media plates supplemented with the correct antibiotic. Plates were incubated overnight at 
370C. 24 Deep-well plates were then setup with 0.7ml of Power Broth supplemented with 
the appropriate antibiotic. Colonies were then picked from the solid LB media plates and 
added to each well. Deep-well blocks were then sealed with gas permeable adhesive seals 
(ABgene AB-0718) and grown overnight at 370C shaking at 200-225 rpm. 
 
For expression screening, 24 deep-well plates were setup with 3ml of media in each well 
supplemented with the appropriate antibiotic. Cells were screened in both Power Broth 
media with IPTG induction and autoinduction media (Overnight Express™ Instant TB 
medium). 150 µl of Lemo21(DE3) or 250 µl of Rosetta cells were added to wells of media. 
The plates were resealed with gas permeable adhesive seals and grown shaking at 240 rpm 
at 370C for 3-5 hours until the cells reached ~OD600=0.5. Cells growing in Power Broth were 
then cooled by shaking at 240 rpm at 200C for 20 minutes. Power Broth Cells were then 
induced by the addition of IPTG to a final concentration of 1 mM per well and cells grown 
overnight (~18 hours) at 240 rpm at 200C. Cells growing in autoinduction media were grown 
at cells reached ~OD600=0.5 at 370C before growing the cells overnight (~20-24) hours at 
250C shaking at 240 rpm.  
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Expression screen cell harvesting: 
The following overnight induction, 1 ml of culture from each well was transferred into a 96-
well deep-well block (BC Falcon 353966) maintaining the plate layout. Cells were harvested 
by centrifugation (6000 x g for 10 minutes) and the supernatant carefully discarded. Plates 
were then sealed with corning foils and frozen at -800C for a minimum of 20 minutes to aid 
later cell lysis.  
Robotic miniature Ni2+-NTA purification 
Expressed protein of interest (POI) were then purified using an AVISO Theonyx robotic 
platform using a method adapted from the QIAGEN BioRobot 8000 protocol. 
 
Harvested frozen cell pellets were resuspended in 210 µl of lysis buffer (50 mM NaH2PO4, 
300 mM NaCl, 10 mM Imidazole, 1% v/v Tween20, pH 8.0) supplemented with 1mg/ml 
lysozyme (Sigma Aldrich) and 400 U/ml DNAse I (Sigma Aldrich). Cells were incubated in 
lysis buffer for 30 minutes before centrifugation at 5000 x g for 30 minutes at 40C. The 
supernatant of the lysed cell mixture was then transferred to a 96-well flat bottomed 
magnet compatible microtiter plate (MTP)(Greiner 655101) which contained 20 µl of Ni-
NTA magnetic bead suspension (GE Healthcare) in each well. The insoluble pellet of each 
lysis reaction was then stored at -800C. Each supernatant and Ni-NTA mix was then 
incubated for 30 minutes at room temperature on an MTP shaker.  The 96-well MTPs were 
then placed on a 96-well magnet for 1 min before the supernatant was removed. Ni-NTA 
beads were then washed with 200 µl of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 
mM Imidazole, 0.05% v/v Tween20, pH 8.0) for 5 minutes with agitation before placing 
back on the 96-well magnet and the supernatant was removed. This wash step was 
repeated twice. POIs were eluted from the Ni-NTA beads by mixing with 50 µl of elution 
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole, 0.05% v/v Tween20, pH 8.0) for 
1 minute before collecting the eluate supernatant. The eluate was then analysed by 
running samples on 10% (w/v) polyacrylamide SDS-PAGE gels and staining with 
InstantBlue™ Coomassie Protein Stain, see section 2.4.2.  
 
2.5.3 Baculovirus transfected Sf9 insect cells 
High-throughput screening of RRS1 and RPS4 constructs in Baculovirus transfected Sf9 
insect cells, a clonal isolate derived from the Sfrugiperda IPLB-Sf21-AE parental cell line, 
was conducted at the OPPF. Each pOPIN construct was screened in Sf9 cells transfected 
with two different titres of P1 virus. The protocol described below follows OPPF’s standard 
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operating procedure for ‘Insect expression’ produced by Joanne Nettleship 
(https://www.oppf.rc-harwell.ac.uk/OPPF/protocols/). All Sf9 cell work prior to protein Ni-
NTA purification was conducted under sterile conditions. Alongside the RRS1 and RPS4 
pOPIN constructs an eGFP construct was also transfected as a control. Cell density was 
monitored by mixing 10 µl of Sf9 cells with 10 µl of trypan blue and pipetting into the 
reservoir of a countess slide (Invitrogen). Cells were then counted and checked for dead cell 
to attain viability count and the ratio of cell stock to Sf900II medium needed for a specific 
dilution calculated. 
 
Sf9 cell transfection for P0 virus stock generation: 
Although expression screening can be conducted with P0 virus (Passage 0), P1 (Passage 1) 
virus stock is more reliably used for small to medium scale screening. To generate the P0 
virus stock 500 µl of Sf9 cells (density: 5x105 cells/ml) in Sf-900™ medium (Invitrogen) were 
added to each well of a 24-well culture plate and the cells left to attach to the plate at room 
temperature for 1 hour. Separately, the following transfection mix reagents were mixed: 
100-500 ng pOPIN vector, 250 ng linearized bacmid, 50 µl Sf-900™II medium, 1.5 µl FuGene 
HD Transfection Reagent (Promega). The transfection reaction mix was then gently mixed 
and incubated at room temperature for 30 minutes. This transfection mix was then slowly 
added to the Sf9 cells in the 24-well culture plate to avoid disrupting the cell monolayer and 
gently swirled to distribute transfection mix across the well. The plates were then 
incubated for 6-7 days at 270C. The viral supernatant was then collected and stored in the 
dark at 40C in a sealed 96-well storage block. This supernatant is the P0 virus stock. 
 
Viral amplification of P1 virus stock: 
To generate the P1 virus stock 500 µl of Sf9 cells (density: 1x106 cells/ml) in Sf-900™ II 
medium (Invitrogen)were added to each well of a 24-well culture plate and left to allows 
cells to attach to plate at room temperature for 30-60 minutes. 5µl of P0 virus was then 
added to the Sf9 cells and left to incubate for 6-7 days at 270C. The eGFP control virus was 
monitored to ensure the amplification was working efficiently. Following incubation, the 




A 24-well deep block plate was prepared with 3ml of Sf9 cells (density: 1x106 cells/ml) in 
each well. Sf9 cells well infected with two different titres of P1 virus stock, 3 µl or 30 µl. 
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Cells were incubated for 3 days at 270C shaking at 250 rpm. To asses for protein expression 
levels, 1 ml of each well culture was transferred to a 96-well and centrifuged for 15 min at 
6000 x g. The supernatant was then removed and cells frozen at -800C for a minimum of 30 
minutes. Ni-NTA purification was then performed as per ‘Robotic miniature Ni2+-NTA 
purification’ protocol described in section 2.5.1.  
 
2.6 E. coli Protein Purification 
 
Protein purification methods were based of the protocol developed in the Banfield lab70. 
2.6.1 Small-scale expression screening  
In addition to the high-throughput expression screens conducted at OPPF (Section 2.5) 
screening of constructs for expression in E. coli cells was also conducted by myself in the 
Banfield laboratory at JIC. For these screens, constructs were transformed into E. coli 
strains as described in section 2.2.7. As a starting point for expression screening, constructs 
were first transformed into Rosetta™ 2 (DE3) and BL21(DE3) cells as previous experience in 
the lab highlighted these two strains as having good protein expression rates. Some screens 
were subsequently expanded out to include SHuffle® T7 and Lemo21 (DE3) cells as well. 10 
ml universals of LB media supplemented with the correct antibiotics were inoculated with 
colonies from the transformant plates or a scraping from a glycerol stock and grown 
shaking at 200 rpm overnight at 370C. A 24 deep-well block with 5ml of media per well or 
10 ml universals were then supplemented with the appropriate antibiotics. Each construct 
was initially tested in two types of media, LB and autoinduction media. Fresh 10 ml 
universals or 5ml deep-well blocks were then inoculated with 200-400 µl of overnight 
bacterial cultures and grown shaking at 200 rpm at 370C until cells reached a density of 
OD600=0.4-0.8. Cells grown in LB media were then cooled and induced with a final 
concentration of 1 mM IPTG unless stated otherwise, cells grown in LB media were grown 
in duplicate cultures where one culture was not induced with IPTG to help with identifying 
POI bands by SDS-PAGE analysis. Cell cultures were then grown overnight at 18 or 200C. 
Cells were harvested by centrifuging 1ml of each culture at 3800 x g for 10 minutes and the 
supernatant discarded. 1ml cell pellets were then lysed in 300 µl 1x BugBuster® Protein 
Extraction Reagent (Merck) supplemented with 0.5 µl Benzonase (Merck). Cells were 
incubated in lysis buffer for 5 minutes at room temperature with gentle agitation. A sample 
of the total lysate was then collected for SDS-PAGE analysis. The lysate was then 
centrifuged at 13,300 x g for 5 minutes at 40C to pellet the insoluble fraction of the mixture. 
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A sample of the supernatant was then taken for SDS-PAGE analysis of the soluble protein 
fraction. SDS-PAGE gels were run as per section 2.4.2. Should these small-scale screens 
identify conditions for soluble protein production the conditions were scaled up as per 
2.6.2.  
 
2.6.2 Large-scale culture growth 
50ml of LB media in 250 ml conical flasks supplemented with the appropriate antibiotics 
were inoculated with a scraping taken from a glycerol stock and grown overnight shaking at 
200 rpm at 370C. 1 L of fresh expression media (LB or AIM) was then inoculated with the 
overnight culture to OD600=0.07 (usually 25-35ml of overnight) and grown shaking at 200 
rpm at 370C until culture reached OD600=0.4-0.8. A total of 6-8 L of culture were grown for a 
large-scale purification. For LB grown cultures, cells were then induced with IPTG (final 
concentration 1 mM unless otherwise stated) and cultures grown overnight (~16 hours) at 
the appropriate temperature. For cells grown in AIM, no additional inducer needs to be 
added. As cells grow in AIM they initially metabolise glucose preferentially over lactose. 
Once the glucose in the AIM is depleted lactose is taken up and converted by β-
galactosidase to inducer allolactose. Allolactose then release the lac repressor thereby 
inducing the expression of T7 RNA polymerase which allows expression of POI165. AIM 
grown cultures were grown at 200 rpm at 370C until culture reached OD600=0.4-0.8 then 
grown overnight at 18-250C. Cells were harvested by centrifugation at 5000 x g for 10 
minutes at 40C. Pellets were then completely resuspended in ~50 ml of lysis buffer (50 mM 
Tris-HCl pH 8.0, 500 mM NaCl, 20 mM Imidazole, 50 mM glycine, 5% v/v glycerol with 1 
protease inhibitor tablet per 50 ml buffer) for every 2 L of culture unless otherwise stated. 
Pellets were then frozen for a minimum of 16 hours at -800C.  
 
2.6.3 Large-scale E. coli purification 
Frozen cell pellets were defrosted at room temperature before cells were sonicated on ice 
using a single 10-12 mm probe Vibra-Cell™ sonicator (Sonics). Cells were sonicated at 40% 
amplitude for 1 second on and 3 seconds off for a total of ~10 minutes on. A total protein 
sample was then taken for later SDS-PAGE analysis. The cell lysate was then sonicated for 
30 minutes at 18,500 x g at 40C to pellet the insoluble fraction. The soluble protein fraction 
supernatant was then collected and a sample taken for later SDS-PAGE analysis. The POI 
was then purified from the cell lysate using an automated protein purification system on an 
ÄKTAxpress system (GE healthcare). The soluble cell lysate was first loaded onto a nickel-
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charged 5ml HisTrap™ HP IMAC column (GE healthcare) and unbound protein washed out 
of column with binding buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM Imidazole, 50 
mM glycine and 5% v/v glycerol). IMAC column bound protein were eluted by washing with 
elution buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 500 mM Imidazole, 50 mM glycine 
and 5% v/v glycerol). Eluted protein was immediately loaded onto a Superdex™ 75 HiLoad™ 
26/600 gel filtration column (GE Healthcare) pre-equilibrated in gel filtration running buffer 
(standard buffer: 20 mM HEPES pH 7.5, 150 mM NaCl). See Table 2.7 for a full list of 
construct extraction and running buffers. Gel filtration column elution was collected in 8 ml 
fractions in 24 deep-well blocks and samples from wells corresponding to UV absorbance 
280 nm trace peak analysed by SDS-PAGE for presence of POI. Gel filtration fractions 
containing POI were pooled and concentrated ~20ml. Proteins were concentrated by 
ultrafiltration using Vivaspin® concentrators (Satorius)of various molecular weight (MW) 
cut-off sizes depending on the size of the POI. A concentrator MW cut-off of less than half 
the POI’s MW was used and concentrators centrifuged as per manufactures instructions.  
Once concentrated, POI containing a 3C protease cleavable His/solubility tag were 
incubated with 12µg of His-tagged 3C protease (produced by Richard Hughes) per mg of 
POI overnight at 40C to remove His and solubility tags from the POI. To remove the 
uncleaved POI, His-tagged 3C protease and cleaved solubility tags the cleaved protein 
mixture was manually loaded onto a 5 ml HisTrap™ HP IMAC column (GE healthcare) pre-
equilibrated in binding buffer. The unbound fraction containing the cleaved POI was 
washed out and collected with 15ml binding buffer. Uncleaved POI, 3C protease and 
cleaved solubility tag was eluted in elution buffer and disposed of. The cleaved POI was 
then loaded onto Superdex™ 75 HiLoad™ 26/600 gel filtration column (unless otherwise 
stated) pre-equilibrated in gel filtration running buffer to undergo a second gel filtration 
purification. Gel filtration fractions from the UVA280 trace peak were analysed by SDS-PAGE 
for presence of POI. Fractions containing pure POI were concentrated in an appropriately 
sized Vivaspin® concentrator and purified protein used immediately or flash frozen in 
aliquots of 50-75 µl in liquid nitrogen and stored at -800C.  
 
Protein complexes were produced my three methods. Method 1 involved co-expressing the 
two proteins of interest in the same E. coli cell line where one protein contained a His-tag 
and one protein did not (pOPINA vector). Once pelleted, these cells were processed as 
described above. For complexes where the two-proteins required different growth 
conditions Method 2 was used. In this strategy two cultures are grown separately one 
expressing protein with a 6xHis-tag and one with untagged protein (pOPINA vector).  
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Following culture growth, the cells pellets were resuspended in lysis buffer and frozen 
separately but the cell lysates were mixed after thawing. The rest of the process was then 
conducted with mixed lysates. Method 3 was used for the production of RRS1B WRKY-
AvrRps4 complex only. In this method cells were processed separately as described above 
until the manual Ni-IMAC column to remove His-tagged proteins where both cleaved POI 
were eluted into the same vessel and incubated together on ice for 1 hour prior to the 
second gel filtration. Cell lines, buffer amendments (relative to those listed above) and E. 
coli growth conditions used for each large-scale purified construct in this study can be 
found in Table 2.7. 
 
Table 2.7 Growth and purification conditions for large-scale E. coli preps in this study 

















AIM 18   
RRS1 WRKY  
Dom6SE1195-
C1290 
pOPINS3C Rosetta™ 2 
(DE3) 
LB 20 +1 mM TCEP +1 mM TCEP 






pOPINS3C Rosetta™ 2 
(DE3) 
LB 20 +1 mM TCEP +1 mM TCEP 





pOPINS3C Rosetta™ 2 
(DE3) 
LB 20 +1 mM TCEP +1 mM TCEP 





pOPINF/A BL21(DE3) LB 18   
RRS1  
TIRK6-G153114 
pMCGS7 BL21(DE3) AIM 20  +1 mM TCEP 
 
2.6.4 Measuring protein concentration 
Protein concentration was measured by two methods depending of the number of 
aromatic residues contained within the POI and thereby the protein’s absorbance at 280 
nm. The concentration of proteins containing aromatic residues was measured using a 
NanoDrop™ One spectrophotometer (Thermo Fisher) by absorbance at 280 nm. 
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Absorbance readings were corrected using extinction coefficient of the POI which adjust 
the value based on the aromatic residue composition of the protein. The extinction 
coefficient for a POI was calculated using the ExPASy ProtPram online tool167. For proteins 
which contained little to no aromatic residues (e.g. AvrRps4) protein concentration was 
determined using a Direct Detect® Infrared Spectrometer (Merck). This apparatus 
determines protein concentration based on the amide bonds in the protein chain and 
therefore is independent of the POI’s amino acid composition.  
 
2.6.5 Mass Spectrometry 
Protein samples were submitted to JIC Proteomic platform to determine a POI’s intact mass 
using a Synapt G2-Si mass spectrometer coupled to an Acquity UPLC system (Waters). 
Samples were run and analysed by Dr Gerhard Saalbach. In order to confirm the peptide 
coverage of a POI SDS-PAGE gel bands thought to contain the POI were excised using a 
sterile blade. Excised gel samples were prepared for mass spec analysis by in-gel trypsin 
digestion performed by Dr Paul Derbyshire as described by Bender et al, 2018168 . Samples 
were run on a Thermo Scientific™ Orbitrap Fusion™ Tribid™ Mass Spectrometer. 
 
2.7 Cell-free wheat germ expression system 
 
Proteins were expressed in two different cell-free wheat germ sources; one system was 
using the Protein Research Kit S from Cell Free Sciences and the other using a wheat germ 
extract supplied by Professor Yasuomi Tada from Nagoya University. All proteins were 
expressed in a pEU-E01-MCS vector which had been modified to enable golden gate cloning 
by Dr Cheng Chang. This modified vector allowed for the golden gate constructs to be 
generated with HellFire (6xHis with 3xFLAG) tagged POI under a SP6 promoter. The plasmid 
preparation and transcription protocols were the same for both wheat germ systems and 
followed the protocol outlined in Cell Free Sciences ‘ENDEXT® Technology Protein Research 
Kit (S,H,G) for ‘Protocol for plasmid DNA-based protein synthesis’.  
 
Plasmid preparation and transcription: 
Sequence verified pEU expression plasmids containing the POI were transformed as per 
section 2.2.7 in to Dh10B E. coli cells and 25 ml overnight cultures grown from the 
subsequent transformed colonies. The pEU plasmid was then prepped from the 25 ml 
overnight cultures and purified using QIAGEN Plasmid Plus Midi Kit as per the 
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manufacturer’s instructions. Plasmid was eluted from spin columns in 400 µl of TE buffer 
and plasmid concentration adjusted to 1 µg/ul. Plasmid purity was checked by measuring 
absorbance using a spectrometer ensuring the 260/280 nm absorbance ratio was between 
1.7-1.85. 2000 ng of high purity pEU plasmid was then added to each thawed Transcription 
premix LM reactions supplied with the Cell Free Sciences Protein Research Kit S and the 
reaction gently mixed by pipetting. The transcription reaction was then incubated for 1 
hour at 370C in a C1000 Touch thermocycler (Bio-Rad). After incubation, the quality of the 
transcribed mRNA was assessed by gel electrophoresis of 1 µl of the reaction on a 1% 
agarose TAE gel. Clear bands should be visible when imaging the gel indicative of a high-
quality mRNA prep. A laddering pattern or smearing below 500 bp indicates possible 
degradation of mRNA by RNase and the transcription reaction should be repeated.  
 
Method 1: Cell Free Sciences Protein Research Kit S 
The Cell Free Sciences kit used WEPRO® 9240 extract (wheat germ extract mixed with 
creatine kinase) for expression of proteins. WEPRO® 9240 extract and SUB-AMIX®SGC 
(translation mix including amino acid mix) were removed from -800C storage and thawed 
on ice. Once thawed the two reagents were spun down and the SUB-AMIC®SGC gently 
resuspended by pipetting. 10 µl of the 20 µl mRNA transcription reaction was then mixed 
with the WEPRO® 9240 extract my gentle pipetting. A bilayer translation reaction was then 
setup. The WEPRO® 9240 extract and mRNA mix were gently pipetted to the bottom of the 
tube containing SUB-AMIX®SGC carefully dispensing the extract-mRNA mix to avoid mixing 
with the SUB-AMIX®SGC such that a bilayer is created, see Figure 2.1. This bilayer setup 
allows for diffusion-controlled translation which can be sustained for longer period of time 
than the standard mixed batch setup which typically can only be sustained for a few hours 
dependant on the wheat germ extract concentration. This bilayer setup therefore allows 
for a higher protein yield to be attained169,170. The bilayer reaction tubes were sealed with 
aluminium foils and the whole reaction incubated at 150C for 20 hours to allow for 
translation. Following the translation incubation, the entire contents of the reaction were 
mixed and a 3 µl sample analysed for protein expression by SDS-PAGE.  





Method 2: Wheat germ extract from Professor Yasuomi Tada 
Plasmid preparation and mRNA transcription was conducted as described above. A 
translation bilayer reaction was setup as described for Cell Free Sciences Protein Research 
Kit S but instead of using WEPRO® 9240 extract wheat germ purified in Professor Yasuomi 
Tada’s lab was used to enable testing of protein production efficiencies of different wheat 
germ sources. 
 
His-tagged protein purification from wheat germ 
To purify the His-tagged POI from wheat germ translation reactions a protein pull down 
with Ni-Sepharose resin was performed as per the method described in Cell Free Sciences 
‘ENDEXT® Technology Protein Research Kit (S,H,G)’. 200 µl of the completed translation 
reaction was transferred to a fresh 1.5 ml Eppendorf and mixed with 6.7 µl of 600 mM 
Imidazole (pH 8.0). 15 µl of Ni-Sepharose High performance resin (GE Healthcare) was then 
added to the tubes and the mixture incubated at 40C for 1 hour with gentle agitation. Tubes 
were then centrifuged to collect the Ni-Sepharose resin at 500 x g for 5 minutes at 40C. 
Before being discarded a sample of the supernatant was collected for SDS-PAGE analysis for 
the unbound fraction. The pelleted resin was then washed in IP-wash buffer (20 mM 
Na3PO4 pH 7.5, 0.3 M NaCl, 20 mM Imidazole) and the tubes 5 minutes at 40C with gentle 
agitation before the resin was pelleted again by 500 x g for 5 minutes at 40C. This wash step 
was repeated 4 times in total. POI was eluted from the resin by incubating in 30 µl of 
elution buffer (20 mM Na3PO4 pH 7.5, 0.3 M NaCl, 500 mM Imidazole) for 10 minutes at 40C. 
The resin was pelleted by centrifugation at 500 x g for 5 minutes at 40C and the supernatant 






Translation mixture containing 
WEPRO®9240/9240H/9240G
 
4.4. Translation of Target Protein 
 
1) Remove from storage (-80 °C) required number of WEPRO®9240/9240H/9240G 
tubes and single-break strip wells (clear) containing SUB-AMIX® SGC (*1). Keep the 
remaining tubes and wells in storage at -80 °C 
2) Thaw the two reagents on ice. After thawing, spin down each tube containing 
WEPRO®9240/9240H/9240G for a short time to drop down the reagent staying on 
the tube wall or on the cap. Avoid excessive centrifugation. Resuspend 
SUB-AMIX® SGC by pipetting gently in the well (*2). 
3) Let the mRNA tube(s) cool down to the room temperature. DO NOT forcibly cool it 
on ice or in the refrigerator. Resuspend the mRNA by pipetting gently (*3). 
4) Add 10 µl of resuspended mRNA into WEPRO®9240/9240H/9240G and then mix 
gently by pipetting. Avoid bubble formation. 
5) Carry out bilayer reaction. 
Carefully transfer the whole mixture (20 μl) of WEPRO®9240/9240H/9240G and 
mRNA to the bottom of the single-break strip well containing SUB-AMIX® SGC 
(206 μl) to form bi-layer with WEPRO® mixture in the lower layer and 
SUB-AMIX® SGC in the upper layer as illustrated below. DO NOT mix the 
reagents in the well by pipetting or any other means. (Important !!) 
6) Seal the well with aluminum seal included in the kit to avoid evaporation (*4). 
7) Incubate at 15 °C for 20 hours. 
8) After translation, mix the bilayer reaction gently by pipetting. 
 
(Notes) 
*1 The sets of WEPRO®9240/9240H/9240G tubes and SUB-AMIX® SGC wells can be 
split into individual tubes and wells by bending or cutting. Hold the tubes or wells 
firmly so that they may not pop when they are separated. 
*2 Take special care to keep SUB-AMIX® SGC wells upright, since they easily tip over. 
*3 If there is white precipitate in mRNA tube, resuspend the mRNA together with the 
precipitate by pipetting gently. 
*4 Cut aluminum seal in an appropriate size to cover the wells. Save the remaining 
seal. 
 
Figure 2.2.1 Bilayer setup for wheat germ protein translation. Figure taken from Cell Free 
Sciences ‘ENDEXT® Technology Protein Research Kit (S,H,G)’ protocol 
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90 µl of elution fraction. POI yield was analysed by SDS-PAGE and western blot analysis 
described in section 2.4.2 and 2.4.3. 
 
2.8 Large-scale protein purification from plant tissue 
 
For A. thaliana plant tissue protein purification purposes, seeds were grown shaking in 
conical flasks as per 2.1.11. For harvesting from LexA:: inducible transgenic A. thaliana 
inducible lines the growth 1% MS media was poured out from each flask and replaced with 
fresh 1% Murashige and Skoog (MS) media155 containing estradiol, control non-induced 
lines had media replaced with fresh 1% MS media only. N. benthamiana tissue for 
purification purposes was grown as per 2.1.10 and infiltrated with agrobacterium carrying 
expression constructs as per 2.3 before harvesting 2 dpi. The purification was carried out in 
a cold room at 50c.  
 
2.8.1 Protein extraction of from nuclear preparation 
The method used for nuclear extraction from A. thaliana tissue is adapted from a protocol 
developed by Dr Pingtao Ding. 300 ml of ice-cold grinding buffer (40 mM MES, 4 mM EGTA, 
80 mM KCl, 250 mM Sucrose, 0.5 mM Spermidine, 0.1 mM Spermine, 5 mM 2-ME, 0.5% v/v 
TritonX-100 and anti-protease tablet (cOmplete™ EDTA-free, Sigma Aldrich) was added to 
100 x g of A. thaliana tissue and blended in short bursts (~7x 10 second) in a whirring 
blender until homogenized. Using a Pasteur pipette the blended mix was filtered through 
two layers of miricloth to remove large pieces of cell debris. The mixture was left to flow 
through the miricloth by gravity and collected in a clean tube. The collected flow through 
was then centrifuged at 2000 x g for 20 minutes at 40C to pellet the nuclei. A sample of the 
supernatant for later analysis was collected before the supernatant was discarded. The 
nuclei pellet was then resuspended in nuclear resuspension buffer (10% v/v glycerol, 150 
mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl, 0.1% v/v Tween20 and anti-protease 
tablet). Following initial trials to evaluate the effectiveness of different sonication 
treatments for nuclear disruption, a treatment of 5 repeats of 10 seconds on, 120 seconds 
off at 40% amplitude (Vibra-Cell™ sonicator, Sonics) was decided on. The resuspension was 
sonicated in two batches. The lysed nuclei were then centrifuged at 5000 x g for 20 minutes 
at 40C. If the suspension was not clear after this centrifugation the lysate was subsequently 
re-centrifuged at 5000 x g for 20 minutes at 40C. The supernatant was then collected and 
split into 50 ml falcon tubes to be taken forward for immunoprecipitation purification. 
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2.8.2 Protein extraction from total protein preparation 
This method of protein purification from a total plant protein extract was used for both A. 
thaliana and N. benthamiana tissue. The method is adapted from a protocol developed by 
Dr Benjamin Petre and Juan-Carols De la Concepcion. 100 x g of liquid nitrogen frozen leaf 
tissue was blended to a fine powder using a pre-cooled pestle and mortar. The ground leaf 
powder was then vortexed in 300% (v/w) ice-cold protein extraction buffer (150 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 % v/v glycerol) supplemented with 10mM DTT, 
0.2%Nodinet-40 (NP40), anti-protease tablet (cOmplete™, EDTA-free, Sigma Aldrich) until 
the powder was completely thawed. For N. benthamiana tissue the extraction buffer also 
contained 2% (w/v) PVPP (Polyvinylpolypyrrolidone). The suspension was then filtered 
through 2 layers of miricloth to remove large pieces of cell debris and the filtrate collected 
in a beaker on ice. The filtrate was then centrifuged for 30 minutes at 4000 x g at 40C. The 
supernatant was then transferred to fresh tubes and centrifuged again at 50,000 x g for 90 
minutes at 40C. The supernatant was then collected and split into 50 ml falcon tubes to be 
taken forward for immunoprecipitation purification. 
 
2.8.3 Immunoprecipitation purification 
POI was purified from protein extraction solution of either nuclear or total extraction 
methods described above using immunoprecipitation with anti-FLAG or anti-HA resins 
depending on the tag on the POI. Anti-FLAG/HA affinity bead resin were prepared as per 
manufactures instructions and equilibrated in IP buffer (150 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 10 % v/v glycerol, 0.2%Nodinet-40, anti-protease tablets). 50 µl of resin 
was added to each 50ml aliquot of protein suspension. The protein solution was then 
incubated for 2 hours at 40C with gentle rotation. The anti-FLAG/HA affinity resin was then 
collected by centrifugation at 800 x g for 5 minutes at 40C and the supernatant removed. 
The pelleted resin was then pooled resuspended in 2x 45 ml of wash buffer (150 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 % v/v glycerol, 0.2%Nodinet-40). The resin was 
then pelleted again by centrifugation at 800 x g for 5 minutes at 40C and the supernatant 
removed. The resin from both tubes was then resuspended and pooled in 1x 45 ml of wash 
buffer and the resin pelleted as before. This step was then repeated twice. The resin was 
then resuspended and pooled together in 2 ml of wash buffer and then the resin was 
pelleted as before. This step was then repeated. Proteins were then eluted from the resin 
by incubating 2 ml of wash buffer supplemented with 150 ng/µl 3xFLAG peptide for 1 hour. 
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The resin was then pelleted as before and supernatant collected. This step was then 
repeated with 2 ml of wash buffer supplemented with 150ng/µl 3xFLAG peptide. The eluted 
supernatant was pooled and centrifuged at 15,000 x g for 30 seconds at 40C to pellet any 
residual resin or aggregated protein. For analytical gel filtration analysis, the eluate was 
concentrated by ultrafiltration to ~120 µl using Vivaspin® concentrators (Satorius) with a 30 
kDa molecular weight cut-off. 
 
2.9 Analytical Gel Filtration 
 
Analytical gel filtration was conducted at 40C using ~100 µl of protein per run. For proteins 
and complexes less then 75 kDa, proteins were loaded on Superdex™ 75 10/300 GL column 
(GE Healthcare) pre-equilibrated in gel filtration buffer, see Table 2.7 for buffer 
amendments. For proteins larger than 75 kDa proteins were loaded onto Superose™ 6 
Increase column (GE Healthcare) pre-equilibrated in running buffer (150 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 1 mM EDTA).  Protein samples were eluted from the gel filtration 
column in a total of 1.5 column volumes at a flow rate of 0.5ml/min. Column elution was 
collected in 0.5ml fractions and analysed by SDS-PAGE. To analyse protein complex 
formation, proteins of interest were mixed in a 1:1 molar ratio and incubated on ice for 2 
hours or overnight at 40C. Prior to loading proteins were centrifuged at 17,000 x g for 10 
minutes at 40C to pellet any contaminants or protein aggregates. Molecular weights of 
eluted proteins were estimated using molecular weight calibration curves produced for 
each analytical gel filtration column generated by Dr John Steele and Dr Abbas Maqbool, 
see Appendix 3. These methods were based of the protocol developed in the Banfield lab70. 
 
2.10 Surface Plasmon Resonance (SPR) 
 
SPR is a method which allows the analysis of biomolecular interactions e.g. protein-protein 
and protein-DNA. The system measure changes in the refractive index on the surface of a 
chip to which one bio-molecule is immobilized as another biomolecule is injected over the 
chip surface in the analyte. The system provides real-time information of interactions 
between bio-molecules. In the correct experimental conditions, kinetic information of this 
interactions can also be obtained. All SPR experiments were conducted using a Biacore 
T200 system (GE Healthcare) and based of a method developed in the Banfield lab70. 
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2.10.1 Protein-Protein interactions 
Protein-protein interactions were quantitatively measured using an SPR Sensor NTA chip 
(GE Healthcare). This allowed for the immobilization of a His-tagged protein, cloned in 
pOPINE with a non-cleavable 6xHis-tag, onto the NTA sensor chip surface. Initial trials using 
this system showed that RRS1 WRKYE1195-T1273 and WRKY Dom6SE1195-C1290 were prone to 
sticking to the surface of the NTA sensor chip non-specifically. Optimisation of the NaCl 
levels in the SPR buffer was found to help reduce these non-specific interactions. The SPR 
buffer used for the final Rmax experiments was 20 mM HEPES pH 7.5, 0.1% Tween20 with 
500 mM NaCl for RRS1 WRKYE1195-T1273 and 860 mM NaCl for RRS1 WRKY Dom6SE1195-C1290 
analysis. Following additional optimisation experiments, Rmax data was collected at 80C. All 
proteins were diluted fresh in SPR running buffer. For Rmax experiments the NTA sensor chip 
was activated with 30 µl of 0.5 mM NiCl2 then 30 µl of His-tagged AvrRps4 effector protein 
was immobilized on the surface of the NTA sensor chip. The concentration of wild-type and 
mutant effectors used was adjusted to give a reliable capture rate of 25-35 response units 
(RU). Following effector immobilization, either 500 nM or 3 µM RRS1 WRKY/WRKY Dom6S 
protein was then injected over the chip surface at a rate of 30 µl/min for 120 seconds 
contact time followed by a 60 second dissociation time. Following RRS1 WRKY/WRKY 
Dom6S binding the chip was regenerated in 30 µl of 350 mM EDTA pH 8.0. Before the next 
experiment cycle started the chip was then further washed for 30 seconds in 15 µl of SPR 
buffer to remove any residual EDTA prior to nickel loading. For Rmax calculations both the 
reference cell response unit (flow cell 2-1) and a buffer blank (average of three buffer blank 
cycles) was subtracted from each data point to reduce the effect of non-specific binding in 
calculations. Rmax calculations, were generated using binding stability or level values. The 
Rmax of each experiment was calculated using the equation below which is dependent on 
the molecular weight (MW) of the analyte and ligand, the amount of ligand immobilized on 
the surface of the sensor chip (RLigand) and stoichiometry of the interaction between ligand 
and analyte. %Rmax  plots were generated using a ggplot2 package171 in R using code written 




Equilibrium dissociation constant values (KD) were attempted to be calculated using 




MW of analyte (RRS1 WRKY) 
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2.10.2 Protein-DNA interactions 
To analyse protein-DNA interactions between the WRKY domain of RRS1 and WRKY motif 
recognised W-box DNA, the SPR ReDCaT (Re-usable DNA Capture Technique) chip method 
developed by Dr Clare Stevenson at JIC was used172 . This method of SPR allows the 
reversible application of different DNA sequences to the surface of a streptavidin SPR chip 
over which varying proteins can be flown as analyte to investigate protein-DNA 
interactions, see Figure 2.2.  
 
These experiments were conducted using a single sensor SA chip (GE Healthcare) which 
contains four cells with pre-immobilized streptavidin on a carboxymethylated dextran 
matrix as described by Stevenson et al, 2013172. The immobilized streptavidin allows for the 
convenient binding of biotinylated molecules on the chip surface. For the purpose of this 
experiment, biotinylated single stranded DNA fragments referred to as ‘ReDCaT linkers’ 
were then flown over and attached to the SA chip, this stage was conducted by Dr Clare 
Stevenson. This then allows the attachment of DNA fragments with a double stranded DNA 
sequences for DNA region of interest (i.e. the test region presented to protein for binding) 
with a single stranded DNA region complementary to the attached ReDCaT linked DNA. 
These DNA fragments were synthesised as oligonucleotides (Merck Millipore) with the 
reverse primer containing the ReDCaT linker complementary extension at the 3’end plus 
the region of interest DNA sequence and the forward primer containing on the region of 
interest DNA sequence. A list of primers used in this experiment can be found in Table 2.8. 
 
The experiment used both one and three time repeats of the test DNA sequences. In 
addition to wild-type w-box DNA sequences173, protein binding was also tested against 3 
mutants. Mutant 1 was taken from previous EMSA work in the Jones lab65, Mutant 2 was a 
mutant sequence often used in the literature174,175 and Mutant 3 was produced by 
scrambling the wild-type w-box sequence using an online tool from GenScript 
(https://www.genscript.com/tools/create-scrambled-sequence). The forward and reverse 
primers were diluted to 100 µM in ReDCaT running buffer (10 mM HEPES, 300 mM NaCl 
(varied as stated), 3 mM EDTA, 0.05% v/v Tween20). To anneal the two primers together, 
45 µl of Reverse strand primer was then mixed with 55µl of forward strand primer and 
heated to 950C for 10 minutes before being allowed to cool gradually. This generated a 
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stock of 45 µM double stranded DNA which was then diluted to 1 µM in ReDCaT running 
buffer prior to the ReDCaT experiment.  
 
 
Table 2.8 ReDCaT SPR experiment primers 
Primer name Sequence Reference 
ReDCaT Linker GGATGGGATGCAGGAGGACG Stevenson et al, 2013172 
WT w-box 1x repeat CGTTGACCG (Fwd) 
Maeo et al, 2001173 
WT w-box 1x repeat CGGTCAACGCCTACCCTACGTCCTCCTGC (Rev) 
WT w-box 3x repeat CGTTGACCGTTGACCGAGTTGACTTTTTA 
Maeo et al, 2001173 
WT w-box 3x repeat TAAAAAGTCAACTCGGTCAACGGTCAACGCCTACCCT
ACGTCCTCCTGC 
Mutant 1 w-box 1x 
repeat  
CGTAGACGG 
Sarris et al, 201565 
Mutant 1 w-box 1x 
repeat 
CCGTCTACGCCTACCCTACGTCCTCCTGC  
Mutant 1 w-box 3x 
repeat  
CGTAGACGGTAGACGGAGTAGACGTTTTA 
Sarris et al, 201565 




Figure 2.2 ReDCaT SPR experimental setup. Procedure for creating and regenerating ReDCaT chip 






Biotinylated ReDCaT linker 
 
Complement to ReDCaT linker 
 
Test strand 1 (Forward primer) 
 
Test strand 2 (Reverse primer 
required if shorter fr gments are used. For these experi-
ments, we chose a fragment length of 29 nt, which resulted
in 14 overlapping sequences (Supplementary Figure S2
and Supplementary Table S2). For each fragment, FCtest
was loaded with the 29 bp test DNA plus the 20 nt
overhang for annealing to the linker (Figure 3A), and
this gave responses of !400 response units (RU)
(Supplementary Table S3). The responses resulting from
the interaction between SCO3205 and each of the frag-
ments were then recorded in duplicate at three different
protein dimer concentrations (10, 50 and 100 nM).
Negligible protein binding to FCref was observed in all
experiments, with the response not exceeding 11 RU
(data not shown). The level of protein binding to FCtest
was measured 10 s after the end of the injection, and then
expressed as a percentage of the theoretical maximum
response, Rmax, assuming a single SCO3205 dimer
binding to one immobilized ds DNA oligomer (see
Supplementary Methods and Supplementary Table S3).
This normalization process enabled the various responses
to be readily compared, irrespective of the quantity and
length of the DNA captured. ‘Hits’ were considered to be
fragments that gave !100% of the theoretical Rmax value
at 100 nM SCO3205.
Footprinting putative SCO3205 operator sites using SPR
The hits from intergenic screening were used to generate
new oligomers as starting points to define the protein foot-
prints of putative SCO3205 operator sites. Adjacent hits
were combined into longer oligomers and captured using
ReDCaT (Figure 3A). To determine the right-hand (RH)
boundary of the site (defined relative to the forward
strand), a series of progressively shorter DNA oligomers
were synthesized, each being truncated by two nt from the
Time
=  (a) biotinylated ReDCaT linker
=  (b) Complement to ReDCaT linker
=  (c) Test strand 1 (forward strand)































































































Figure 2. The ReDCaT methodology. (A) Procedure for creating, using and regenerating the ReDCaT Chip, specifically illustrating the events taking
place in the test flow cell. (B) A typical sensorgram for the test flow cell of the ReDCaT Chip showing the responses observed during its use and
regeneration. The response returns to the original baseline after stripping off the test DNA. (C) The composition of bound DNA in the reference and
test flow cells before injecting protein in the ReDCaT screening and affinity experiments. (D) Key to the macromolecular components illustrated in
the other three panels.
4 Nucleic Acids Research, 2013
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Mutant 2 w-box 1x 
repeat  
CGTTGCACGG 
Zhou et al, 2008175  
Wang et al, 2009174 Mutant 2 w-box 1x 
repeat 
CCGTGCAACGCCTACCCTACGTCCTCCTGC  
Mutant 2 w-box 3x 
repeat  
CGTTGCACGGTTGCACGGTTGCACGG 
Zhou et al, 2008175 
Wang et al, 2009174 
 








Mutant 3 w-box 1x 
repeat 
GCGATCACCTACCCTACGTCCTCCTGC  









For ReDCaT experiments 10 µl of 1 µM test primers were injected over the ReDCaT chip 
(pre-prepared with annealed linker DNA fragments). RRS1 WRKY Dom6SS1184-C1290 protein 
was then flowed over the chip at a rate of 30 µl/min with a contact time of 60 seconds and 
60 seconds dissociation time. The chip was then regenerated in 10 µl of 1 M NaCl 50 mM 
NaOH. Prior to the start of the next experimental cycle the chip was further washed for 60 
seconds in ReDCaT running buffer to remove any residual 1 M NaCl 50 mM NaOH. For Rmax 
calculations, the reference cell response unit (flow cell 2-1) was subtracted from each data 




For protein crystallisation screening, protein was freshly prepped or previously flash frozen 
aliquots of protein thawed on ice. Prior to screen setup, proteins were centrifuged at 
17,000 x g for 10 minutes at 40C to pellet any contaminants or protein aggregates. 
Crystallisation screens were setup as sitting drop vapour-diffusion experiments. This 
method of crystallisation screen involves a setup with a sealed chamber containing a 
reservoir of solution containing buffers, additives and precipitants, see Figure 2.3. A drop of 
protein mixed with the reservoir solution is placed on a raised well above the reservoir 
solution and the chamber sealed with a foil seal to prevent evaporation. As the 
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concentration of solute is higher in the reservoir than the protein drop, water diffuses from 
the protein drop to the reservoir. As equilibrium is reached, the concentration of protein, 
reservoir solution solutes, and precipitants increases in the protein drop to the point where 
the protein precipitates. If this precipitation occurs in a slow and controlled manner this 
precipitation can lead to protein crystal formation. The conditions which support this form 
of gradual precipitation are often narrow and therefore the screening of many different 
reservoir solutions is often required to obtain suitable crystallisation conditions. 
 
 
A range of commercial crystallisation screens were used in this study which covered a large 
range of different buffer compositions, salts and additives. For this study these screens 
were: Morpheus® (Molecular Dimensions), JCSG-plus™ (Molecular Dimensions), PropPlex™ 
(Molecular Dimensions), PACT Premier™ (Molecular Dimensions), MIDAS™(Molecular 
Dimensions), PEGs suite (Qiagen), Structure(Molecular Dimensions) and KISS (a custom 
screened designed by Dr Clare Stevenson and Dr Dave Lawson in JIC’s crystallography 
department). These screens cover a wide range of the crystallisation space including sparse 
matrix screens (e.g. JCSG-plus™), screens with low molecular weight ligands observed to 
promote crystal formation (e.g. Morpheus®) and screens targeted towards gaining protein 
complex structures (e.g. PropPlex™- Molecular Dimensions). 
 
Crystallisation screens were setup in 96-well sitting drop vapour-diffusion plates which 
contained 2 wells (A and B well) per solution reservoir. Each crystallisation screens were set 
up at two different protein concentrations with well B setup with half the concentration of 
protein compared to well A. This meant the protein precipitation rates could be better 
analysed in each reservoir solution condition. Sitting drops containing 0.3 µl of protein and 
0.3 µl of reservoir solution were dispensed in each well using an Oryx Nano crystallisation 
robot (Douglas Instruments). Following screen setup, plates were immediately sealed to 
prevent evaporation and placed in an incubator at 200C or 40C. Plates incubated at 200C 
were imaged at regular intervals with a Minstrel Crystallisation Imager (Rigaku) which 
imaged plates in both visible and UV light to check for crystal formation. Plates incubated at 
40C were checked for crystal formation manually by eye using a Nikon SMZ800 microscope.  
 










Figure 2.3 Sitting drop vapour diffusion crystal screen experimental setup. A protein drop of 
purified protein and reservoir solution is placed in a sealed chamber with a partially filled reservoir 
of solution. As water gradually diffuses from the protein drop to the reservoir, the concentration of 
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3 Investigating heterologous expression systems for plant NLR expression 
3.1 Introduction & chapter aim 
 
Since the cloning of the first NLR over 25 years ago our understanding of NLRs structure and 
biochemical behaviour has significantly lagged behind our genetic understanding of these 
receptors. This disparity has largely been due to the difficulties with expressing soluble NLR 
protein at yields required for biochemical and structural characterisation. Until the recent 
publication of the Arabidopsis NLR ZAR1 structure108,109, structures of plant NLRs were 
largely restricted to the class defining N-terminal CC and TIR regions or integrated domains 
of NLR proteins176. This restriction in available NLR structural data has been a major 
obstacle to understanding the structural basis of NLR’s activation mechanisms and the 
rational design of NLRs with extended pathogen recognition capabilities. There is therefore 
a high incentive in the field to expand our structural understanding of NLRs and increase 
the variety and number of available protein structures of NLRs.  
 
Heterologous systems used for expression of both animal and plant NLRs have largely 
focussed on the use of the well-studied systems of S. frugiperda insect cells and E. coli. A 
list of published structures of plant NLR proteins and the heterologous expression systems 
used in the studies can be found in Table 3.1. In addition to the examples listed in Table 
3.1, other plant NLRs and truncations of have been heterologously expressed but not 
resulted in the determination of a protein structure with studies often relying on the use of 
refolded protein104 or very low protein expression yields. For example, full-length soluble 
expression of  Linum usitatissimum NLR M177 and Hordeum vulgare MLA27178, expressed in 
Pichia pastoris and S. frugiperda Sf21 cells respectively, has been observed but to very low 
yield levels. 
 
There are several factors to consider when choosing a heterologous expression system 
which focus around the core facets of the: protein folding environment provided, ability to 
conduct high-throughput screening, feasibility of physical scalability and the economics of 
scalability. The S. frugiperda insect cell and E. coli systems excel in many of these areas and 
3 
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have consequently historically been widely utilised for heterologous protein expression 
studies.  
 
Table 3.1 Summary of published plant NLR structures listing the heterologous expression system 
utilised. Adapted from Burdett et al, 2019176 
NLR Domain Species of origin Heterologous 
expression species 
Reference 
L6 TIR Linum usitatissimum E. coli Bernoux et al, 201187 
SNC1 TIR Arabidopsis thaliana E. coli Hyun et al, 201683 & Zhang 
et al, 2017179 
RPS4 TIR Arabidopsis thaliana E. coli Williams et al, 2014114 
RPV1 TIR Vitis rotundifolia E. coli Zhang et al, 2017179 
RRS1 TIR Arabidopsis thaliana E. coli Williams et al, 2014114 
 WRKY Arabidopsis thaliana E. coli Zhang et al, 201771 
MLA10 CC Hordeum vulgare E. coli Casey et al, 201695 & 
Maekawa et al, 2011178 
Sr33 CC Aegilops tauschii E. coli Casey et al, 201695 
Rx CC Solanum tuberosum E. coli Hao et al, 201394 
NRC1 NB-ARC Solanum lycopersicum E. coli & 
S. frugiperda (Sf9) 
Steele et al, 2019180 
PikP-1 HMA Oryza sativa ssp. 
japonica 
E. coli & 
S. frugiperda (Sf9) 
Maqbool et al, 201570 & 
De la Concepcion et al, 
2018181 
Pikm-1 HMA Oryza sativa ssp. 
japonica 
E. coli De la Concepcion et al, 
2018181 
RGA5 HMA Oryza sativa ssp. 
japonica 
E. coli Guo et al, 2018182 
ZAR1 Full-length Arabidopsis thaliana S. frugiperda 
(Sf21) 
Wang et al, 2019183 
 
E. coli excels in its ease of use in terms of high-throughput screening and scalability. The 
system is quick to setup and scale and has a relatively low running cost compared to other 
expression systems as well as a wide range of available compatible expression vectors. 
However, this system does come with several major disadvantages. Firstly, codon usage is 
often a problem when expressing eukaryotic proteins in E. coli using the POI (protein of 
interest) origin organism’s cDNA sequence. E. coli’s bias towards preferred codons often 
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significantly differs from other organisms leading to problems with gene translation and 
protein yield184. This issue can be circumvented however by codon optimising the cDNA 
sequence of the POI for E. coli expression185 either by point mutagenesis or gene synthesis. 
Secondly, as a prokaryotic system a major disadvantage associated with this system is E. 
coli’s poor folding environment for eukaryotic protein production and the lack of eukaryotic 
post translational modifications. The poor folding environment is caused by several factors 
including the inability of the majority of E. coli strains to catalyse disulphide bridges and 
carry out correct eukaryotic post-translational modifications such as glycosylation and fatty 
acid acylation186. The chaperone repertoire of E. coli may also be insufficient to aid the 
correct folding of the POI and may lack key complex chaperones the POI has co-evolved 
with in the original host species to enable correct folding. Incorrect folding may lead to 
misfolded insoluble protein aggregates which often accumulate in the bacterial cytoplasm 
in inclusion bodies186. Whilst proteins can be recovered, solubilized and refolded from 
inclusion bodies, as demonstrated with N-terminal domains of tomato NLR I-2104, the 
recovery yield of recovered bioactive protein is often low, at around 15-25% of total 
protein187.  
 
Whilst the majority of published plant NLR structures have utilised an E. coli expression 
system, these have thus far been restricted to single domains of plant NLRs such as the N-
terminal regions and integrated domains, see Table 3.1. For example, E. coli systems have 
already proved successful for expressing both the TIR domains of RRS1 and RPS4114 and 
RRS1’s WRKY domain71. The ease of high-throughput screening and proven success with 
expressing singular domains of RRS1 and RPS4 therefore make E. coli an attractive system 
to trial for the purposes of this study.  
 
As a eukaryotic expression system, the S. frugiperda insect cells provide a protein folding 
environment more akin to the native environment of plant NLRs. Widely utilised in the 
pharmacological and vaccine fields, insect cells have also proven to be a suitable expression 
system for both the full-length plant NLRs such as  ZAR1108,109 and MLA27178 and 
mammalian NLRs such as NLRC4101. The major benefit offered by insect cell expression 
systems compared to bacterial based systems is in insect cells’ eukaryotic protein 
processing capabilities. Insect cells are capable of processing proteins with post translation 
modifications such as glycosylation and the formation of disulphide bonds both of which 
are lacking in bacterial systems.  It should be noted however that the glycosylation patterns 
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of insects differ from other organisms which can lead to issues with recombinant protein 
bioactivity188.  
 
Though the scaling up of insect cell production once a system is in place is relatively 
straightforward, high-throughput screening in this system is not as quick or simple as 
bacterial systems due to the need to amplify Baculovirus viral stocks for expression 
transfection which can take several weeks. Insect cells also require more complex and 
costly culturing conditions than bacterial cells in terms of scale up and maintenance of cells. 
Using dedicated high-throughput screening facilities such as those provided at OPPF 
however make screening in Baculovirus-insect cell systems a viable option for this study. 
This combined with the proven success of multi NLR-domain soluble protein expression in 
insect cells highlighted this system as a strong candidate for trialling expression of domains 
of RRS1 and RPS4.  
 
This chapter will investigate the use of E. coli and S. frugiperda Sf9 insect cell expression 
systems for the expression of RRS1 and RPS4 protein. The aim of the work in this chapter 
was to conduct a large-scale screen of single and multi-domain constructs of RRS1 and RPS4 
to identify potential constructs to take forward for scale up purification for biochemical and 
structural studies. The screen focussed on the well-studied NLR pair RRS1 and RPS4 such 
that any structural or biochemical data produced could be used to support and further 
probe our biological understanding of the activation mechanism of these NLRs.  
This chapter will discuss the results of these screens of which full methodologies can be 
found in chapter 2. A list of the cloned vectors and maps can be found in Appendix 2 and 4. 
 
3.2 Producing RRS1 and RPS4 cDNA for heterologous expression 
 
In order to generate truncation variants of RRS1 and RPS4 for expression trialling in 
heterologous systems, cDNA constructs of RRS1 and RPS4 was generated, methods for 
which are described in 2.2.8. The first strategy for generation of these cDNA constructs was 
to purify RRS1 and RPS4 cDNA in N. benthamiana to be used as a template for PCR 
amplification in subsequent cloning. As such, N. benthamiana leaves were infiltrated with 
agrobacterium carrying vectors for 35S::RRS1Ws-2-HF(gDNA) or 35S::RPS4col-0-HF (gDNA) 
(plasmids were generated by Dr Yan Ma). Tissue was subsequently harvested 3 dpi and 
total RNA purified. RNA quality checked by gel electrophoresis before subsequent cloning, 
Fig 3.1A. cDNA was then generated from the RNA library by reverse transcription. Initial 
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attempts to produce full-length cDNA constructs of RRS1 and RPS4 focussed on amplifying 
full-length coding sequences of each gene from the purified N. benthamiana cDNA library 
which would then be subsequently cloned into a golden gate level 1 acceptor vector with a 
C-terminal HF-tag. Following optimisation of PCR conditions, which looked at trialling 
annealing temperature and extension time, a full-length PCR product of RRS1Ws-2 was 
generated (annealing temperature 580C extension time 6 minutes), Figure 3.1B, and cloned 
into a golden gate level 1 acceptor vector. However, attempts to amplify a full-length 
RPS4col-0 coding sequence PCR product resulted incorrectly assembled transformants 
despite multiple attempts and therefore could not be achieved. 
 
As there were problems in cloning a single full-length PCR product of RSP4, the next 
strategy involved PCR amplifying each individual domain of RPS4 (TIR, NB-ARC, LRR and 








































Figure 3.1 Cloning of RRS1Ws-2 and RPS4 cDNA. (A) Checking for N. benthamiana transiently 
expressing 35s::RPS4-HF or 35s::RRS1-HF purified RNA integrity by gel electrophoresis. (B) RRS1Ws-
2 cDNA full-length PCR product cloned from cDNA library. (C) PCR amplification of individual 
domains of RPS4 cDNA from N. benthamiana cDNA. (D) Amplification of ligated exons 1-4 and 
exon 5 of RPS4 from RPS4 gDNA plasmid. Asterisks indicate band of expected size, DNA and RNA 
visualised on 1% TAE agarose gel with 1Kb DNA ladders. 
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single construct using digestion-ligation reaction. Although this method resulted in the 
generation of a few transformants, all contained mutations or base pair dropouts in the 
cDNA sequence. Due to issues in attaining reliable quantities of RPS4 amplified coding 
sequence from the cDNA library, I also tried amplifying each of RPS4’s five exons from a 
RPS4col-0 gDNA plasmid generated by Dr Pingtao Ding. These exon PCR products were then 
used to produce a full-length cDNA through an exon reassembly digestion-ligation reaction, 
method found in 2.2.4 . The aim of this was to increase the efficiency of the digestion-
ligation reaction, resulting in the generation of more transformants which could then be 
screened for correct assembly of RPS4 cDNA sequence. This however also failed to 
generate a full-length cDNA construct with the longest correct construct reassembled 
including only RPS4 exons 1-4 (1-2856 bp cDNA). Attempts to ligate PCR products of exons 
1-4 and exon 5, Figure 3.1D, resulted in either no transformants or recovered 
transformants displaying a consistent 63 bp deletion in the CTD of RPS4 (3442-3504 bp), 
Figure 3.2.  
 
This led to the hypothesis that RPS4 cDNA may be lethal in E. coli. This would explain our 





























D  69bp Deletion  
RPS4 
Figure 3.2 RPS4 69 bp deletion found in cDNA clones. Emboldened text indicates region of gene 
consistently found deleted in recovered RPS4 cDNA E. coli clones representing RPS4 G1148-N1168. 
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of RPS4 which may render the RPS4 protein non-toxic. As such deletions may be result of 
homologous recombination events, I investigated cloning with RPS4 exons fragments in 
ElectroMAX™Stbl4™ strain of E. coli. This strain is recommended for use in cloning with 
unstable inserts and are optimised to reduce frequency of homologous recombination.  
However, the same unsuccessful transformant pattern was also observed using this strain. 
Dr Zane Duxbury also tried using the Gibson Assembly method of cloning to reassemble 
RPS4 exons but again was unable to recover full-length transformants. I subsequently 
submitted the full-length RPS4Col-0 cDNA sequence for commercial synthesis (Twist 
Bioscience) but the company was also unable to recover a verified full-length sequence 
clone. 
 
This led us to believe that full-length RPS4Col-0 cDNA is likely toxic in E. coli. Using the various 
exon reassembly constructs that were generated during attempts to create a full-length 
cDNA construct, I was able to clone a variety of domain truncations of RPS4 for expression 
testing. Interestingly, none of the truncations appeared toxic to E. coli suggesting that all 
domains are required in situ in order for RPS4 to be toxic to E. coli.  
 
3.3 RRS1-R cDNA is functional in planta 
 
To confirm the biological functionality of the RRS1 cDNA construct generated in 3.2, RRS1-
RcDNA-HF was transiently expressed in the plant model organisms N. benthamiana and N. 
tabacum by agroinfiltration. Agroinfiltration involves infiltrating leaf tissue with A. 
tumefaciens transformed with a gene of interest. Once in the intracellular space of the leaf, 
the agrobacterium transfers tDNA of the gene of interest to the plant cells which leads to 
transient expression of the encoded genes in planta189.   
 
To confirm functionality, RRS1-RcDNA-HF was transiently expressed in N. tabacum along with 
RRS1’s partner RPS4-HA and recognised effector AvrRps4-mcherry. Agroinfiltration of RRS1-
RgDNA-HF (construct generated by Dr Yan Ma) was used as a positive control. 3 days post 
infiltration (3 dpi), a cell death HR was visible in tissue infiltrated with RPS4-HA and 
AvrRps4-mcherry with either RRS1-RcDNA-HF or RRS1-RgDNA-HF, Figure 3.3A. This indicated 
that the RRS1 cDNA construct translated to a functional protein in planta that was capable 
of activating RPS4 in an effector dependent manner. N. tabacum shows induction of a rapid 
HR upon activation of the RRS1/RPS4 complex. HR degrades the leaf tissue such that 
sampling infiltrated leaves to confirm the presence of expressed protein is not possible in 
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this species. Conversely, N. benthamiana shows a delayed and leaf-position dependant cell-
death HR following AvrRps4-RRS1-RPS4 induced activation. This means it is possible to 
collect leaf tissue for protein expression confirmation before cell death degrades the leaf 
tissue. Therefore, to confirm expression of proteins in planta the same constructs used for 
N. tabacum HR assays were infiltrated in to N. benthamiana tissue for protein expression 
confirmation.  Accordingly, RPS4-HA, AvrRps4-mcherry, mcherry, RRS1-RcDNA-HF and RRS1-
RgDNA-HF constructs were transiently expressed in N. benthamiana leaves before tissue was 
harvested 3dpi.  
 
Total protein extracts were purified from each leaf sample and protein expression 
confirmed by immunoblot analysis, Figure 3.3B,C. RRS1-RcDNA-HF and RRS1-RgDNA-HF 
appeared to express to proteins of the same size and expression level confirming the 
appropriate expression and functionality of RRS1-RcDNA-HF. HR assays were repeated across 
three technical replicates and protein expression in two biological replicates with the same 
result observed across all repeats.  
 
Similar analysis was conducted with RRS1B cDNA which was also used for heterologous 
expression in this study. A RRS1BcDNA-HF construct was generated by Dr Maximiliano 
Jiménez Dalmaroni which I subsequently tested for protein expression in planta in N. 
benthamiana alongside a RRS1BgDNA-HF construct generated by Dr Yan Ma. Western blot 
analysis confirmed appropriate expression of both RRS1BcDNA-HF and RRS1BgDNA-HF in N. 
benthamiana, Figure 3C.  This protein expression experiment was conducted across 2 
biological replicates with the same result observed across all repeats. 
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Figure 3.3 RRS1-HF cDNA is expressed and functional in planta. (A) Transient assay in N. tabacum 
leaves using agrobacterium infiltration shows functionality of RRS1-HF cDNA. Each leaf section was co-
infiltrated to express different combinations of a RRS1-HF cDNA/gDNA, RPS4-HA and 
mcherry/AvrRps4-mcherry. Pictures were taken 5 days post infiltration, all pictures to same scale. (B) 
Immunoblot confirmation of protein expression RPS4, mcherry and AvrRps4-mcherry constructs in N. 
benthamiana total protein extract 3 dpi. (C) Immunoblot detection of RRS1-HF cDNA/gDNA and RRS1B-
HF cDNA/gDNA expression in N. benthamiana total protein extract. Bottom panel shows ponceau 
staining of membrane as loading control. Protein were visualised using an HRP-conjugated anti-FLAG 
or anti-HA antibody or primary anti-mcherry followed by HRP-conjugated α-rabbit IgG. Asterisks 
indicates presence of protein of predicted molecular weight. Experiment A and C were conducted 
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3.4 High-throughput heterologous system expression screening of 
RRS1 and RPS4 
 
Note: All RRS1 and RPS4 constructs described in 3.4 were cloned at TSL by myself with the 
exception of construct 39-43 which were cloned by Dr Lennart Wirthmüller. I then conducted 
screening of constructs in E. coli and Sf9 cells at OPPF under the supervision of Heather Rada 
(OPPF). All E. coli screening was conducted by myself with the exception of samples with gel 
codes A7-B8 which were cloned by myself but screened by Dr Maximiliano Jiménez 
Dalmaroni (JIC) at OPPF. I generated the P0 virus stock for Sf9 insect screening under the 
supervision of Heather Rada who was then responsible for subsequent expression 
transfection and harvesting of Sf9 cells. 
 
Success of downstream structural and biochemical studies strongly hinges on the rational 
design of protein expression constructs. Often the native termini of eukaryotic proteins are 
not suitable for expression in heterologous systems due to the presence of disordered 
protein in these regions190. Therefore, expression of truncated protein or individual 
domains of multi-domain proteins of interest, often increases the chances of soluble 
protein expression and subsequent crystallization. Consequently, I decided to conduct a 
large-scale expression screen of various domain truncations of RRS1 and RPS4, to identify 
constructs for use in downstream studies. I decided to conduct trials in both E. coli and Sf9 
insect cells, as I predicted the more complex eukaryotic cell environment of Sf9 cells may 
better facilitate soluble expression of multi-domain constructs NLR proteins, whilst E. coli 
has proven a successful system for singular domain NLR expression, see Table 3.1. These 
screens were conducted at OPPF (Oxford Protein Production Facility) using their high-
throughput protein heterologous expression screenings systems designed to increase the 
likelihood of identifying constructs with soluble expression. 
 
Truncation variants for expression trialling of RRS1 and RPS4 were designed by myself and 
Dr Lennart Wirthmüller (JIC). Constructs were designed to span the entire lengths of RRS1 
and RPS4 and were designed by two methods. Firstly, using the domain boundaries of RRS1 
and RPS4 previously predicted by members of the Jones lab. The TIR, NB-ARC and LRR 
domains of RRS1 and RPS4 had been previously defined on the basis of sequence homology 
with boundaries in other characterised plant TNLs, and the WRKY domain as the 22-25 
amino acids preceding the ‘WRKYGQK’ amino acid motif till the end of the zinc-finger 
(‘HNH’ amino acids sequence). The second method involved using RONN protein disorder 
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prediction analysis162 (https://www.strubi.ox.ac.uk/RONN) or IUPred2A163 
(https://iupred2a.elte.hu/), see Figure 3.4, to design constructs which excluded regions of 
protein disorder at their N- and C-terminuses of constructs, inclusion of which can often 
hinder soluble expression of a protein. This information was supplemented with secondary 
protein structure prediction analysis using PHYRE2164 (www.sbg.bio.ic.ac.uk/phyre2/) which 
was used to ensure the N- and C-terminal regions of protein expression constructs did not 
terminate mid-secondary structure which can lead to the destabilisation of a protein.  
 
Previous bimolecular fluorescence complementation (BiFC) studies using a split cCFP and 
nVenus in the Jones laboratory had shown that Dom6S and Dom4 interacted using the 
construct cCFP-RRS1 Dom4-Dom6S-nVenus152. I hypothesised that the interaction of the 
two fluorescent molecules may help to lock down the conformation of these RRS1 domains 
and stabilise the protein, aiding solubility. To test this, two constructs containing split cCFP 
and nVenus on either end of RRS1 Dom4-WRKY-Dom6S were also considered for expression 
testing (constructs 23 and 24).  
 
In addition to RRS1 and RPS4, three WRKY transcription factors (WRKY18/40/41) were also 
included in expression trials due to these proteins varying interactions with the RRS1 
recognised effectors PopP2 and AvrRps4. AtWRKY41 belongs to the same group of WRKYs 
as RRS1-R, group III, and also interacts with both the effectors AvrRps4 and PopP2, with the 
latter acetylating the WRKY domain58. AtWRKY18 and AtWRKY40 belong to group IIa WRKY 
proteins but interestingly only AtWRKY18 is acetylated my PopP266.Therefore, AtWRKY41 
represents an interesting positive control as a possible host target of AvrRps4 and PopP2 
and AtWRKY18 represents a negative control for biochemical interaction studies as a WRKY 
proteins which does not interact with these effectors. The three constructs included 
expressed AtWRKY18A157-E240, AtWRKY40V124-N213 and AtWRKY41L121-E208 in the expression trial, 
and were cloned by Dr Lennart Wirthmüller 
 
Though no single tag is considered a ‘silver-bullet’ for soluble expression of all proteins 
universally, fusion of solubility tags to POIs can often improve the stability and yield of 
proteins191. For this study, constructs were cloned into pOPIN vectors under T7 promoters 
with a variety of solubility tags which have been observed in the literature to improve 
protein solubility and yield along with a 6xHis affinity tag required for Nickel-NTA protein 
purification. Tags trialled in this screen included SUMO tag192 (pOPINS3C) and MBP193 
(pOPINM) as well 6xHis tag only (pOPINF). This resulted in the generation of 43 constructs 
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listed in Table 3.2 which I then took to OPPF for high-throughput expression screening. The 























































































































































Figure 3.4 Predicted disordered region of RRS1 and RPS4. Emboldened amino acids highlight 
predicted disordered regions. Disorder precited using RONN162 and IUPred2A163 analysis. Predicted 
domains of RRS1 and RPS4 are highlighted in various colours with N- and C-termini domain 
boundary   boundary amino acids listed to the right. 
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Table 3.2 RRS1 & RPS4 expression construct trialled at OPPF. Gel code refers to lane reference in 
SDS-PAGE gels, MW indicates predicted molecular weight of expressed protein with solubility tag 
Construct 





1 RRS1 TIR-Dom6R M1-Y1373 pOPINF A1 157.6 
2 RRS1 NB-ARC I154-T595 pOPINF E1 52.9 
3 RRS1 NB-ARC-Dom6S I154-C1290 pOPINF C7 130.7 
4 RRS1 NB-ARC-Dom6S I154-C1290 pOPINS3C D7 141.6 
5 RRS1 NB-ARC-Dom6R I154-Y1373 pOPINF E7 140.0 
6 RRS1 NB-ARC-Dom6R I154-Y1373 pOPIS3C F7 151.0 
7 RRS1 NB-ARC-LRR I154-T595 pOPINS3C H7 93.8 
8 RRS1 LRR K596-L867 pOPINS3C G7 43.4 
9 RRS1 LRR-Dom4 K596-K1189 pOPINF F1 68.4 
10 RRS1 LRR-Dom6R K596-Y1373 pOPINF G1 89.5 
11 RRS1 LRR-Dom6R K596-Y1373 pOPINS3C A8 100.4 
12 RRS1 
Leucine Zipper 








motif-Dom6R L1089-Y1373 pOPINS3C 
D1 45.3 
15 RRS1 Dom4  P868-K1189 pOPINF H1 38.4 
16 RRS1 Dom4  P868-K1189 pOPINS3C A2 49.3 
17 RRS1 Dom4-WRKY L929-T1273 pOPINF F4 41.1 
18 RRS1 Dom4-WRKY A1063-T1273 pOPINF G4 25.8 
19 RRS1 Dom4-Dom6S P868-C1290 pOPINF D2 50.0 
20 RRS1 Dom4-Dom6S P868-C1290 pOPINS3C E2 60.9 
21 RRS1 Dom4-Dom6R P868-Y1373 pOPINF B8 59.5 
22 RRS1 Dom4-Dom6R P868-Y1373 pOPINS3C C2 70.4 
23 RRS1 
cCFP-Dom4-




Dom6S-nVenus P868-C1290 pOPINF 
B7 82.7 
25 RRS1 WRKY-Dom6R S1184-Y1373 pOPINF F2 24.0 
26 RRS1 WRKY-Dom6R E1209-Y1373 pOPINM G2 59.0 
27 RRS1 WRKY-Dom6R R1194-Y1373 pOPINS3C H2 33.7 
Investigating heterologous expression systems for plant NLR expression 
 93 
Construct 






















K1219R WRKY-Dom6S E1209-C1290 
pOPINS3C 
D3 22.6 
32 RRS1 slh1 WRKY-Dom6S E1209-C1290 pOPINS3C E3 22.6 
33 RRS1 slh1 WRKY-Dom6S E1209-C1290 pOPINF F3 11.7 
34 RPS4 TIR-LRR M1-P879 pOPINF G3 102.0 
35 RPS4 TIR-LRR M1-P879 pOPINS3C H3 112.9 
36 RPS4 NB-ARC S477-T659 pOPINF C4 56.7 
37 RPS4 NB-ARC S477-T659 pOPINS3C D4 67.7 
38 RPS4 LRR-CTD P660-F1217 pOPINS3C A4 75.5 
39 RPS4 CTD E880-F1217 pOPINF B4 40.0 
40 RPS4 CTD L954-L1120 pOPINF E4 20.5 
41 AtWRKY 41 WRKY L121-E208 pOPINF H4 12.8 
42 AtWRKY 18 WRKY A157-E240 pOPINF A5 11.5 
43 AtWRKY 40 WRKY V124-N213 pOPINF B5 12.5 






C8 68.3  
+75.5 
45 RRS1/RPS4 









3.4.1 E. coli high-throughput screen design 
 
Expression trialling was conducted in E. coli with a number of variables outlined in Figure 
3.5. Firstly, two different expression strains of E. coli were used Rosetta (DE3) pLys and 
Lemo21 (DE3). Rosetta (DE3) pLys strain has been developed to enhance expression of 
eukaryotic proteins often limited by codon usage in E. coli by supplying rare tRNAs scarcely 
used by E. coli.  Rosetta (DE3) carries rare codons for amino acids Arginine (AGG, AGA and 
CGG), Isoleucine (AUA), Leucine (CUA), proline (CCC) and glycine (GGA). In this way the 
strain provides a more ‘universal’ translation environment which was of particular use to 
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this study as I was using RRS1 and RPS4 cDNA sequence which had not been codon 
optimised for E. coli use. The second strain trialled was Lemo21 (DE3). This strain allows for 
tuneable protein expression levels through the addition of L-rhamnose which varies the 
level of lysozyme, the natural inhibitor of T7 RNA polymerase, thereby modulating 
expression of the POI. This tuneable expression is of particular use for toxic proteins and 
those prone to insoluble expression as well as membrane proteins. The workflow used by 
OPPF initially expresses proteins in Lemo21 (DE3) without the addition of L-rhamnose with 
the use of L-rhamnose tuning used as a secondary optimisation of constructs which have 
low expression in the absence of L-rhamnose.  
 
There is no universal optimal media for all E. coli protein expression194C. Consequently, 
trialling of multiple media conditions in parallel is required to identify a POI’s optimal 
expression conditions. The screen at OPPF was conducted by growing cells in either Power 
Broth or Autoinduction media. These two medias offer different methods of protein 
expression induction which can have a large effect on soluble protein expression195.   
 
 Cells grown in Power Broth were induced with 1mM IPTG once cultures reached a set 
optical density (OD600=0.5) whilst induction of AIM cultures is self-regulated by the culture’s 
growth. AIM induction utilises the regulatory elements of the lac operon to deliver cell 
culture density dependant protein induction. The system relies on the switching from 
glucose to lactose metabolism once the preferentially metabolised glucose levels have 
been depleted by the growing E. coli cell culture196. Lactose metabolism then produces β-
galactosidase which relieves the repression of the lac operon controlling T7 RNA 
polymerase expression. The use of AIM thereby places the transition from un-induced to 
induced under the metabolic control of growing culture. Cultures grown in AIM often reach 
higher cell densities than those grown in IPTG induced cultures. This can increase soluble 
yields of POI but can also lead to adverse issues with aeration. 
 
Combining conditions tested between different E. coli strains and growth medias meant 
that each construct was tested in four varying conditions totalling 180 individual trials in 
total. The pipeline for screening in E. coli conducted at OPPF can be seen in Figure 3.5. All 
screens included expression of a GFP positive control vector to confirm to asses for correct 
transformation and growth of E. coli and insect cell cultures.  







Rational design of protein 
constructs
Cloning of POI into pOPIN 
expression vectors
pOPINF pOPINS3C pOPINM

























3 days of growth
Cells harvested and lysed
Figure 3.5 E. coli and Sf9 insect cell expression screening pipeline conducted at OPPF. Figure 
created using BioRender 
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3.4.2 E. coli high-throughput expression screen results 
 
The E. coli expression screen highlighted five construct/condition combinations of RRS1 
which showed soluble protein expression, although all except one combination yielded very 
low protein expression levels details of which can be found in Table 3.3.  The one construct 
which yielded medium expression levels was construct 15-RRS1 Dom4P868-K1189 pOPINF (gel 
code H1) expressed in Rosetta (DE3) pLys cells in AIM, Figure 3.7D. However, the expressed 
protein appears to be a truncation of the protein which this construct should express, as 
the SDS-PAGE gel band runs at around ~29 kDa rather than the expected size of 38.35 kDa. 
This band also correlates with a band seen in for this construct in Sf9 screen, section 3.4.4, 
which mass spectrometry analysis suggests represents P868-K1101 of RRS1 Dom4. This 
band was also visible in Rosetta (DE3) pLys cells grown in Power broth media but at lower 
expression levels than cells grown in AIM and was not observed to be expressed in Lemo21 
cells. Subsequent scale up expression of this construct on a 6 litre growth media scale 
however resulted in very low protein yields and hence this construct was not taken forward 
for further study, data not shown.  
 
Similarly, a truncated variant of ~36 kDa compared to 93.8 kDa predicted translated protein 
size of construct RRS1 NB-ARC LRRI154-T595 pOPINS3C (gel code H7) was seen to be expressed 
in Rosetta (DE3) pLys cells grown in AIM, Figure 3.7F. Expression however was very low and 
therefore was not followed up with a large-scale purification. Constructs RRS1 NB-ARCI154-
T595 pOPINF (gel code E1) and RRS1 Leucine-zipper motif-Dom6RL1089-Y1373 pOPINF (gel code 
B1) both appeared to be expressed but at very low levels in Rosetta (DE3) pLys cells grown 
in AIM, Figure 3.7D. The SDS-PAGE band size for both these constructs matches the 
predicted protein size for fully translated constructs suggesting the proteins were not being 
truncated in vitro. However, the expression levels observed in this is screen for these 
constructs are too low to carry forward with larger scale-up expression and purification.  
 
One construct RRS1 WRKY-Dom6RE1209-Y1373 appeared to be expressed in the soluble fraction 
of Lemo21 cells grown in AIM though expression was observed to be very low again and 
not suitable for scale up purifications, Figure 3.6D. 
 
Crude lysate samples of Rosetta (DE3) pLys and Lemo21 cells grown in AIM were analysed 
by SDS-PAGE to assess for protein expression in the total fraction. However, bands were 
not clear enough to confirm presence of POI in these samples.  
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Figure 3.6 Coomassie stained SDS-PAGE of Lemo21(DE3) E. coli expression of RRS1 and RPS4 
domains. SDS-PAGE soluble extract from Lemo21(DE3) E. coli cells following Nickel IMAC. Soluble 
A1 B1 C1 D1 E1 F1 G1 H1 A2 B2 C2 D2 E2 F2 G2 H2 A3 B3 C3 D3 E3 F3 G3 H3
SUMO >
Lemo21 (DE3) cells: Power Broth media
KDa
Gel Code:
A4 B4 C4 D4 E4 F4 G4 H4 A5 B5
Lemo21 (DE3) cells: AIM media
Gel Code:
A1 B1 C1 D1 E1 F1 G1 H1 A2 B2 C2 D2 E2 F2 G2 H2 A3 B3 C3 D3 E3 F3 G3 H3






































































protein expression is indicted by arrow. (A-C) cells were grown in AIM with overnight expression at 
250C, (D-F) cells were grown in PB media with overnight expression at 200C. SDS-PAGE stained with 
Coomassie dye. Experiment was conducted once. 
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Figure 3.7 Coomassie stained SDS-PAGE of Rosetta (DE3) pLys E. coli expression of RRS1 and RPS4 
domains. SDS-PAGE soluble extract from Rosetta (DE3) pLys E. coli cells Following nickel IMAC. 
Soluble 
A1 B1 C1 D1 E1 F1 G1 H1 A2 B2 C2 D2 E2 F2 G2 H2 A3 B3 C3 D3 E3 F3 G3 H3
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l l  protein expression is indicted by arrow. (A-C) cells were grown in AIM with overnight 
expression at 250C, (D-F) cells were grown in PB media with overnight expression at 200C. 
Experiment was conducted once. 
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In summary it appears that E. coli is not a suitable heterologous expression to be used for 
the expression of full-length or truncated RRS1 and RPS4. This correlates with previous 
struggles in the field to express soluble plant NLR proteins in this host system. The 
expression of truncated constructs, albeit to very low levels, appeared to be significantly 
more successful in Rosetta (DE3) pLys cells than Lemo21 cells with 4/5 of occurrence of 
soluble expression in the screen seen in Rosetta (DE3) pLys. I hypothesise this is due to the 
fact that Rosetta (DE3) pLys cells carry several tRNAs which are rarely used in E. coli but are 
found in the cDNA sequence of RRS1Ws-2 and RPS4Col-0, see Table 3.4. Unfortunately, the 
bands in the total fraction samples from this screen which were also analysed by SDS-PAGE 
were not clear enough to confirm expression of constructs in the total fraction so this 
hypothesis cannot be confirmed (gels not shown as bands are unreadable). 
 
Table 3.4 Codon occurrence in RRS1 and RPS4 of tRNAs supplied in Rosetta (DE3) cells (GenScript) 
Amino acid Codon 
Codon occurrence in 
cDNA 
Fraction for each codon within 
synonymous family 
RRS1Ws-2 RPS4Col-0 A. thaliana E. coli S. frugiperda 
Arg AGG 10 13 0.2 0.04 0.21 
 AGA 24 17 0.35 0.07 0.16 
Ile AUA 25 13 0.24 0.11 0.12 
Leu CUA 21 14 0.11 0.04 0.08 
Pro CCC 8 5 0.11 0.13 0.31 
Gly GGA 25 29 0.37 0.13 0.27 
 
3.4.3 Baculovirus transfected Sf9 insect cells high-throughput screen design 
 
High-throughput screening of Baculovirus transfected Sf9 insect cells was conducted using a 
P1 virus stock as though screening can be conducted with P0 virus, screening using P1 virus 
stocks gives a more reliable expression result. Infectious titre of Baculovirus viral stock has 
been shown in the literature to have potentially significant effects on the yield of soluble 
recombinant protein production197. To investigate this, screening at OPPF was setup using 
two different titres or MOI (multiplicity of infection) of P1 virus stock, 3 µl and 30 µl, Figure 
3.5. As a general principle, if Sf9 cells are transfected with too little virus this can lead to 
poor protein yields as a synchronous infection across all Sf9 cells will not be established. If a 
subset of Sf9 cells are not infected after the addition of the virus stock then uninfected cells 
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may continue to multiply and increase the cell density to the stationary phase of culture 
growth where virus replication is inhibited. This results in only a small fraction of the Sf9 
cell culture expressing the POI and reduces yield of the recombinant protein. Conversely, 
the addition of too higher titre of virus stock can be detrimental to the growth of the Sf9 
cell culture and reduce yields of recombinant protein. Previous studies have shown the 
effect of a low and high MOI on recombinant protein expression appears to vary between 
proteins198, with no universal correlation pattern and therefore different viral titres were 
investigated in this study.  
 
3.4.4 Baculovirus transfected Sf9 insect cells high-throughput expression 
screen results 
 
The Sf9 cell expression screen highlighted four construct/condition combinations of RRS1 
and one of RPS4 which showed soluble protein expression. Whilst most constructs which 
exhibited soluble expression in the Sf9 trials were at expression levels too low to carry 
forward for scale up purification, RRS1 WRKY-Dom6RE1209-Y1373 pOPINM (gel code G2) and 
RPS4 CTDL954-L1120 pOPINF (gel code E4) showed expression levels which could yield good 
quantities of protein upon scale up, Figure 3.8A,B,D. Work continues at JIC by Dr Nitika 
Mukhi and Dr Richard Hughes to take forward these two constructs for scale up expression 
and purification to produce protein for crystallography and biochemical analysis.  
 
The screen also showed that the AtWRKY40V124-N213 and AtWRKY18A157-E240 constructs to 
express well in Sf9 cells transfected with 3 μl of P1 Baculovirus stock. As expression of the 
potential host target AtWRKY41 was not soluble however, scale up purifications of the 
negative effector interaction controls AtWRKY40 and AtWRKY18 have not been currently 
taken forward, Figure 3.8B. 
 
Whilst RRS1 Dom4P868-K1189 showed low levels of soluble expression at the predicted 
molecular weight when fused with a SUMO tag in the pOPINS3C vector (gel code H1), when 
expressed in the pOPINF vector (gel code A2) only a truncation of this construct appeared 
to show soluble expression, Figure 3.8A,D. In gel digestion mass spectrometry suggested 
this truncated soluble construct of ~ 28 kDa represented P868-K1101 of RRS1 Dom4 by 
peptide coverage. This might suggest the SUMO tag is helping to stabilize this protein in 
vitro. pOPINS3C however did not universally help against the expression of truncations of 
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the cloned protein construct as only a ~27 kDa variant of the predicated 93.8 kDa RRS1 NB-
ARC-LRRI154-T595 in pOPINS3C showed low levels of soluble expression.  
 
Figure 3.8 Coomassie stained SDS-PAGE of Sf9 insect cell expression of RRS1 and RPS4 domains. 
SDS-PAGE soluble extract from Baculovirus transfected Sf9 insect cells following nickel IMAC. Soluble 
A1 B1 C1 D1 E1 F1 G1 H1 A2 B2 C2 D2 E2 F2 G2 H2 A3 B3 C3 D3 E3 F3 G3 H3
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protein expression is indicted by arrow. (A-C) Sf9 cells were transfected with 3µl of P1 Baculovirus, 
(D-F) Sf9 cells were transfected with 30µl of P1 Baculovirus. Experiments were only conducted once. 
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I also tried co-expressing RRS1 LRR-Dom4 pOPINF with RPS4 LRR-CTD pOPINF and RRS1 
LRR-Dom6R pOPINF with RPS4 LRR-CTD pOPINF under the hypothesis that co-expression 
may help to stabilise these two proteins which are predicted to interact. However soluble 




The aim of this project was to trial the expression of full-length and truncated RRS1 and 
RPS4 constructs in the heterologous expression systems of E. coli and insect cells to 
produce soluble protein for downstream experiments. Previous work in the NLR field to 
produce soluble NLR protein has faced many difficulties with obtaining good yields of 
soluble multi-domain NLR protein. The lack of published structural data of multi-domain 
NLR constructs does likely not reflect a lack of effort to attain such data in the field and as 
such I wanted to trial a range of experimental conditions with these systems to increase the 
likelihood of achieving successful expression. We chose to focus our initial round of NLR 
expression trials on the heterologous systems of E. coli and Sf9 insect cells. A summary 
figure of the results of this screen can be found in Figure 3.9 and list of all soluble 
expression results in study found in Appendix 5. 
 
The majority of published crystal structures of domains of plant NLR proteins have utilised 
E. coli for protein expression, see Table 3.1. E. coli’s rapid growth in simple culturing 
conditions requiring little specialist equipment make the system a straightforward and 
economic system for a high-throughput expression screen such as this project looked to 
conduct. The system however is not without significant drawbacks outlined in detail in 3.1 
including protein folding capabilities, lack of post translational modifications and codon E. 
coli usage bias.  
 




Figure 3.3.9 Summary of RRS1 and RPS4 expression trials in E. coli and Sf9 insect cells. Each 
horizontal bar indicates the summarised results for all pOPIN vectors expressing that protein 
construct in both E. coli and insect cell. Bar colours indicate expression result with blue bars 
indicating low levels of soluble protein expression, green bars medium-high levels of soluble 
expression and grey bars no soluble protein expression as determined by SDS-PAGE analysis. A 
dashed line indicated a truncation of the cloned protein predicted molecular weight was observed.  
If expression was observed, the heterologous species in which expression was seen is listed on the 
left of the bar with ‘E.c’ indicating E. coli and ‘Sf9’ indicating Sf9 insect cells. Total number of 
conditions each protein construct was expressed in is listed on the right of each bar for E. coli and 
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Given the failure of most RRS1 and RPS4 constructs tested in this project to show soluble 
expression in E. coli, it is likely these issues hinder the soluble expression of these plant 
NLRs. What was observed was a clear trend of higher soluble expression rates of Rosetta 
(DE3) pLys over Lemo21(DE3). The main difference in terms of expression capabilities of 
these two BL21 derivative lines is that Rosetta (DE3) pLys cells are supplied with extra 
copies of rare tRNAs uncommonly found in E. coli. As these rare codons are found in the 
cDNA sequence of RRS1 and RPS4 used in this study, see Table 3.4, and cDNA sequences 
were not codon optimised for E. coli, it could be hypothesised that supply of these rare 
tRNAs allowed for more efficient translation of RRS1 and RPS4 protein in Rosetta (DE3) pLys 
than Lemo21 (DE3) cells184. This potential bottleneck in NLR protein expression could be 
removed in future studies by codon optimising the cDNA sequence of the POI for E. coli to 
ensure for efficient protein translation. As SDS-PAGE protein bands of the total fraction 
from each trial were not clear enough to confirm the presence of the POI, we are unable to 
say what effect inefficient protein translation had on the screen’s success and how much of 
a bottleneck translation efficiency was on soluble protein production.   
 
Another potential avenue for improving the folding of NLRs in E. coli is through co-
expression of NLRs with eukaryotic chaperone proteins. The dependency of certain plant 
NLRs on co-evolved chaperones for appropriate protein folding has been documented in 
the literature. For example, the dependency of tomato NLR I-2 on the small heat shock 
chaperone RSI2199 and RPS4’s dependency on eukaryotic conserved chaperones complex of 
SGT1-Hsp9088,200 has been demonstrated. Going forward, this knowledge of NLR required 
chaperones could be expanded by conducting ribosome profiling studies201 of RRS1 and 
RPS4 to provide a list of chaperone proteins utilised in the folding of these proteins in their 
native A. thaliana environment. A line of E. coli could then be generated which 
heterologously expressed these chaperones in which RRS1 and RPS4 protein could be 
additionally expressed. This would create a line of E. coli with a chaperone repertoire more 
akin to Arabidopsis which may aid soluble expression of NLRs in this heterologous 
expression system. A similar pipeline was recently applied for the expression of the 
Arabidopsis ~540 kDa RuBisCo complex202. In this study researchers achieved for the first-
time soluble expression of the functional RuBisCo complex in E. coli by co-expressing the 
RuBisCo subunits with five additional chloroplast chaperones thereby enabling correct 
protein folding in the prokaryotic system. Generation of an ‘NLR chaperone’ E. coli 
expression line which co-expresses a range of chaperones known to be involved in NLR 
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folding but are not present in prokaryotic systems, could therefore provide a viable avenue 
for increasing soluble expression of NLRs in this system. 
 
A variable I tested as part of the E. coli screen at OPPF was the cell growth media. Two 
different medias were tested, AIM and PB, which both employ different POI induction 
methods previously discussed in 3.4.1. The screen results show that AIM appeared to 
better support soluble protein expression of RRS1 and RPS4. This may be due to the fact 
cultures grown in AIM often grow to a higher cell density than IPTG-induced media’s 
leading to higher yields of POI. It should be noted that is not the case for NLR expression 
universally as for example the RRS1 WRKY constructs used in Chapter 5 were found to 
express best in LB media induced with a low level of IPTG. This result does emphasise the 
need however to screen for multiple media conditions as in this project media was found to 
play an important role in soluble protein production levels. If this screen was to be 
expanded a range of IPTG induction concentrations used for PB grown cells could be tested 
as can have significant effects POI yield203 potentially due to the metabolic burden on E. coli 
cell of the POI204.  
 
Other variables which could be tested could include the temperature at which cells are 
grown, especially during the overnight protein induction phase of growth. For example, 
lowering the cultivation temperature often increases levels of correct protein folding and 
helps prevent the formation of aggregated inclusion bodies205,206. Additionally further 
solubility tags could be tested for their ability to enhance the POI solubility187,191.  For 
example, possible fusion tags to explore include: Glutathione S-transferase (GST) which 
protects against intracellular proteolysis and aids stability207, thioredoxin which helps refold 
proteins in reducing environments208 or N-utilization substance (NusA) which works to slow 
protein translation allowing a long time frame for  protein folding209.  Other strains of E. coli 
could also be tested as protein folding environments can greatly differ between strains. For 
example, to facilitate proper disulphide bond formation, strains containing mutated in 
glutathione reducatase (gor) and thioredoxin reductase (trxB), the enzymes responsible for 
reducing thioredoxins, could be used such as Origami and SHuffle210. 
 
The second heterologous system I explored for RRS1 and RPS4 protein production was 
Baculovirus transfected Sf9 insect cells. Though insect cells are significantly more time 
consuming and costly to grow and culture than E. coli, as a eukaryotic system they provide 
a more complex protein folding environment that we hypothesised would better support 
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for soluble expression of NLRs. However, similarly to E. coli, expression of RRS1 and RPS4 in 
Sf9 insect cells showed very limited success particularly at the multidomain level. With the 
exception of RRS1 WRKY-D6RE1209-Y1373 pOPINM and RPS4 CTDL954-L1120 pOPINF all soluble 
expression observed was of a yield too low to take forward for subsequent scale up 
experiments. Work to scale up production of RRS1 WRKY-D6RE1209-Y1373 and RPS4 CTDL954-L1120 
is currently being conducted in the lab by Dr Nitika Mukhi and Dr Richard Hughes. Should 
scale up of these constructs prove successful, structural and biochemical interaction 
information of both these constructs could provide interesting biological insights into the 
functioning of RRS1 and RPS4.  
 
Production of RRS1 WRKY-D6RE1209-Y1373 would enable the exploration of the structural basis 
of RRS1-R’s ability to bind structurally and enzymatically distinct effectors by comparing 
binding of AvrRps4 and PopP2 to this domain and provide intriguing insights into NLR 
effector recognition strategies.  Genetic and biochemical evidence suggests that the post-
LRR CTD region of RPS4 plays an important role in the functioning of RRS1-RPS4 complex152. 
RPS4 CTD has been observed in co-immunoprecipitation studies to interact with RRS1 
Dom4-D6R but the activation of RRS1-RPS4 complex cannot be explained by the presence 
or absence of this interaction alone. This implies there are more subtle changes in domain 
interactions occurring during complex activation which only structural biology can provide 
insights on. As our ability to model RPS4’s CTD is very low due to low homology with other 
protein domains, gaining structural insights of this domain would provide vital biological 
insights into the functioning of this domain. As a truncation of RPS4’s CTD the RPS4 CTDL954-
L1120 pOPINF construct covers the central ~50% of this domain. Whilst this does include 
residues previously identified to be important in RRS1-RPS4 immune signalling such as RPS4 
G997 it does not include other RPS4 CTD residues also known to impact the complex’s 
signalling abilities such as S914 and G952161. Future work could therefore investigate 
identifying longer constructs of RPS4’s CTD with soluble expression which covers all these 
key residues. 
 
Despite having eukaryotic protein folding capabilities, Sf9 insect cells did not show a greatly 
increased range of soluble RRS1 and RPS4 protein expression. It could therefore by 
hypothesised that lack of appropriate chaperones may also be limiting the production of 
soluble RRS1 and RPS4 protein in this system similar to E. coli. Future studies could employ 
a similar strategy to that described above for E. coli in co-expressing NLRs with chaperones 
identified in the literature or ribosome profiling to be required for NLR functioning in 
Investigating heterologous expression systems for plant NLR expression 
 110 
planta. Similar to E. coli, the SDS-PAGE bands of POI from insect cell trials total fraction 
were unclear to see we do not know the extent protein translation efficiency had on 
soluble protein expression and future studies could benefit from codon optimising NLR 
cDNA for insect cell expression.  
 
Looking across both E. coli and insect cell systems there are several options to consider 
should future studies wish to further explore the use of these heterologous expression 
systems for RRS1 and RPS4 or alike NLR protein production which could help improve the 
protein folding environment of these hosts. In addition to previously discussed use of co-
expression with chaperones future studies could explore the use of chemical chaperones to 
aid soluble protein production. Such chemical chaperones include: ethanol which is thought 
to induce expression of heat shock proteins211, glycerol which helps with protein 
stability212,213 or DMSO which is hypothesised to protect proteins from thermal 
denaturation and aggregation213,214. Beyond changing expression conditions, future studies 
of this kind could employ new screening technologies which expand on traditional PCR 
cloning methods such as ESPRIT screening technology developed at EMBL by Dr Darren 
Hart. This method involves the creation of unidirectional truncations of a target gene using 
exonuclease degradation to create a diverse library of potential expression constructs. 
Constructs are then “printed” onto nitrocellulose membranes and soluble POI expression 
screened for by hybridisation of fluorescent antibodies215,216. This enables the screening of 
up to 30,000 individual clones for yield and soluble POI expression in a single experiment 
and has already been utilised for similar studies with the Symphytum tuberosum NLR R3a217 
conducted in the Banfield laboratory. 
 
What the results in the chapter highlight is that both E. coli and Sf9 insect cells appear to be 
an inappropriate expression system for the production of multi-domain soluble RRS1 and 
RPS4 protein, likely due to insufficient protein folding environment. The expression trials 
described in this chapter and chapter 5 suggested that whilst singular domains or 
truncations of RRS1’s WRKY and Dom6 could be expressed in E. coli and Sf9 insect cells, 
multi domain expression was not supported. Work taking forward RRS1 WRKY Dom6 
expression is described in chapter 5. The expression screen results in this chapter suggested 
that going forward with trials to produce soluble full-length RRS1 and RPS4 protein, I would 
need to utilise systems which provided the protein folding machinery and conditions more 
akin to that of the RRS1/RPS4’s native A. thaliana environment such that would support the 
correct folding of these NLR proteins. 
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Notes: Figures and results presented in section 4.3 of this chapter include my contribution 
to Ngou et al, 2019218. Contributions of other authors from this paper are acknowledged 
throughout. Work presented in 4.4 was conducted with Freya Hartshorn, an undergraduate 
summer student under my supervision. A list of the cloned vectors and maps used in this 
chapter can be found in Appendix 2 and Appendix 4. Summary of all soluble expression 
results from study can be found in Appendix 5. 
 
4.1 Introduction & chapter aims 
 
High-throughput screens of RRS1 and RPS4 in E. coli and Sf9 insect cells described in 
chapter 3 highlighted that these heterologous systems are inappropriate for the production 
of soluble multi-domain RRS1 and RPS4 protein. I hypothesised that the inability of these 
systems to produce multi-domain soluble protein of RRS1 and RPS4 was likely due to failure 
to support protein folding of these NLRs. Consequently, I next wanted to test expression 
systems with protein folding machinery and conditions more akin to RRS1 and RPS4’s 
native A. thaliana. For this I decided to expand trials to plant-based protein expression 
systems with the rationale that these systems would provide a protein folding environment 
better suited for soluble production of RRS1 and RPS4. 
 
Plant-based expression systems are increasingly being utilised as a general platform for 
production of recombinant proteins, particularly in the pharmaceutical field219,220. A variety 
of different plant-based expression systems have been developed utilising a wide range of 
production and transformation strategies including: stable transgenic plants221,222, 
agrobacterium mediated transient expression223,224, virus infected plants225, cell cultures 
(e.g. tobacco BY2 cells)226 and wheat germ cell-free expression170. These systems are 
generally valued for their eukaryotic folding capabilities, economic scalability and 
production timescales all of which are highly relevant to this project.  
 
Recombinant protein production relies on three expression strategies: chemical synthesis, 
in vivo expression and cell-free protein synthesis. As previously discussed, NLR protein 
4 
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production is recognised to be notoriously difficult, so to increase any chances of success I 
set out to explore a diverse range of protein synthesis systems for production of RRS1 and 
RPS4 protein. Whilst chemical synthesis is not suitable for proteins of the length of RRS1 
and RPS4, I wanted to investigate the use of cell-free expression systems in addition to the 
various in vivo strategies. The three best established cell-free systems used for protein 
production are rabbit reticulocyte, E. coli cell and wheat germ extract227. Of these systems 
wheat germ extract seemed the most appropriate for this study given the limited success of 
in vivo E. coli trials described in chapter 3 and observations in the literature that protein 
yields in wheat germ tend to be higher than rabbit reticulocyte extracts228. Due to its role in 
wheat kernel germination, wheat germ contains all the components required for wheat 
protein translation, with the exception of mRNA, and as such we hypothesised that this 
eukaryotic plant system would be a suitable environment for soluble expression of NLRs. 
Whilst examples are limited, use of wheat germ extract for NLR expression has been 
demonstrated, for example in the expression of Oryza sativa coiled-coil NLR Pb1107, though 
protein production was not to levels required for structural or quantitative biochemical 
work. 
 
For whole-plant based expression systems, I tested both transgenic A. thaliana plants and 
agroinfiltrated N. benthamiana. Though initially time-consuming and labour-intensive, once 
generated, stable transgenic plants provide an economical and relatively straightforward 
scalable production system, especially for the protein quantities I set out to produce RRS1 
and RPS4. The physical ease of scaling transgenic A. thaliana for this project was enhanced 
by our ability to grow sterile A. thaliana seedlings shaking in liquid media 229. Alternatively, 
transgenic lines can be grown on soil for several weeks before leaf tissue is harvested. 
Whilst this would be a productive strategy if a protein of interest (POI) was restricted to 
leaf tissue expression, the promoters used for this work (35S, pAt2 and pAt3) are expressed 
across A. thaliana cell types. As RRS1 and RPS4 are native to A. thaliana, transgenic A. 
thaliana lines have the complete protein folding capabilities for producing functional 
correctly folded and post translationally modified RRS1 and RPS4 protein.  
 
The final expression strategy I set out to evaluate is agroinfiltrated N. benthamiana. Whilst 
increasingly used for the purposes of protein production in the pharmaceutical field220, use 
of this system for production of NLRs for structural biology and quantitative biochemical 
work has only recently been investigated. Prior to this development, the system was widely 
used for small-scale (single leaf) NLR production for the purpose of co-immunoprecipitation 
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studies, microscopy and HR assays including RRS1 and RPS4 studies65,114. The benefits the 
system offers over transgenic plants is the speed with which proteins can be expressed and 
harvested, enabling faster evaluation of the performance of different expression 
constructs. This method utilises A. tumefaciens to deliver genes to leaf cells of N. 
benthamiana which can then be harvested for protein purification ~3 dpi. Protein yields 
from this system vary but yields of 1 gram of protein product per kilogram of leaves have 
been recorded220. Previous work with small-scale (single leaf) experiments have shown this 
system is capable of producing full-length RRS1 and RPS4 protein so it was well established 
that this system provides a suitable folding environment for these NLR proteins. Compared 
to transgenic plants, agroinfiltration offers more flexibility in trialling a range of expression 
conditions for protein production. As constructs can be transformed into agrobacterium 
and protein harvested from leaves days later, this system can be used to investigate a range 
of variables in protein production including trialling different expression vectors or affinity 
tags for the purification of POI.  
 
Following on from E. coli and Sf9 insect cell expression screens in the previous chapter, this 
chapter will investigate the use of a range of plant-based expression systems for the 
production of RRS1 and RPS4 protein. Strategies evaluated for protein production are: cell-
free wheat germ system, transgenic A. thaliana lines expressing full-length and truncated 
RRS1 and RPS4 and agrobacterium-mediated transformation of N. benthamiana to express 
full-length and truncated RRS1 and RPS4 protein. This chapter will discuss the results of 
these screens of which full methodologies can be found in chapter 2.  
 
4.2 Expression of full-length and truncated RRS1 in a cell-free wheat 
germ system 
 
4.2.1 Full-length RRS1Ws-2 and RRS1 WRKY Dom6S show soluble expression in a 
wheat germ cell-free system-CellFree Sciences WEPRO® extract  
 
Full-length coding sequence of RRS1Ws-2 and RRS1 WRKY Dom6S with C-terminal HF tag 
were cloned in to pEU wheat germ expression vector (CellFree Sciences) using golden gate 
cloning. This pEU vector was made golden gate compatible by Dr Cheng Chang using PCR 
mutagenesis. I chose to trial expression of full-length RRS1Ws-2 to evaluate the wheat germ 
cell-free expression system for its suitability to express full-length NLRs which had 
previously proved insoluble in insect cell and E. coli expression systems. Additionally, I 
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chose to express RRS1 WRKY D6S alongside full-length RRS1 as a form of positive control 
given we knew this construct expressed well in E. coli and therefore was predicted to 
express in wheat germ’s folding environment. I initially trialled a wheat germ expression 
system using a CellFree Sciences ENDEXT® Technology Protein Research Kit S 
(https://www.cfsciences.com/eg/products/kit/138-kit/products-for-research-premixed-
kit/465-protein-reseach-kit-s) using the workflow described in Figure 4.1. 
 
Cloned RRS1Ws-2-HF pEU vectors were transformed into E. coli DH10B cells and plasmid 
midiprepped from a 25 ml culture. High purity mRNA was then generated for each 
construct (from 2000 ng of purified pEU plasmid) using a transcription mix supplied by 
CellFree Sciences. Following transcription, mRNA integrity was assessed by gel 
electrophoresis. 
 
There are several methods for setting up a wheat germ translation system which vary in 
their potential protein yields and simplicity of setup170. The traditional method is a batch 
reaction format where all reagents are mixed and incubated together for a limited time 
period. This is the simplest method to setup and typically has the lowest protein yields. A 
variation on this is the repeat-batch method in which the reaction is set up in the batch 
format, but in a reaction vial with a membrane which allows through small molecular 
weight translation by-product inhibitors from the reaction mix. These by-products can then 
be periodically removed from the reaction mix by centrifugation and the translation 
reaction topped up with fresh substrate buffer. Proteins can also be expressed in a dialysis 
protein expression format where the translation reaction is setup in a dialysis cup which is 
in contact with a feeding substrate buffer that supplies the reaction with fresh substrate 
whilst removing small molecular weight inhibitors like the repeat batch format. These two 
methods have been shown to offer higher yields of POI for a given volume of wheat germ 
extract but with a more complex setup which works better with a larger volume of wheat 
germ extract170. Alternatively, the bilayer reaction method is setup with the substrate 
buffer (amino acids, ATP, GTP etc) added on top of a translation mix which contains a 
mixture of mRNA and wheat germ extract to form two separate layers169. This reaction 
setup allows for a diffusion-controlled translation process which can be run for longer than 
a traditional mixed batch reaction format which will end after a few hours. Conversely, 
bilayer reactions can by maintained for up to 24 hours yielding substantially higher protein 
yields170.  




Figure 4.1 Wheat germ cell expression system workflow. Following cloning of gene of interest into a 
pEU expression vector with a Hell-Fire (HF) tag, plasmid was midiprepped from E. coli. mRNA of gene 
of interest was then generated from midiprepped DNA template in a transcription reaction. mRNA 
was then mixed with wheat germ extract and setup in a bilayer translation reaction with a top layer 
of sub-AMIX mixture which contained amino acids, ATP and GTP. Protein translation reaction 
continued at 250C for 15 hours before the two translation layers were mixed and POI purified using 
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Figure 4.2  Expression of full-length RRS1Ws-2-HF and truncated WRKY Dom6S-HF in CellFree 
Sciences wheat germ cell-free system. (A&B) Immunoblot analysis of RRS1Ws-2-HF and RRS1 WRKY 
Dom6S-HF in total extract of CellFree Sciences Protein Research Kit (S) wheat germ cell-free extract, 
bands were visualized using Pico PLUS chemiluminescent substrate with 30 second exposure, arrows 
indicate the expected protein bands. Protein were visualised using an HRP-conjugated anti-FLAG 
antibody. (C&D) Coomassie stained SDS-PAGE of total protein of wheat germ cell-free extract arrows 
indicate the expected band size of POI. Volume loaded of total translation reaction mix is indicated 
above gel lane. Experiment conducted jointly with Dr Yan Ma. Experiments were repeated twice with 
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For this investigation, protein translation was set up in a bilayer system as it offers better 
yields than batch reactions and can be easily set up with the small reaction volumes (226 
µl) I was working with. Following translation, the substrate SUB-AMIX buffer and translation 
mix were mixed and protein yield assessed by SDS-PAGE and immunoblot analysis. 
Following a 15-hour translation reaction, immunoblot analysis showed that the wheat germ 
cell-free system was capable of expressing both full-length RRS1Ws-2-HF and RRS1 WRKY 
Dom6S-HF, Figure 4.2A,B. However, SDS-PAGE analysis showed the yields of these protein 
were not high enough to visualise via Coomassie staining, Figure 4.2C,D. 
 
4.2.2 Full-length RRS1Ws-2 and RRS1 WRKY Dom6S show soluble expression in a 
wheat germ cell-free system- Wheat germ extract from Professor Yasuomi 
Tada  
 
In addition to the wheat germ WEPRO® extract supplied in the CellFree Sciences ENDEXT® 
Technology Protein Research Kit S, I also tried expressing full-length RRS1Ws-2-HF and 
truncated RRS1 WRKY Dom6S-HF using an alternative wheat germ extract sourced from 
Professor Yasuomi Tada at Nagoya University to investigate how this would affect the yield 
of the POI. Translation reactions were setup in a bilayer format as mentioned before with 
the reaction run for 15 hours at 250C.  
 
Similar to the CellFree Sciences system, Figure 4.2, whilst full-length expression of RRS1Ws-2 
and RRS1 WRKY Dom6S was observed by immunoblot analysis using this system, Figure 
4.3A,B ,  the proteins of interest were still of an insufficient quantity to be observed by 
Coomassie staining of an SDS-PAGE gel, Figure 4.3C,D. Inferring from the immunoblot 
conditions required to visualise the POI in Figure 4.2A & 4.3A, which were 30 seconds with 
pico chemiluminescent substrate and  120 seconds with 1:1 pico:femto chemiluminescent 
substrate respectively, it appeared full-length RRS1Ws-2-HF was expressed to higher levels in 
the CellFree Sciences WEPRO® extract. Therefore, this source of wheat germ extract was 
taken forward for subsequent studies. 
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Figure 4.3 Expression of full-length RRS1Ws-2-HF and truncated WRKY Dom6S-HF in wheat germ 
extract. (A&B) Immunoblot analysis of RRS1 Ws-2-HF and RRS1 WRKY Dom6S-HF in wheat germ cell-
free extract from Professor Yasuomi Tada’s laboratory, bands were visualized using Pico PLUS and 
Femto chemiluminescent substrate in a 1:1 ratio with 120 second exposure, arrows indicate the 
expected protein bands. Protein were visualised using an HRP-conjugated anti-FLAG antibody. (C&D) 
Coomassie stained SDS-PAGE of total protein of wheat germ cell-free extract arrows indicate the 
expected band size of POI. Volume loaded of total translation reaction mix is indicated above gel lane. 
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4.2.3 HF-tagged proteins can be purified from wheat germ cell-free expression 
system using anti-FLAG affinity beads 
In order to establish the best method for purifying POI expressed in CellFree Sciences 
wheat germ WEPRO® extract, both full-length RRS1Ws-2-HF and RRS1 Dom4 WRKY Dom6R-
HF was expressed in vitro from mRNA generated from pEU vectors. As each of these 
proteins were fused to an HF-tag (6xHis, 3xFLAG epitopes) at the C-terminus, I first tried 
purifying the POI by its 6xHis tag using the well utilised system of Ni-NTA resin230 as used in 
previous E. coli and insect cell work in this study. However, this method failed to purify 
proteins from the wheat germ extract. Secondly, I tried to purify the HF-tagged proteins 
using anti-FLAG affinity beads. This purification method proved successful in 
immunoprecipitating the POI, Figure 4. 4. However, release of POI from the anti-FLAG 
beads by competitive elution with 3 x FLAG peptide was inefficient, as boiling of the anti-
FLAG affinity beads post FLAG peptide elution showed significant amount of protein still 











Figure 4.4 Anti-FLAG affinity bead purification of full-length RRS1Ws-2-HF and Dom4 WRKY Dom6R 
truncated protein from wheat germ extract. For immunoblotting, samples were taken throughout 
purification process from: total soluble input, competitive elution with FLAG peptide and boiled anti-
FLAG affinity beads post FLAG peptide elution. Volume loaded for each of the samples is indicated 
above gel lane. Total sample volume indicates the total volume of sample at each stage of 
purification of which 20 µl was loaded on an SDS-PAGE gel. Protein were visualised using an HRP-
conjugated anti-FLAG antibody. 
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4.2.4 RRS1Ws-2-HF appears to form a multimeric complex when expressed in wheat 
germ cell-free extract 
There has been much discussion in the NLR field as to the ability of NLRs to form multimeric 
complexes231,232. To investigate whether full-length RRS1Ws-2-HF could form multimeric 
complexes when expressed in wheat germ cell-free extract, post translation samples were 
analysed using Blue Native PAGE. Blue Native PAGE showed a smearing of FLAG-tagged 
protein between 480-1048 kDa suggesting that the RRS1Ws-2-HF protein was not in a 
monomeric state (161 kDa), Figure 4.5A.  
 
 
Figure 4.5 RRS1Ws-2-HF forms a multimeric complex when expressed in wheat germ extract. (A) Blue 
Native PAGE showing assembly of a multimeric complex as indicated by bracket, band smear may 
indicate a range of partially formed complexes. Protein was loaded on 3-12% Native PAGE gel and 
electrophoresed before transfer to nitrocellulose membrane and immunoblotting with an HRP-
conjugated anti-FLAG antibody, equal loading was indicated by staining of membrane with Instant 
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(B) Presence of RRS1-HF protein in Blue Native PAGE sample was shown by SDS-PAGE analysis of 
same protein sample followed by immunoblotting with an HRP-conjugated anti-FLAG antibody. 
Volume loaded of total sample is indicated above gel lane. Experiment was only conducted once. 
 
Whilst we cannot infer the exact size of complex formed by RRS1Ws-2-HF in wheat germ due 
to inaccuracies with the size prediction of the Blue Native PAGE method, this result gives us 
a promising lead that RRS1Ws-2 may form a multimeric complex in vivo. This result is also in 
accordance with previous findings in which RRS1 was shown to self-associate in the 
absence of RPS4233. Furthermore, the retained ability of the wheat germ extract-produced 
RRS1 to self-associate is consistent with the protein produced in this system being correctly 
folded. Correct folding can be inferred from this observation as incorrectly folded protein 
would likely aggregate and now elute from the column in a single peak. Further analysis 
such as circular dichroism could be used in the future to verify this.  
 
In addition to establishing the size of complex this RRS1 material was forming in wheat 
germ, another interesting aspect to be investigated would be whether any non RRS1 
proteins were contained in this complex. If so, this would highlight potential downstream 
interactors of RRS1. However, as the yield of POI in this system after immunoprecipitation 
with anti-FLAG affinity beads was of a quantity which cannot be visualised by Coomassie 
staining of SDS-PAGE gels, we are unable to say if this complex of RRS1 Ws-2-HF contains 
other proteins as well.  
 
Ultimately, we would want to investigate the NLR complex of RRS1 and RPS4 together as 
this is how they work in their native environment and therefore presents a more valuable 
model to investigate. However, given our current inability to produce RPS4 cDNA I was 
unable to co-express both RRS1 and RPS4 in this system, to test whether we could 
recapitulate formation of an RRS1-RPS4 complex. Should RPS4 cDNA become available in 
the future this would be an interesting goal for future studies. 
 
Though RRS1 Ws-2-HF protein appears to show soluble expression and correct folding in the 
wheat germ cell-free system, the inability to visualise expressed protein on a Coomassie 
stained SDS-PAGE indicates the yields of protein we are producing in this system is 
insufficient for follow up quantitative biochemical and structural work. Whilst theoretically 
protein yield could be increased by increasing the volume of wheat germ extract used for 
translation, given the quantities of POI yields observed in this study, the volume of wheat 
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germ extract which would be required to scale up expression was beyond the scope of this 
project. 
 
4.3 Purifying RRS1 and RPS4 from transgenic over-expression lines of 
Arabidopsis thaliana 
 
Successful expression of RRS1 in cell-free wheat germ extract but not insect cells indicated 
that a plant-based protein folding environment is better suited for soluble expression of 
RRS1. However, the major bottleneck with wheat germ cell-free system was our inability to 
economically scale-up the production of RRS1 protein to quantities sufficient for 
biochemical and structural studies. I therefore needed a system which could provide a 
plant-based folding environment for the production of soluble RRS1 and RPS4, and could 
also be scaled with suitable physical and economical ease to provide a viable source of 
RRS1 and RPS4 protein for further study. Our inability to produce RPS4 cDNA also meant 
that switching to a system which utilised gDNA would enable us to investigate purifying 
both these NLRs together, preferably in complex. At this time, Dr Pingtao Ding had 
generated a transgenic line of A. thaliana by crossing two lines each carrying 35S::RPS4-HS 
(HA and Strep affinity tags) and 35S::RRS1Ws-2-HF both in a Col-0 background233, Figure 4.6A. 
Dr Pingtao Ding had shown that this line could produce biologically functional RRS1Ws-2-HF 
and RPS4-HS protein as demonstrated by the line’s extended ability to perceive PopP2 
effector delivered by Pf0-1, Figure 4.6B.  
 
This transgenic A. thaliana line therefore presented itself as a valuable tool for production 
of soluble full-length RRS1 and RPS4, as protein purified from this system would be folded 
in the protein’s native Arabidopsis environment, albeit under higher expression levels. 
Furthermore, transgenic A. thaliana plants can easily and scalably be grown by shaking 
sterilized seed in liquid 1% MS media cultures. For this, sterilised seed grown in liquid 
media and cultivated under long day conditions for ~2 weeks prior to harvesting. Tissue was 
then snap frozen in liquid nitrogen and stored at -800C for later use or used fresh as 
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 short-day conditions at 22˚C, Scale bar = 1.0 cm, figure adapted from Huh et al, 2017. (B) Over-
expression of RPS4 and RRS1Ws-2 confers recognition of PopP2 in Col-0. Col-0 is known as the 
accession carrying RRS1-S that can only recognize WT AvrRps4 and activate hypersensitive cell death 
response (HR), but not able to recognize PopP2 unless RRS1 Ws-2 (RRS1-R) is artificially supplied. All 
plant leaves were infiltrated with Pseudomonas fluorescence (Pf) 0-1 strains carrying wither wild-
type AvrRps4WT, unrecognized mutant AvrRps4KRVY135-138AAAA or wild typePopP2. figure generated by 
Dr Pingtao Ding. (C) Immunoblot analysis shows expression of RRS1 Ws-2 using an HRP-conjugated 
anti-FLAG antibody or (D) RPS4-HA using an HRP-conjugated anti-HA antibody in transgenic 
35S::RPS4-HS / 35S::RRS1 Ws-2-HF lines. Total extract of A. thaliana tissue was loaded onto 4-20% 
gradient SDS-PAGE gel and Ponceau S Staining (PS) of Rubisco large subunit was used as a loading 
control. Volume of total extract loaded is indicated above gel lane with the experiment repeated 
twice with similar results observed. 
Figure 4.6 Overexpression of RRS1 Ws-2-HF rescues 35S::RPS4-HS phenotype and confers 
recognition of PopP2 to Col-0 plants (A) Stunting and dwarf phenotype of Arabidopsis transgenic 
line stably overexpressing RPS4 is attenuated by crossing with RRS1Ws-2  transgenic Arabidopsis line 
to generate a 35S::RPS4-HS / 35S::RRS1 Ws-2-HF transgenic line. Images were taken with 4-week-old 
plants grown in  
Col-0 35S::RPS4-HS
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Figure 4.7 Purification of full-length RRS1 and RPS4 from transgenic Arabidopsis workflow. 
Arabidopsis seed was sterilized and sown in 1% MS liquid media and grown shaking for ~2 weeks. 
Proteins were then purified by two different methods. In the nuclear extraction method fresh tissue 
was blended in nuclear extraction buffer, filtered and nuclei harvested by centrifugation, nuclei were 
then lysed by sonication and the lysate recentrifuged to pellet debris. In the total protein extraction 
method, tissue was harvested and frozen in liquid nitrogen, tissue was then ground in extraction 
buffer, filtered and centrifuged twice to pellet cell debris. Following both methods POI was then 
purified from lysate by immunoprecipitation incubation with anti-FLAG or anti-HA affinity beads. 
Figure created using BioRender. 
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4.3.1 Purifying pre-activation RRS1 and RPS4 from transgenic overexpression 
A. thaliana 
 
Full-length inactive RRS1 and RPS4 was purified using the transgenic A. thaliana line 
expressing 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF generated by Dr Pingtao Ding. Firstly, I 
confirmed the expression of RPS4-HS and RRS1 Ws-2-HF proteins in total extract of these 
plants grown in shaking liquid media culture by immunoblotting, Figure 4.6C,D. As RRS1 
and RPS4 have been shown previously to localise into the nucleus of the plant cell65,233, I 
hypothesised that purifying RPS4-HS and RRS1 Ws-2-HF proteins from a nuclear enriched 
sample would improve the purity and yield of these NLR proteins. To do this, I used a 
method adapted from Dr Pingtao Ding to purify the nuclei from ~2 week old 35S::RPS4-HS/ 
35S::RRS1 Ws-2-HF material from which RPS4-HS and RRS1 Ws-2-HF protein was purified by co-
immunoprecipitation following lysis of nuclei via sonication, see Figure 4.7.  I trialled three 
different sonication treatments for nuclei lysis based on recommendations in the literature: 
1:3 seconds on:off at 20% amplitude for a total of (i) 30 seconds on and (ii) 15 seconds on 
and (iii) 10:120 seconds on:off at 40% amplitude for a total of 50 seconds on. These trials 
suggested treatment iii (10:120 seconds on:off at 40% amplitude for a total of 50 seconds 
on) was most effective for rupturing nuclei of A. thaliana tissue and was therefore taken 
forward for subsequent studies, Figure 4.10. 
 
To purify RRS1 Ws-2-HF and associated proteins, I used anti-FLAG affinity beads to pull down 
RRS1 Ws-2-HF from lysed nuclear extract. For immunoblot analysis, samples were taken 
throughout the purification process to track the progression of RRS1 Ws-2-HF and RPS4-HS 
protein throughout purification, Figure 4.8. Interestingly RPS4 protein appeared to be 
nearly exclusively present in the nuclear fraction of the A. thaliana extract whilst RRS1 
protein appeared in both the nuclear and non-nuclear fraction. This suggests that RPS4 
might predominantly reside in the nucleus of the A. thaliana cell whilst RRS1 may be 
enriched in the nucleus (as suggested by previous microscopy data in the Jones lab), but 
may also be present in the non-nuclear fractions of the cell as well. This observation was an 
important lead and could be used for future our work to purify RPS4 from plant material as 
purification strategies will need to ensure nuclei are adequately lysed during the 
purification process to release RPS4 protein through the use of sonication or detergents. It 
should be noted that this observation was not seen in all purifications of RRS1 Ws-2-HF and 
RPS4-HS protein from this line, but we hypothesise this may be due to variations between 
preps in effectiveness of pelleting of nuclei in the A. thaliana extracts.  
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Figure 4.8 Anti-FLAG affinity bead purification of RRS1 and RPS4 from 35S::RPS4-HS/ 35S::RRS1 Ws-
2-HF A. thaliana by nuclear extraction. For immunoblot analysis, samples were taken throughout the 
purification process. Proteins were eluted from anti-FLAG beads by competitive binding with 3xFLAG 
peptide. Samples were loaded on 4-20% gradient SDS-PAGE gel and proteins detected by 
immunoblot analysis with an HRP-conjugated anti-FLAG or anti-HA antibody. Total sample volume 
indicates the total volume of sample at each stage of purification of which 20 µl was loaded on SDS-
PAGE gel. Experiments were repeated twice with similar results found across repeats. 
 
Immunoblot analysis of samples taken throughout the RRS1 Ws-2-HF purification process 
revealed that major protein losses occurred during immunoprecipitation of the RRS1Ws-2-HF 
protein. This is likely due to both the inefficiency in the release of RRS1 Ws-2-HF from the 
anti-FLAG affinity beads by competitive binding with 3xFLAG peptide, and the quantity of 
beads used to immunoprecipitate the RRS1 Ws-2-HF protein which come with cost 
limitations. Whilst previous work has observed RRS1 Ws-2 and RPS4 to form a complex pre-
effector activation233, attempts to coimmunoprecipitate RPS4-HS with RRS1 Ws-2-HF and 
RRS1 Ws-2-HF with RPS4-HS in this study failed, Figure 4. 9 & 4.10. The reason for this is not 
established but could reflect non-optimized conditions used to extract the NLRs, such as 
buffer composition. However, it should be noted that previous studies which observed this 
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HA in N. benthamiana leaves. We therefore cannot rule out the possibility this interaction 
may not occur, or not with enough strength, in the native Arabidopsis environment and in 
the absence of PTI activation as agrobacterium infiltration triggers a PTI response in the N. 
benthamiana tissue. 
 
Additionally, I set out to purify RPS4 protein using anti-HA affinity beads using the same 
flow path as RRS1 Ws-2-HF immunoprecipitation purification with anti-FLAG affinity beads. 
Similar problems with release of protein from anti-FLAG affinity beads were seen too with 
release of RPS4-HS protein from the anti-HA affinity beads with competitive binding with 
HA peptide, Figure 4.9. Mirroring results in Figure 4.8, co-immunoprecipitation of RPS4-HS 
failed to pull down RRS1 Ws-2-HF which remains unbound in the supernatant of the anti-HA 
affinity beads. Similarly to RRS1 co-immunoprecipitation experiments, we cannot 
conclusively say if inability to detect an interaction between RRS1Ws-2-HF and RPS4-HS 
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Figure 4.9 Anti-HA affinity bead purification of RRS1 and RPS4 from 35S::RPS4-HS/ 35S::RRS1 Ws-
2-HF A. thaliana by nuclear extraction. Immunoblot analysis samples taken throughout 
purification process. Proteins were eluted from anti-HA beads by competitive binding with HA 
peptide. Samples were loaded on a 4-20% gradient SDS-PAGE gel and proteins detected by 
immunoblot analysis with an HRP-conjugated anti-FLAG or anti-HA antibody. Total sample 
volume indicates the total volume of sample at each stage of purification of which 20 µl was 
loaded on the SDS-PAGE gel.  
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4.3.2 RRS1 Ws-2-HF appears to form a multimeric complex when 
overexpressed in A. thaliana 
 
Having established I could purify quantities of RRS1 Ws-2-HF suitable for initial biochemical 
characterisation, I first wanted to determine the size of the RRS1 Ws-2-HF complex. Previous 
published work233 as well as my own observations using a wheat germ cell-free expression 
system suggested RRS1 Ws-2-HF may form a multimeric complex. I therefore set out to 
measure the size of RRS1 Ws-2-HF purified from transgenic 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF 
A. thaliana using analytical gel filtration chromatography. Analytical gel exclusion 
chromatography separates proteins by size. Sample protein is run through a porous resin 
packed column containing pores of various sizes. Larger protein/complexes cannot enter 
smaller pores and elute from the column earlier than smaller proteins which are retained in 
the porous resin, slowing their passage though the column. The elution volume of proteins 
is detected through absorption at 280 nm. Analytical gel filtration can thus be used to 
estimate the size of a protein complex depending on its retention volume. However, whilst 
estimates can be drawn, an exact size of complex cannot always be concluded from data of 
this kind, especially at high molecular weights. For example, proteins of the same molecular 
weight can have different retention volumes depending on the shape the protein/complex 
resides in, e.g. globular proteins will have a lower retention volume than elongated 
proteins.  
 
RRS1 Ws-2-HF was purified from 100 g of fresh 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF  A. thaliana 
seedlings and concentrated to ~100 µl in volume. This sample was loaded onto a 
Superose™ 6 Increase column (GE Healthcare) pre-equilibrated in running buffer (150 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA). RRS1 Ws-2-HF protein eluted at 14.39 ml, Figure 
4.10A, with presence of RRS1 Ws-2-HF in the fractions of this peak confirmed by immunoblot 
analysis, Figure 4.10. A monomer of RRS1 Ws-2-HF (161 kDa) would be predicted to run at 
16.86 ml (calibration curve generated by Dr Abbas Maqbool) whilst an elution volume of 
14.3 ml equates to a ~640 kDa complex using the calibration curve. Whilst we cannot 
accurately state that RRS1Ws-2-HF is running in a complex of this size, this earlier elution 
volume did suggest that the protein is forming a multimeric complex. Samples from the 
RRS1Ws-2-HF analytical gel filtration peak were also tested for the presence of RPS4-HS 
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protein, however, no RPS4-HS protein was detected. It should be noted however that no 
positive control for HA antibody activity was included in this experiment.  
 
Samples of RRS1 Ws-2-HF purified from fresh 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF  were also 
analysed for multimeric complex formation by Blue Native-PAGE. Samples were prepared 
from a singular nuclear extraction preparation of fresh 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF 
tissue. I then split this extract into three samples each of which was lysed by a different 
sonication treatment as per 4.3.1 before being centrifuged to remove cell debris. This 
enabled me to evaluate if varying sonication treatment affected the size of the RRS1 Ws-2-HF 
protein complex. I found that apart from effectiveness in ability to lyse nuclei, the various 
sonication treatments did not affect the apparent complex size of RRS1 Ws-2-HF. Immunoblot 
analysis of Blue Native-PAGE gel showed that RRS1 Ws-2-HF was running in a multimeric 
complex of a similar size to that observed in wheat germ cell-free extract, Figure 4.5, and 
via analytical gel filtration, Figure 4.10B. RPS4-HS protein was not able to be purified in 
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Figure 4.10 RRS1 Ws-2-HF purified from 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF A. thaliana lines forms a 
multimeric complex. (A) Gel filtration analysis of anti-FLAG bead 3xFLAG peptide eluted RRS1 Ws-2-HF 
protein, presence of protein in peak highlighted in blue was confirmed by immunoblot analysis of 
fractions from this peak using anti-FLAG antibody. These fractions were also immunoblot probed for 
RPS4-HS protein but no protein was detected, experiment repeated twice with similar results 
observed. (B) Blue-Native PAGE analysis of samples of 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF A. thaliana 
nuclear extract sonicated with different treatments shows a multimeric speared band of RRS1 Ws-2-HF 
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4.3.3 Purifying activated RRS1 and RPS4 from transgenic A. thaliana with 
inducible AvrRps4 expression 
 
In order to gain mechanistic insights into the functioning of the RRS1-RPS4 complex, we 
need to compare biochemical and structural properties of both pre- and post-effector 
activated RRS1 and RPS4. This requires a source of effector-activated RRS1-RPS4 protein. Dr 
Pingtao Ding and Bruno Ngou had developed a resource for this material in the form of a 
transgenic line of A. thaliana expressing pAt3::RPS4-HA/ pAT2::RRS1Ws-2-HF with an β-
estradiol inducible promoter LexA::AvrRps4-mNeon named the Super-ETI line (SETI line), 
Figure 4.11. This line expressed RRS1 and RPS4 under the moderately expressed promoters 
of pAt2 and pAt3 respectively, but crucially also used an β-estradiol-inducible system234 for 
expression of the P. syringae effector AvrRps4. Generation of this line is described in Ngou 
et al, 2019218. This line therefore represents a system in which RRS1 and RPS4 can be 
activated by inducing the expression of AvrRps4-mNeon using β-estradiol without 
activating PTI in the plant cell. Expression of AvrRps4-mNeon through β-estradiol induction 
results in a biologically relevant activation of RRS1 and RPS4 as demonstrated by SETI line 
seedlings grown on 50 µM β-estradiol containing growth media which display severe 
growth arrest indicative of an activated immune response, Figure 4.11B. 
 
As well as a line expressing WT AvrRps4-mNeon, a line expressing mutant AvrRps4KRVY135-
138AAAA-mNeon was also generated as a control. In the AvrRps4KRVY-AAAA  mutant, residues 
135-138 (KRVY amino acids) are mutated to alanine residues resulting in a AvrRps4 protein 
which does not activate RRS1-RPS4 dependent immunity147, but retains the ability to bind 
to the WRKY domain of RRS158, and therefore serves as a negative control for WT AvrRps4 
activation.  
 
For protein purification, pAt3::RPS4-HA/ pAT2::RRS1 Ws-2-HF/LexA::AvrRps4-mNeon A. 
thaliana seeds were sown in liquid 1% MS media as per 4.3.1 and grown for ~ 2 weeks. As 
β-estradiol can permeate cell membranes, this method of induction represents a method 
for inducing AvrRps4 expression in A. thaliana plants on a large scale by placing plants in 
liquid media containing β-estradiol. After two weeks of growth in 1% MS media, seedlings 
were treated with β-estradiol by replacing liquid growth media with fresh 1% MS media 
containing 50 µM β-estradiol. For mock treatment, plant growth medium was replaced with 
fresh 1% MS medium.  
 



















Figure 4.11 Single T-DNA expresses RRS1 Ws-2-HF, RPS4-HA and inducible wild-type AvrRps4-mNeon 
or AvrRps4 mutant variants (A) Illustrative layout of the SETI construct. There are five individual 
expression units listed, which are indicated position 1 to position 5. Position 1; expression unit of the 
FastRed selection marker (Shimada et al. 2010). Position 2 & 5; chimeric transactivator XVE (LexA-
VP16-ER) and the corresponding LexA inducible system to express AvrRps4 or its mutant variants 
under the control of β-estradiol treatment. Position 3 & 4; full-length RRS1-R and RPS4 proteins with 
HF and HA epitope tags, respectively. LB: Left Border, RB: Right Border, CDS: Coding sequence, Ter: 
Terminator (B) Seedling phenotype of SETI Arabidopsis transgenic line at 14 days after germination 
in growth media containing Mock (0.1% DMSO) or 50μM β-estradiol. Col-0 was sown as control for 
Position 1: P+5U(AtOleosin) g(AtOleosin) tag(RFP) Ter(AtOleosin)
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the effect of β-estradiol on seedling growth. Scale bar = 0.5cm. Figure taken from Ngou et al, 
2019218. 
 
To establish the best time point to harvest RRS1Ws-2-HF and RPS4-HA protein from 
transgenic seedlings post β-estradiol induction, I sampled seedlings for immunoblot 
analysis of AvrRps4-mNeon protein expression levels from 0-960 minutes post β-estradiol 
induction. This showed that though AvrRps4 expression could be observed shortly after β-
estradiol induction, accumulation of AvrRps4WT-mNeon protein appeared to peak at ~360 
minutes post induction, before decreasing by 960 minutes, Figure 4.12. The immunoblots 
also suggested that the LexA::AvrRps4-mNeon may show very low levels of leaky expression 
of AvrRps4-mNeon prior to β-estradiol induction. However as demonstrated in Figure 4.11B 
seedlings grown on solid growth media containing no β-estradiol do not show the immune-
activated stunting of seedlings grown on β-estradiol-containing media suggesting that leaky 




Figure 4.12 Accumulation of AvrRps4 protein in SETI line post β-estradiol induction. 
Immunoblot analysis of accumulation of AvrRps4WT and AvrRps4KRVY/AAAA protein from 0-960 
minutes post β-estradiol treatment. Total protein extract was loaded onto a 4-20% SDS-PAGE 
gradient gel and proteins detected with immunoblot analysis using anti-mNeon primary antibody 
and anti-rabbit secondary antibody. Ponceau S Staining (PS) of the Rubisco large subunit was 




Minutes post estradiol treatment 
PS 
α mNeon 







   
Investigating plant-based expression systems for plant NLR purification 
 134 
Having established AvrRps4-mNeon protein accumulation appeared to peak ~360 minutes 
post β-estradiol treatment, I next investigated fluctuations in RRS1-HF and RPS4-HA protein 
levels in this time course. There has been discussion in the field as to whether effector 
activation of NLRs can lead to stabilization of NLR proteins as part of the ETI response, 
particularly in regards to nucleocytoplasmic NLRs such as RPS4235. In this model, pathogen 
perception leads to an accumulation of NLRs in the nucleus where receptors then activate 
immune signalling responses via transcriptional reprogramming236. I hypothesised that we 
might observe changes in the accumulation of RRS1 or RPS4 protein in the SETI lines 
following AvrRps4 expression by β-estradiol induction. To investigate this, I sampled β-
estradiol SETI line seedlings for immunoblot analysis of RRS1-HF and RPS4-HA protein levels 
from 0-480 minutes post β-estradiol induction. Immunoblot analysis showed that whilst 
RPS4-HA protein levels appeared to strongly accumulate over this time span, RRS1 protein 
levels appeared to decrease, Figure 4.13.  
 
 
Figure 4.13 Changes in RRS1 and RPS4 protein levels post β-estradiol induction of AvrRps4 in SETI 
lines. Immunoblot analysis of changes in protein level of RRS1-HF and RPS4-HA 0-480 minutes post 
β-estradiol induction of AvrRps4. Total protein extract was loaded onto a 4-20% gradient SDS-PAGE 
gel and proteins visualised using an HRP-conjugated anti-FLAG or anti-HA antibody. Ponceau S 
Staining (PS) of Rubisco large subunit was used as a loading control. Experiment was repeated 
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This observation may provide interesting insights into the mechanism of this immune 
receptor complex. Conceivably, RRS1 perception of AvrRps4 and subsequent activation of 
the receptor may help to stabilise RPS4 protein allowing RPS4 to accumulate to the 
threshold levels required for the activation of immune signalling. Further investigation is 
needed to validate this hypothesis. This model however does fit with observations in the 
literature which have shown for example that the Barley NLR MLA10 accumulates in the 
nucleus upon perception of the barley mildew effector AvrA10237.  
 
For purifying activated RRS1-RPS4 complex from SETI A. thaliana tissue, seeds were grown 
as described above and AvrRps4-mNeon protein induced by replacing the liquid growth 
medium with 1% MS supplemented with 50 µM β-estradiol. Tissue was then harvested and 
frozen in liquid nitrogen 360 minutes post AvrRps4-mNeon induction. Protein was purified 
using the total extract method described in Figure 4.7, and protein immunoprecipitated 
using anti-FLAG affinity beads to pull down RRS1-HF and its associated proteins. Samples 
were taken for immunoblot analysis of RRS1-HF and RPS4-HA protein throughout the 
purification process, Figure 4.14. However, a significant amount of RPS4-HA protein was 
found in the supernatant fraction of the anti-FLAG affinity beads. 
 
Purified RRS1-HF was concentrated and loaded onto a Superose™ 6 Increase column (GE 
Healthcare) pre-equilibrated in running buffer (150 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 
mM EDTA) but unfortunately due to machine malfunctions I was unable to analyse the 
complex size of this protein by analytical gel filtration. This work is now being followed up 
by Dr Hee-Kung Ahn who is investigating purifying RRS1 and RPS4 protein from this line for 
biochemical characterisation.  
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4.3.4 Conclusions of expressing RRS1 and RPS4 in transgenic A. thaliana 
 
Whilst I was able to show that I could purify both RRS1 and RPS4 from 35S::RPS4-HS/ 
35S::RRS1Ws-2-HF  A. thaliana and both NLRs together in complex from pAt3::RPS4-HA/ 
pAT2::RRS1 Ws-2-HF/LexA::AvrRps4-mNeon following β-estradiol induction, it was clear from 
immunoblot analysis of the purification processes that the limiting factor for producing 
large quantities of NLR protein was in the economic constraints of using anti-FLAG/HA 
affinity beads. Whilst A. thaliana seedlings provided a good source of economically and 
physically scalable plant material, the use of this pipeline was limited in this study due to 










































































Figure 4.14 Purification of RRS1Ws-2-HF and RPS4-HA via anti-FLAG affinity beads post AvrRps4 β-
estradiol induction. Immunoblot analysis samples taken throughout purification process. Following 
immunoprecipitation, proteins were eluted from anti-FLAG beads by competitive binding with 
3xFLAG peptide. Samples were loaded on 4-20% gradient SDS-PAGE gel and proteins detected by 
immunoblot analysis. Proteins were visualised using an HRP-conjugated anti-FLAG or anti-HA 
antibody. Total sample volume indicates the total volume of sample at each stage of purification of 
which 20 µl was loaded on SDS-PAGE gel. Experiments were repeated twice with similar results 
found across repeats. 
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affinity beads are not rechargeable, the cost of the quantity of beads required to purify POI 
to sufficient quantities for biochemical analysis was not viable for this project. 
 
4.4 Transient expression of RRS1 and RPS4 in Nicotiana benthamiana  
 
Based on the success of producing and purifying soluble RRS1 in A. thaliana, I wanted to 
trial an alternative in planta expression system for RRS1 and RPS4 protein. As the limiting 
factor for purification of RRS1 and RPS4 using transgenic A. thaliana lines was the use of 
anti-FLAG/HA affinity beads, I next wanted to test a system which would enable us to trial a 
variety of different affinity tags for purification whilst keeping the scalability and folding 
environment that was successful in the A. thaliana trials. For this we decided to utilise 
agrobacterium-mediated transient expression in N. benthamiana. We hypothesised this 
system would offer a similar protein folding environment akin to A. thaliana and small-scale 
co-immunoprecipitation work in the Jones laboratory had previously showed that RRS1 and 
RPS4 could be expressed in this system58. Additionally, unlike the use of stable transgenics, 
a variety of different purification tags and expression vectors can be trialled in this system 
on a rapid timeline.  
 
To demonstrate that agrobacterium mediated transient transformation of N. benthamiana 
is a viable source of the production of RRS1 and RPS4 protein, I set out to repeat the 
expression and purification pipelines used for the purification of these proteins from the 
total extract of transgenic A. thaliana lines in N. benthamiana, Figure 4.15. Following this 
method, I showed that I could immunoprecipitate full-length RRS1Ws-2-HF and RRS1B-HF 
from cDNA and gDNA expressing constructs, Figure 4.16. However similar to A. thaliana 
trials, significant amounts of RRS1Ws-2-HF and RRS1B-HF protein could be seen in the 
unbound fraction post treatment with anti-FLAG affinity beads. This suggests that the anti-
FLAF affinity beads were saturated such that significant quantities of protein were not 
coimmunoprecipitated and implies therefore the limiting factor for yield of POI is quantity 
of affinity beads, Figure 4.16. 
 
In addition to full-length RRS1Ws-2, I wanted to explore whether shorter domain truncations 
of RRS1 and RPS4 could be also be expressed and purified using this method. I focussed 
these experiments on regions of high interest of RRS1 and RPS4, namely RRS1’s Dom4 
WRKY Dom6R/S and RPS4’s CTD. Following the same pipeline seen in Figure 4.15, I was able 
to immunoprecipitate RRS1 Dom4 WRKY Dom6R/S and RPS4 CTD using anti-FLAG affinity 
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beads, Figure 4.17A,B. However, Coomassie staining of boiled affinity beads post 
immunoprecipitation showed no bands of RRS1 Dom4 WRKY D6R/S-HF or RPS4 CTD 
implying that protein yields were likely not high enough for the downstream biochemical 
and structural experiments we wished to conduct such as crystallography and ITC, Figure 
4.17C.  
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Figure 4.15 Purification of NLRs from agroinfiltrated N. benthamiana leaves workflow. The gene 
of interest was transformed in a level 1 golden gate vector into agrobacterium which was then 
grown and cultured. N. benthamiana leaves were then agroinfiltrated with this agrobacterium 
and leaves harvested and frozen in liquid nitrogen 3 dpi. Tissue was then ground in extraction 
buffer, filtered and centrifuged twice, low-speed and high-speed spin, to pellet cell debris. POI 
was then purified from lysate by immunoprecipitation using anti-FLAG beads. Figure generated 
using BioRender. 
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The major advantage of using agroinfiltration of N. benthamiana as a source of the 
production of RRS1 and RPS4 protein compared to transgenic A. thaliana is the speed of 
testing different purification variables, especially protein construct and affinity tag. Trials, 
particularly with full-length RRS1Ws-2-HF and RRS1B-HF, suggested that whilst these proteins 
were well expressed in the system, the bottleneck in protein yields was in the cost of anti-
FLAG affinity beads. Future studies will therefore be able to utilise this system to quickly 
and efficiently trial different affinity tags that would allow for more economical purification 
techniques. For example, using a Streptavidin based system where recombinant protein is 
expressed with a Strep® epitope tag, purified using a Strep-Tactin® resin and eluted with 






















Total input Bound FLAG 
beads 








Figure 4.16 Anti-FLAG affinity bead purification of RRS1Ws-2-HF and RRS1B-HF from agroinfiltrated 
N. benthamiana leaves expressing cDNA and gDNA constructs. (A) immunoblot samples of total 
input, unbound anti-FLAG bead fraction and immunoprecipitated boiled anti-FLAG affinity bead 
fraction from the total extract of N. benthamiana leaves expressing cDNA and gDNA constructs of 
RRS1Ws-2-HF or (B) RRS1B-HF. Leaves were infiltrated with transformed agrobacterium and leaves 
harvested 3 dpi.  Protein samples was run on 4-20% SDS-PAGE gel and proteins visualized using 
immunoblot analysis with HRP-conjugated anti-FLAG antibody. POI was released from anti-FLAG 
beads by boiling in SDS buffer. Experiment was repeated twice with similar results observed each 
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continues with Dr Nitika Mukhi to trial other affinity tags in this system including use of 
Streptavidin tag and an Im9-E9 tag system.  
 
Figure 4.17 Anti-FLAG affinity bead purification of RRS1 and RPS4 domain truncations from 
agroinfiltrated N. benthamiana leaves. (A) Immunoblot samples of total input, unbound anti-FLAG 
bead fraction and immunoprecipitated boiled anti-FLAG affinity bead fraction from the total extract 
of N. benthamiana leaves expressing RRS1 Dom4 WRKY Dom6R/S-HF or (B) RPS4 CTD-HF. Leaves 
were infiltrated with transformed agrobacterium and leaves harvested 3 dpi. (C) Samples of boiled 
anti-FLAG affinity beads were run analyzed for POI yields by Coomassie staining, arrows indicate the 
predicted protein size for each protein and antibody heavy and light chain. Protein samples was run 
on 4-20% SDS-PAGE gel and proteins visualized using immunoblot analysis with HRP-conjugated anti-
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4.5.1 Comparing plant-based expression systems for RRS1 and RPS4 protein 
production 
 
Following failures to produce soluble multidomain RRS1 and RPS4 protein in the 
heterologous systems of E. coli and Sf9 insect cells, I hypothesised that RRS1 and RPS4 
proteins may require a folding environment more akin to their native A. thaliana to support 
soluble expression. I therefore investigated the use of a variety of plant-based expression 
systems for their ability to produce soluble RRS1 and RPS4 protein in an economical and 
physically scalable manner. As well as in vivo systems, I evaluated use of a cell-free 
expression system to expand the conditions investigated. The systems subsequently 
evaluated were a cell-free wheat germ system, transgenic A. thaliana and agroinfiltrated N. 
benthamiana, a list of successful soluble protein expression trials can be found in Appendix 
5.  
 
The first system trialled was a cell-free wheat germ extract. I showed that soluble 
expression of both truncated WRKY Dom6S and full-length RRS1Ws-2 was supported in this 
system. This suggested that as hypothesised, using an expression system with a folding 
environment and capabilities more analogous to RRS1’s native A. thaliana, facilitated 
soluble expression of this NLR protein. Expression was observed in wheat germ extract 
from two different sources, commercially produced CellFree Sciences and from extract 
generated by Professor Yasuomi Tada at Nagoya University. Evaluating on the basis of 
immunoblot signal development conditions it appeared the extract from CellFree Sciences 
expressed the POI to a higher level though this is not an accurate enough method of 
protein level comparisons to draw a conclusive statement. However, neither system was 
capable of producing RRS1 protein, truncated or full-length, to quantities such that could 
be observed by Coomassie staining of an SDS-PAGE gel.  
 
This study used a bilayer method for protein translation in wheat germ extract as previous 
reports have shown this method to produce higher protein yields compared to traditional 
batch method style. For example, one study found that 1 ml of wheat germ extract was 
capable of producing 3.2 mg of GFP by bilayer translation compared to 1.6 mg for batch 
method setup170. There are alternative higher yielding methods for protein translation with 
wheat germ extract which were not trialled in this study as they were not practical for 
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quantities of wheat germ I was using. Methods such as dialysis for example was shown in 
the same study described above to produce 20 mg of GFP protein per 1 ml of wheat germ 
extract170. Future studies using this system to produce NLRs could therefore investigate use 
of other translation method systems in efforts to boost yields. However, given the 
quantities of RRS1 protein I detected from this system in this study it is clear, at least in the 
case of RRS1, that higher quantities of wheat germ extract would be needed to produce the 
quantity of protein required for structural studies such that the system is too costly for our 
purpose. It should be noted that whilst this system may be inappropriate for producing 
RRS1 protein quantities for structural work, it could potentially be utilised for quantitative 
biochemical techniques such as SPR (surface plasmon resonance). SPR requires significantly 
lower protein quantities that other interaction measuring techniques such as ITC 
(isothermal titration calorimetry). Furthermore, in SPR analysis the POI can be purified 
directly from extracts by using various SPR immobilization matrix chip coatings such as 
biotin or nickel-NTA. In this manner, SPR could be well suited for downstream studies of 
wheat germ extract-produced protein.  
 
Work with expressing RRS1 and RPS4 protein in cell-free wheat germ extract demonstrated 
the importance of a plant protein folding environment for the soluble expression of these 
proteins. However, the required scale up of this to the yields of protein needed for 
downstream biochemical and structural studies were too costly. I therefore tested a system 
which provided a plant-based protein folding environment but which could be scaled in a 
more economical manner. For this I investigated a transgenic line of A. thaliana 
overexpressing RRS1 and RPS4 protein (35S::RPS4-HS / 35S::RRS1 Ws-2-HF) in a Col-0 
background. By growing these lines shaking in liquid 1% MS media I was able to produce 
~100 g of fresh weight tissue from ~10 x 250 ml flasks making this system highly scalable. 
 
 Using this system, I was able to produce soluble RRS1 protein to quantities such that the 
protein could be detected during analytical gel filtration analysis. This result is a very 
promising lead for future biochemical and structural work with RRS1 protein as it suggests 
this system could be used to produce significant quantities of protein for downstream 
study. Whilst yields required for crystal trials may still be unachievable, further optimisation 
and scale up could feasibly produce quantities of RRS1 protein appropriate for SAXS (small-
angle X-ray scattering) analysis. Should a SAXS envelope of RRS1 protein be attained, the 
published structures of RRS1’s WRKY domain71 and TIR domain114 along with modelling, 
based on published structures such as ZAR1109, could then be used to gain a full-length 
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structure of RRS1. In doing so this would be the first full-length structure of a plant paired 
NLR protein. RPS4 protein however could not be purified to adequate quantities from the 
same fresh weight of 35S::RPS4-HS / 35S::RRS1Ws-2-HF tissue, though RPS4 protein was 
detectable by immunoblot analysis. The reason for this is not understood and may reflect a 
the potentially lower stability of RPS4 protein compared to RRS1.  It could be hypothesized 
that post-translation regulation of RPS4 protein may be preventing accumulation of RPS4 to 
levels comparable to RRS1, possibly as a mechanism to control against autoimmunity.  
 
Using an A. thaliana transgenic line expressing pAt3::RPS4-HA/ pAT2::RRS1 Ws-2-
HF/LexA::AvrRps4-mNeon (SETI line) I was able to purify RRS1-RPS4 complex post β-
estradiol induction of AvrRps4. This result demonstrates an exciting avenue for future work 
as this line could provide a feasible source of activated RRS1-RPS4 complex for downstream 
structural studies, particularly SAXS analysis. This transgenic line also provides an exciting 
resource for investigating the biochemical functions of the RRS1-RPS4 complex and 
particularly the interplay of PTI and ETI on activation of this complex as discussed in 4.5.2. 
 
Together these results highlight the valuable resource transgenic plants can provide for 
producing plant NLR protein. Transgenic plants offer a system with sufficient protein folding 
capabilities and both physical and economical scalability, excelling where previous work in 
this study with E. coli, insect cells and wheat germ cell-free extract failed. The bottleneck I 
found in work using this system however came during the purifying of the POI from the 
transgenic tissue extract. The workflow in this study relied on the use of antibody affinity 
beads which are expensive to use and therefore provide a limitation on the quantity of 
protein which can be purified using them. Additionally, RRS1 and RPS4 protein were 
inefficiently released from the affinity beads using competitive binding peptide elution. This 
suggests that future use of transgenic plants for NLR purification may wish to investigate 
the use of other epitope and affinity tags with different purification methods which utilise 
other rechargeable affinity systems. Using rechargeable affinity beads would allow for 
increased quantities of affinity beads to be used per prep due to a reduction of cost 
constraints ensuring more of the POI would be captured and purified from a given volume 
of plant material. For example, use of the Strep® epitope tag and Strep-Tactin® columns 
which are rechargeable and therefore more economical in their use238.  
 
One system which could be used to trial the efficiencies of various affinity tags is 
agroinfiltration of N. benthamiana. The major benefit transient expression using 
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agroinfiltration in N. benthamiana offers over transgenic lines is in the ability to trial 
multiple purification and expression conditions for protein production in a short time 
frame. This system could be therefore be of great use to trial a variety of purification 
variables before a transgenic line was then generated as this would combine the speed of 
trialling conditions of agroinfiltration with the economic and physical scalability of 
transgenic plants. Preliminary work in this study showed the viability of this system to 
produce soluble full-length RRS1 Ws-2 and RRS1B protein as well as truncations of RRS1 and 
RPS4 which could be immunoprecipitated using anti-FLAG beads. Whilst POI purified from 
agroinfiltration N. benthamiana tissue were detectable by immunoblot analysis, proteins 
were not detectable by Coomassie staining of SDS-PAGE gels. This suggests that to produce 
yields of protein for downstream structural studies, production in this system would 
require significant scaling up which would be costly with the use of anti-FLAG beads. This 
again supports the concept of expanding purification trials to include the use of affinity tags 
which utilise rechargeable affinity resins and beads for purification.  
 
Whilst this study investigated the use of a diverse range of plant-based expression systems 
it was not exhaustive and a number of alternative plant-based systems and methods could 
be explored for future studies of this kind. For example, the use of plant cell cultures such 
as N. tabacum BY-2 or NT-1 cells226. The plant cell culture system offers simple 
transformation and propagation pipelines as well as precise control over growth conditions 
and batch-to-batch consistency with recombinant protein production. These factors 
combined with the benefits of a plant eukaryotic protein folding environment, offer future 
studies and interesting alternative to whole plant systems for investigating NLR protein 
production. 
 
4.5.2 Investigating the interactions of RRS1 and RPS4 protein pre- and post-
AvrRps4 activation 
 
Whilst investigating expression and purification of RRS1 and RPS4 from various plant-based 
expression systems a number of interesting observations were made on the interactions of 
these NLRs pre- and post-AvrRps4 activation.  
 
Changes were observed in the total quantity of RRS1 and RPS4 protein post-AvrRps4 
induction. RPS4 protein was seen to accumulate post induction of AvrRps4 whilst RRS1 
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protein appeared to show a small decrease. Previous studies have shown that RPS4 TIR 
domain has a self-association surface and that RPS4 TIR homodimerization is required to 
activate RPS4-mediated HR in N. tobaccum114 . Following on from this, subsequent work 
suggested that a threshold of RPS4 protein accumulation may need to be reached for RPS4 
protein to self-associate and also found that self-association of RPS4 protein requires the 
presence of RRS1233. Taken together, it could therefore be hypothesised that upon 
perception of AvrRps4 by RRS1, RPS4 protein is stabilised such that RPS4 protein 
accumulates enabling dimerization of RPS4’s TIR domains and induction of a defence 
response and HR.  
 
The concept of NLR oligomerisation or formation of multimeric complexes has been widely 
discussed in the field.  The recently published structure of the ZAR1 pentameric 
‘resistosome’ shows that oligomerization of NLRs may have a direct role in cell death by the 
insertion of NLR multimers directly into the cell membrane leading to the formation of 
membrane pores109. Whilst this is likely not the case with all NLRs (e.g. RRS1 and RPS4 are 
found in the nuclei rather than the cell membrane58), it raises an important discussion 
around the role of oligomerisation in NLR activation. I observed that RRS1 Ws-2-HF protein 
produced in both the cell-free wheat germ extract and transgenic A. thaliana plant 
appeared to form a multimeric complex in a consistent molecular weight range. This was 
observed in both Blue Native PAGE and analytical gel filtration data. This result supports 
previous observations in the literature on the ability of RRS1 to self associate233. Whilst 
inabilities to produce RPS4 cDNA meant I was unable to investigate RRS1-RPS4 interactions 
in the wheat germ cell-free extract, the high molecular weight complexes I observed 
formed by RRS1 purified from 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF did not appear to contain 
RPS4. Whether this is due to purification conditions or biologically meaningful is not yet 
understood as interactions between these proteins pre-AvrRps4 induction have been 
observed in other studies218,233. 
 
RRS1 Ws-2-HF purified from 35S::RPS4-HS/ 35S::RRS1 Ws-2-HF  migrated as a diffuse Blue 
Native PAGE band in the range of 480 to approximately 900 kDa indicating the formation of 
heterogeneous high molecular weight complexes. Interestingly work conducted by Dr Hee-
Kyung Ahn in Ngou et al 2019218 found similar heterogeneous forms of complexes in a 
similar molecular weight range were formed by RRS1 and RPS4 protein in pAt3::RPS4-HA/ 
pAT2::RRS1Ws-2-HF/LexA::AvrRps4-mNeon (SETI) A. thaliana lines pre- and post-AvrRps4 
induction. This suggests that there might not be a change in the overall size of the 
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complexes of RRS1 and RPS4 protein upon effector activation. Given the observed changes 
in quantity of RRS1 and RPS4 protein post AvrRps4 induction, one could hypothesise that 
the composition or conformation of the heterogeneous high molecular weight complexes 
may change post effector activation. Following from the observation of elevated 
accumulation of RPS4 protein post-AvrRps4 induction, it could be hypothesised that whilst 
the overall size of complex formed by RRS1 and RPS4 protein does not differ post AvrRps4 
activation, the ratio of RRS1:RPS4 protein may, with an increasing proportion of RPS4 
protein found in the complex. Alternatively, other proteins may be recruited into the RRS1-
RPS4 complex post activation replacing pre-activation complex proteins such that little 
change in the overall size of RRS1-RPS4 complex is seen by Blue Native PAGE immunoblot 
analysis. This could provide an interesting avenue of work for future mechanistic studies.  
 
An exciting area of study in the field of NLR mechanisms is in the interplay of PTI and ETI. 
Up until the development of effector inducible lines such as the SETI line, previous work on 
NLR mechanisms was largely done using agroinfiltration meaning observations were made 
in the presence of both ETI and PTI. Using effector-inducible lines such as the SETI line, we 
can now investigate the behaviour of NLRs upon ETI activation without the complications of 
co-activating PTI. It will be exciting to see what future insights these lines can bring in 
investigating conformational and oligomeric changes involved in NLR activation and teasing 
apart the roles that ETI and PTI play in defence induction. 
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5 Gaining biochemical & structural insights into AvrRps4 recognition by RRS1 
5.1 Introduction & chapter aim 
 
Understanding the structural basis of pathogen effector recognition is a primary objective 
in the field of NLR biology. Such knowledge is key for achieving future research goals in 
engineering synthetic NLRs with extended pathogen recognition capabilities. In particular, 
NLRs containing integrated domains offer an excellent foundation for the engineering of 
such synthetic receptors. If we can decipher the requirements of integrated domains to 
bind effectors, this information could then be used to engineer NLRs to target previously 
unrecognized effectors. In order to achieve such outputs, we need to first expand our 
understanding of how NLRs bind and perceive effectors at the structural level, and how 
these binding events leads to NLR activation and induction of ETI. To date, attempts to 
engineer NLRs with expanded recognition capabilities via wholescale integrated domain 
switching has largely resulted in the generation of autoactive phenotypes. For example, 
when the WRKY domain of RRS1 is switched for the WRKY domain of the PopP2 targeted 
transcription factor WRKY 41, the resulting NLR is autoactive in an RPS4 dependent 
manner152. It is therefore likely that only when we understand the intricacies of NLR-
effector binding events at the structural level will we have the tools to begin engineering 
functional synthetic NLRs.  
 
The primary goal of the work in this chapter is to understand the structural basis of effector 
recognition by the WRKY domain of RRS1. Given both the allelic variation of RRS1 A pair 
proteins, primarily RRS1-R and RRS1-S, and the identification of a paralogous B pair, RRS1B, 
this system provides a unique opportunity to understand the inherent flexibilities in 
effector recognition and activation of integrated domain NLRs. Given the limited sequence 
identity of only 56% between the WRKY domains of RRS1 and RRS1B, should structures of 
AvrRps4 in complex with RRS1 WRKY and RRS1B WRKY be obtained we could then gain 
insights into how a single effector protein binds and activates different NLRs, Figure 5.1. 
Additionally, the RRS1-R allele from the A. thaliana Ws-2 accession provides an intriguing 
resource for understanding the activation of an NLR containing an integrated domain, given 
its ability to recognise both structurally and functionally distinct effectors in AvrRps4 and 
5 
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PopP2, Figure 5.1. Following publication of the structure of the RRS1 WRKY domain in 
complex with PopP271, we are now in an exciting position to investigate how one integrated 
domain can perceive and bind two structurally distinct effectors. However, this is 
dependent on attaining a structure of the RRS1 WRKY domain in complex with AvrRps4. 
Additionally, the identification of specific mutations in both RRS1-R and RPS4 that abolish 
recognition of either AvrRps4 or PopP2, but not both, suggest that this NLR pair is capable 
instigating different activation mechanisms through the same NLR complex153. 
Understanding how these different activation mechanisms are coordinated and maintained 
would thereby provide invaluable insights as to how we could synthetically design NLRs 























as some of them can trigger immune responses when over-
expressed alone in planta32–36. We showed overexpression
of RPS4TIR (1–235 a.a.)-triggered cell death in N. tabacum,
whereas RRS1TIR (1–175 a.a.) did not (Fig. 6a), consistent with
previous report24. Interestingly, neither RPS4BTIR (1–235 a.a.)
nor RRS1BTIR (1–166 a.a.) triggered cell death when overexpressed
in N. tabacum (Fig. 6a). This implies either polymorphisms in
RPS4BTIR compared with RPS4TIR abolish its capacity to activate
cell death or that N. tabacum lacks a components required for
RPS4BTIR-triggered cell death.
Many lines of evidence suggest TIR–TIR interactions are
important for TNL function24,37. The TIR domains of RRS1 and
RPS4 interact in a yeast two hybrid assay and associate in planta
after co-IP24. TIR domains of these proteins are essential for
effector recognition and defence activation24. In the pre-
activation state, the RRS1/RPS4 heterodimer is proposed to be
inactive. This correlates with the RRS1TIR suppression of
RPS4TIR-triggered cell death when the TIR domains of these
two paired R proteins associate (Fig. 6a)24. Interestingly, we
found that RRS1BTIR can also suppress RPS4TIR-triggered cell
death (Fig. 6a), suggesting that TIR domains from different pairs
can interact. Therefore, we investigated whether RRS1BTIR and
RPS4BTIR can associate with each other in planta, and whether
they can associate with RPS4TIR and RRS1TIR, respectively, by
co-IP. After agro-infiltration in N. benthamiana, RRS1BTIR-
FLAG co-IP with both RPS4BTIR-GFP and RPS4TIR-GFP; and
RPS4BTIR-FLAG co-IP with both RRS1BTIR-GFP and RRS1TIR-
GFP (Fig. 6b and Supplementary Fig. 13). This suggests that,
similar to full-length proteins, RRS1BTIR and RPS4BTIR can
heterodimerize and also associate with RPS4TIR and RRS1TIR,
respectively, in planta.
TIR swaps between R protein pairs retain function. We next
assessed if, despite association of TIR domains between non-
paired R proteins, the TIR domains contribute to the specificity of
R protein function with each respective pair partner. To answer
this question, we constructed chimeras in which RRS1Ws-2 and
RRS1BWs-2 TIR domains were exchanged, and similarly with
RPS4Ws-2 and RPS4BWs-2 TIR domains. We designated the four
domains of RRS1 and RPS4 (TIR, NB, LRR and C-Terminal
Domain) as ‘AAAA’ and of RRS1B and RPS4B as ‘BBBB’,
defining TIR domain swaps as RRS1BAAA and RRS1ABBB full-
length chimeric proteins (Fig. 6c). These chimeras were tested
with WT R proteins for AvrRps4 and PopP2 recognition in N.
tabacum transient assay. Similar to RRS1AAAA and RPS4AAAA,
RRS1BAAAþRPS4AAAA and RRS1AAAAþRPS4BAAA combina-
tions recognized both AvrRps4 and PopP2 (Fig. 6d). On the other
hand, similar to RRS1BBBB and RPS4BBBB, RRS1ABBBþRPS4BBBB
and RRS1BBBBþRPS4ABBB recognized AvrRps4 only (Fig. 6d).
Accumulation of chimeric proteins was confirmed by immuno-
blot (Supplementary Fig. 14a,b). These results show that exchange
of TIR domains from paralogous R genes does not compromise
AvrRps4 or PopP2 recognition. In addition, the TIR domains
do not drive the pair partner specificity for function, therefore
other domain–domain interactions must account for the pairing
specificity.
We also characterized additional domain swaps between RRS1
and RRS1B, with the breakpoint between the end of exon 4 and
the beginning of exon 5. Exons 5, 6 and 7 encode the WRKY
domain of these proteins and B260 amino acids between the
LRR domain and the WRKY domain. These swaps were
designated as ‘AAAB’ and ‘BBBA’, and tested for recognition of
AvrRps4 and PopP2 in the presence of either RPS4 or RPS4B.
Accumulation of chimeric proteins was confirmed by immuno-
blot (Supplementary Fig. 14c, d). Neither of the RRS1AAAB and
RRS1BBBA chimeras conferred recognition of AvrRps4 or PopP2
(Supplementary Fig. 15). However, RRS1AAAB in combination
with RPS4 showed constitutive activity and triggered cell death in
the absence of effector, but not in combination with RPS4B



























































* * * *
IP-GFPInput
6
Figure 5 | Corresponding pair partner association in planta is required for
function. (a) HR assay in N. tabacum leaves using transient A. tumefaciens
transformation. Each leaf section was co-infiltrated to express a different
combination of R genes (shown on the left) together with GFP, avrRps4-GFP
or popP2-GFP. RRS1, RPS4, RRS1B and RPS4B were cloned from Ws-2 gDNA.
Cell death pictures were taken 5 d.p.i. (b) Co-immunoprecipitation (co-IP)
analysis showing associations within and between RRS1/RPS4 and
RRS1B/RPS4B pair proteins. RRS1, RPS4, RRS1B and RPS4B were fused to
either a C-terminal FLAG or GFP tag. The combination of fusion proteins in
each sample (C-terminal tag indicated on the right) is listed in the panel
with a corresponding number (1–6). Immunoblots show the presence of
proteins in total extracts (Input) and after IP with anti-GFP beads (IP-GFP).
Asterisks indicate the presence of protein bands after co-IP. These
experiments were repeated at least three times with similar results.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7338
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Figure 5.1 Effector recognition capability and sequence similarity of RRS1 alleles and paralogous B 
pair (A) RRS1-R/RPS4 pair together conger recognition of AvrRps4 and PopP2 whilst RRS1B/RPS4B 
confer recognition to only AvrRps4, Figure taken from Saucet et al 2015141 showing recognitio  of 
transiently expressed AvrRps4 and PopP2 by RRS1-R/RPS4 and RRS1B/RPS4B in N. tabacum. (B) 
Sequence identity of the WRKY domains and Dom6 C-terminal regions of RRS1-S, RRS1-R and RRS1B. 
Effector recognition capabilities of each RRS1 variation shown on right with AvrRps4 recognition 
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defining TIR domain swaps as RRS1BAAA and RRS1ABBB full-
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with WT R proteins for AvrRps4 and PopP2 recognition in N.
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tions recognized both AvrRps4 and PopP2 (Fig. 6d). On the other
hand, similar to RRS1BBBB and RPS4BBBB, RRS1ABBBþRPS4BBBB
and RRS1BBBBþRPS4ABBB recognized AvrRps4 only (Fig. 6d).
Accumulation of chimeric proteins was confirmed by immuno-
blot (Supplementary Fig. 14a,b). These results show that exchange
of TIR domains from paralogous R genes does not compromise
AvrRps4 or PopP2 recognition. In addition, the TIR domains
do not drive the pair partner specificity for function, therefore
other domain–domain interactions must account for the pairing
specificity.
We also characterized additional domain swaps between RRS1
and RRS1B, with the breakpoint between the end of exon 4 and
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each sample (C-terminal tag indicated on the right) is listed in the panel
with a corresponding number (1–6). Immunoblots show the presence of
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Previous work has provided key insights into the role of the WRKY domain in the activation 
of RRS1/RPS4 and RRS1B/RPS4B. Studies of allelic variation in the RRS1 protein has shown 
that the C-terminal Dom6R 83 amino acid extension beyond the end of Dom6S, in 
conjunction with the WRKY domain, is responsible for facilitating the extended recognition 
capability of RRS1-R to PopP2. The exact mechanism through which this extension 
facilitates expanded recognition is not yet thoroughly understood. As RRS1-S can still bind 
and be acetylated by PopP2, it is hypothesized that the RRS1 Dom6R extension may assist 
in specific inter-domain reconfigurations both within RRS1 or with RPS4, which allow RRS1-
R specifically to translate PopP2 binding into activation of the RRS1-R/RPS4 complex65,66,152. 
In contrast to PopP2 perception, recognition of AvrRps4 by RRS1 does not require Dom6, 
and the truncation RRS1 ΔDom6S is still capable of activating an immune response in the 
presence of AvrRps4 in an RPS4 dependent manner152.  
 
It has been established that recognition of both PopP2 and AvrRps4 requires an intact 
‘WRKYGQK’ motif in RRS1’s WRKY domain. Specifically, mass spectrometry experiments 
have led to the identification of two lysine residues, K1 (RRS1-R K1217, RRS1-S K1215) and 
K2 (RRS1-R K1221, RRS1-S K1219), in the WRK1YGQK2 motif which are acetylated by PopP2 
and play a key role in the recognition of both effectors65,66. Work expressing mutants in N. 
tabacum leaves showed that RRS1-R WRKY mutant WRKYGQR (K1221R), but not WRRYGQK 
(K1217R), loses recognition of both AvrRps4 and PopP2. AvrRps4 recognition was however 
disrupted by acetyl-lysine mimic mutants WRQYGQK (K1217Q) or WRKYGQQ (K1221Q). This 
observation suggests that ability of RRS1 to perceive AvrRps4 is sensitive to subtle changes 
in the K2 residue of the WRKY motif.  
 
The importance of the conserved ‘WRKYGQK’ motif in RRS1’s recognition of PopP2 was 
highlighted in the published crystal structure of the RRS1 WRKY domain and PopP2 
complex71. This site formed the majority of interactions with PopP2, facilitated by a number 
of hydrogen bonds and van der Waals contacts. The structure also highlighted the K1 and K2 
residues in the WRKY motif as facilitating key interactions with PopP2. The backbone and 
side chain of K1217(K1) formed hydrogen bonds with PopP2 residues D292 and N296, and 
E284, respectively, whilst K1221(K2) was inserted directly into the active site of PopP271. It 
should be noted that this structure did not include any of RRS1’s C-terminal Dom6R, which 
is known to be required for PopP2 recognition by RRS1-R153. 
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Regarding interaction of the RRS1 WRKY domain with AvrRps4, the crystal structure of 
AvrRps4c has provided some key insights into the interactions that may underpin this 
binding event. The electrostatic surface of AvrRps4c revealed a prominent negative patch, 
highlighted in Figure 5.2, which contained two glutamic acid residues, E175 and E187. 
Subsequent mutation analysis showed that bacteria expressing AvrRps4 E175A or E187A 
were not capable of triggering RRS1/RPS4 dependent HR. Interestingly protein-protein 
interaction modelling of RRS1 or RRS1B WRKY with AvrRps4c, Figure 5.7, predicts that E175 
and E187 interact with the K2 residue of the WRKY motif. This suggests that these residues 
may form a key interaction surface in the RRS1/RRS1B WRKY-AvrRps4 binding event. This 
hypothesis is further supported by co-immunoprecipitation data which shows that mutant 
AvrRps4 E187A  shows reduced binding to RRS1 Dom6R and complete loss of binding for 
double mutant AvrRps4 E187A/E175A153. 
 
 In addition to E187 and E175, other residues of interest have also been highlighted in 
AvrRps4. Mutations of AvrRps4 residues K135-Y138, referred as the ‘KRVY’ motif, to alanine 
also abolishes RRS1/RPS4 dependent AvrRps4-triggered HR in N. tabacum. Interestingly, co-
immunoprecipitation experiments show that unlike AvrRps4 E187A/E175A, KRVY/AAAA 
mutants retain the ability to bind to the RRS1 WRKY domain147,166. This suggests that 
AvrRps4 binding to the RRS1 WRKY domain is required, but not sufficient, to induce 
RRS1/RPS4 dependent HR. Such observations highlight the need for structural information 
Figure 5.2 Antiparallel α-helical coiled coil structure of AvrRps4c. (Left) Cartoon representation 
of the α-helices with residues in sticks on left of figure highlighting location of Glu187 and Glu175. 
(Right) Electrostatic surface representation of  AvrRps4c with arrow highlighting prominent negative 
patch containing Glu187 and Glu175, Figure taken from Sohn et al, 2012166 
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on this interaction as only in gaining an atomic structure of this NLR-effector interface will 
we be able to understand the requirements of this binding event.  
 
The importance of DNA binding in RRS1 activation is still not fully understood. It was 
initially proposed that loss of DNA binding might provide a mechanism for RRS1/RPS4 
complex activation by PopP2. However, experiments showing that the RRS1-S WRKY 
domain mutant K1219R abolishes DNA binding of this domain without activating plant 
defence signalling threw this hypothesis into contention65. Alternatively, loss of DNA 
binding by acetylation of this domain by PopP2 may be an artefact, in that PopP2 acetylates 
the integrated WRKY domain as it would its virulence target. Whilst evidence suggests that 
PopP2 disrupts WRKY domain DNA binding through acetylation of lysine residues in the 
WRKY motif, the mechanism for the non-enzymatic AvrRps4 is not understood. One finding 
which remains in contention with RRS1 DNA binding investigations is the observation in 
EMSA studies that AvrRps4 appeared to not disrupt the ability of RRS1-R to bind W-box 
DNA. This observation seems contradictory given the fact that the K1 and K2 lysine residues 
in the WRKY motif have been shown to directly interact with DNA173,239 and are predicted to 
directly interact with AvrRps4 by protein-protein interaction modelling such that mutation 
of these residues abolishes AvRps4 binding. This data would therefore confusingly suggest 
that the K1 and K2 residues can simultaneously bind AvrRps4 and W-box DNA. One 
explanation for this could be that the previously conducted EMSA study is not sensitive 
enough to detect changes in DNA binding abilities of RRS1 in the presence of AvrRps4. It is 
therefore one of the goals of this chapter to investigate this interaction in a more 
quantitative manner.  
 
The aim of this chapter was to investigate the structural basis of AvrRps4 recognition by the 
RRS1 WRKY domain. Given the observation that binding of AvrRps4 is required but not 
sufficient to activate RRS1/RPS4 dependent HR147,150, we require structural and more 
quantitative biochemical information on this interaction to understand this binding event. 
This chapter looked to gain structural, quantitative and qualitative information on AvrRps4 
binding to RRS1 using the diversity of RRS1 alleles and paralogous proteins which make this 
NLR an intriguing system to understand the flexibilities of NLR effector recognition. The 
ultimate goal is to gain an atomic structure of RRS1 or RRS1B WRKY bound to AvrRps4 to 
allow us to investigate two key questions. Firstly, how a single NLR, RRS1-R, binds 
functionally and structurally distinct effectors by comparing the binding interface of RRS1 
WRKY-AvrRps4 with the structure of RRS1 WRKY-PopP2. Secondly, how a single effector, 
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AvrRps4, binds different NLRs by comparing the interaction of AvrRps4 with both RRS1 and 
RRS1B WRKY domains which only share 56% sequence identity. 
 
Through the quantitative and qualitative biochemical techniques of analytical gel filtration 
and surface plasmon resonance (SPR) this chapter looked to validate previous hypothesises 
about RRS1 and AvrRps4 residues involved in this binding event, and to provide mechanistic 
insights into the function of the RRS1/RPS4 complex. In order to gain structural and 
quantitative biochemical information on the RRS1 WRKY-AvrRps4 interface, it was 
necessary to produce soluble protein for each component. This chapter looked to identify 
purification pipelines for RRS1 and RRS1B WRKY domain protein for further studies. 
Following protein purification, this chapter looked to gain qualitative information on RRS1 
WRKY-AvrRps4 binding by analytical gel filtration and quantitative data with SPR (surface 
plasmon resonance), and ultimately gain an atomic structure of this complex. Full 
methodologies used in this chapter can be found in chapter 2. 
 
Regarding nomenclature used in this chapter, definitions for RRS1-R WRKY (E1190-H1269), 
Dom6S (P1270-C1290) and Dom6R (P1270-Y1273) are described in 1.5.1. The residues of 
these domains expressed for protein purification work are denoted as subscript or as 
brackets. Amino acid numbers are given in reference to RRS1-R unless otherwise stated.  
 
5.2 RRS1 WRKY Dom6S interacts with AvrRps4c in vitro 
 
5.2.1 Purifying RRS1 WRKY Dom6S and AvrRps4C 
Initial work with RRS1 WRKY Dom6S focussed on the construct described in 5.4, which 
expressed RRS1-R residues S1184-C1290 in the pOPINF vector. Following publication of the 
RRS1 WRKY structure by Zhang et al, 201771 (PDB ID 5W3X), I moved to working with the 
RRS1 WRKY construct described in the study, to allow for future comparative work. The 
construct used in the Zhang et al, 201771 study covers all five of RRS1’s WRKY β-strands 
expressing residues E1195-T1273, Figure 5.3A. Defining the N-terminus as RRS1-R residue 
E1195, I trialled the expression of constructs RRS1 WRKY (E1195-T1273), WRKY Dom6S 
(E1195-C1290) and WRKY Dom6R (E1195-Y1373), Figure 5.3A. These constructs were all 
expressed from pOPINS3C vectors which include an N-terminal cleavable SUMO solubility 
tag, as was used by Zhang et al, 201771. Further, Zhang et al, 201771 used BL21(DE3) RIL cells 
to express RRS1 WRKYE1195-T1273, which are similar to Rosetta™ 2 (DE3) cells in that they 
carry extra copies of rare E. coli tRNAs that can limit translation of heterologous proteins in 
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E. coli. As such, I trialled the expression of RRS1 WRKY Dom6 construct variants in Rosetta™ 
2 (DE3), BL21(DE3) and SHuffle® T7 cell lines. All cell lines were grown in LB media and 
protein expression induced with 0.4 mM IPTG. Soluble expression of RRS1 WRKYE1195-T1273 
and RRS1 WRKY Dom6SE1195-C1290 was found to be highest in Rosetta™ 2 (DE3) in small-scale 
expression trials, Figure 5.3B (data only shown for Rosetta™ 2 (DE3) expression). However, 
RRS1 WRKY Dom6RE1195-Y1373 did not show soluble expression in any condition tested. 
Expression of RRS1 WRKY Dom6R in the crude lysate (CL) extract can be seen in Figure 5.3B, 
demonstrating that expression problems with this construct were due to production of 
soluble folded protein, not translation efficiency.  The reasons for this are, as yet, 
undetermined but we hypothesise that the predicted highly disordered nature of the 
Dom6R extension beyond the Dom6S boundary may impeded solubility of this construct 
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 (cont) sequence for RRS1 WRKY Dom6, WRKY domain is highlighted in blue whilst Dom6 is shown in  
 yellow highlighting the domain boundaries for Dom6S and Dom6R extension. The secondary 
structure features of RRS1 WRKY are depicted above the sequence numbered β strand1-5 and α 
helix 1 as defined in crystal structure of RRS1 WRKY (PDB ID 5W3X)71. N-terminal expression 
boundary E1195 is highlighted prior to the start of β strand 1. (B) Small-scale expression trial results 
for expressing RRS1 WRKYE1195-T1273, WRKY Dom6SE1195-C1290 and WRKY Dom6RE1195-Y1373 from 
pOPINS3C vector in Rosetta 2 (DE3) cells. Protein samples were run on 16% SDS-PAGE gel and 
stained using Coomassie dye. White arrows indicate protein bands of correct predicted MW size. CL: 
crude lysate, SF: Soluble fraction. 
 
Having identified conditions for soluble expression of RRS1 WRKY Dom6SE1195-C1290 
(expression in pOPINS3C expressed in Rosetta™ 2 (DE3) grown in LB media at 370C prior to 
induction with 0.4 mM IPTG and overnight growth at 200C), purification was scaled up to 6-
8L cultures as per Table 2.7. Following cleavage of the N-terminal 6xHis-SUMO tag, the 
protein underwent a second round of gel filtration using a Superdex™ 75 26/600 column 
from which fractions containing pure RRS1 WRKY Dom6SE1195-C1290, as judged by SDS-PAGE, 
were pooled and concentrated for downstream experiments, Figure 5.4. 
 
To conduct experiments examining the interactions between RRS1 WRKY Dom6S and 






















Figure 5.4 Purification of RRS1 WRKY Dom6S (E1195-C1290) in pOPINS3C. Gel filtration 
trace of RRS1 WRKY Dom6S eluting from a Superdex 75 26/600 gel filtration column peaking 
at 213 ml following 3C protease cleavage of SUMO tag, accompanying SDS-PAGE gel above 
trace shows fractions from peak highlighted in blue. Experiments were repeated twice with 
similar results found across repeats. 
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Q221, was previously used to obtain the crystal structure of AvrRps4c (PDB ID 4B6X)114. 
AvrRps4c (G134-Q221) was expressed from pOPINF in SHuffle® T7 cells grown at 370C prior 
to induction with 1 mM IPTG and overnight growth at 180C. Following cleavage of the N-
terminal 6xHis affinity tag, the protein underwent a second round of gel filtration using a 
Superdex™ 75 26/600 column from which fractions containing pure AvrRps4c, as judged by 
SDS-PAGE, were pooled and concentrated for downstream experiments, Figure 5.5A. 
Following purification of AvrRps4c, the presence and integrity of the protein was confirmed 
by intact mass spectrometry which indicated no protein degradation had occurred, Figure 
5.5B. The expected molecular mass for this protein (10083.19 Da) matched the peak from 








5.2.2 RRS1 WRKY Dom6S and AvrRps4c form a complex in vitro 
 
Having purified WRKY Dom6SE1195-C1290 and AvrRps4c protein, I wanted to determine 
whether these proteins could form a complex in vitro. This demonstrated that the WRKY 
Dom6SE1195-C1290 and AvrRps4c constructs I was working with in vitro covered the minimum 







































Figure 5.5 Purification of AvrRps4c (G134-Q221) in pOPINF. (A) Gel filtration trace of AvrRps4c 
eluting from a Superdex 75 26/600 gel filtration column peaking at 201 ml following 3C protease 
cleavage of SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from peak 
highlighted in blue. (B) Intact mass spectrometry analysis of purified AvrRps4c. Spectra show 
different species identified by peaks in intact mass spectrometry analysis, peak of interest for 
AvrRps4c is circled (10083.52150 Da), exact mass (in Daltons) is labelled above each peak. 
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For this, I first used the qualitative method of analytical gel filtration. Analytical gel filtration 
is an approach used to monitor protein elution from a size exclusion chromatography 
column by absorbance at 280 nm. Elution volume is dependent on the size of the protein or 
complex, with those of a larger size eluting earlier from the column. Therefore, if two 
proteins form a complex when mixed they will elute earlier from the column, observed as a 
peak shift to the left of the trace, then if the proteins are run individually. For this study, 
RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c were first run individually on a Superdex™ 75 
10/300 GL column. To test for complex formation, RRS1 WRKY Dom6SE1195-C1290 and 
AvrRps4c were mixed in a 1:1 molar ratio and incubated on ice for 1 hour. The resulting 
trace from analytical gel filtration of the mixed proteins shows a clear shift to a single 
earlier elution peak at 11.8ml compared to 12.9 ml and 14.2 ml for AvrRps4c and RRS1 
WRKY Dom6SE1195-C1290 respectively, Figure 5.6. Presence of proteins of interest were 
confirmed by SDS-PAGE analysis, Figure 5.6. 
 
Protein-protein interaction modelling conducted by Dr Lennart Wirthmüller and Dr Yan Ma 
of the interaction between RRS1 WRKY and AvrRps4c highlighted two AvrRps4 glutamic acid 
residues, E175 and E187, as having a key role in facilitating AvrRps4’s interaction with RRS1 
WRKY, Figure 5.7. To help validate this interaction model, I generated single and double 
mutant AvrRps4c E187A and E187A/E175A proteins that were expressed and purified using 
the same conditions as wild type AvrRps4c. Interestingly, a peak shift is not observed on 
analytical gel filtration when RRS1 WRKY Dom6SE1195-C1290 is mixed with double mutant 
AvrRps4c E187A/E175A, or single mutant AvrRps4c E187A, indicating the importance of 
these residues in the RRS1 WRKY-AvrRps4 interface, Figure 5.6. When RRS1 WRKY 
Dom6SE1195-C1290 is mixed with either E187A or double mutant E187A/E175A AvrRps4c, the 
two proteins elute in separate peak indicating a complex is not being formed, note that 
AvrRps4c has a very low extinction coefficient and therefore absorbs poorly at 280 nM. This 
result supports both the protein-protein interaction model seen in Figure 5.7 and in planta 
work which demonstrates the inability of AvrRps4c E187A or E175A mutants to induce 
RRS1/RPS4 dependent HR and reduced binding to RRS1 WRKY Dom6R in 
coimmunoprecipitation assays153. 




Figure 5.6 RRS1 WRKY Dom6S and AvrRps4c form a complex in vitro (A) Analytical gel filtration 
traces showing elution volume of AvrRps4c (blue), RRS1 WRKY Dom6SE1195-C1290 (red), RRS1 
WRKYDom6SE1195-C1290-AvrRps4c complex (yellow), mixing of RRS1 WRKY Dom6SE1195-C1290 and 
AvrRps4c E187A (grey) and mixing of RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c E187A/E175A 
(green). SDS-PAGE analysis shows the fractions taken from volumes on trace indicated by 
coloured triangles. Peak volumes shown indicate elution volume. Experiments were repeated 
twice with similar results found across repeats. 
 



























Figure 5.7 Structural modelling of the possible interaction surface between AvrRps4c (c-terminus) 
and the WRKY domains of RRS1-R and RRS1B. (A) Precited protein-protein interaction  between RRS1 
WRKYE1190-H1269 and AvrRps4c generated using ClusPro 2.0265 with RRS1 WRKYE1190-H1269 shown in orange 
and AvrRps4c in cyan. (B) Predicted interaction of RRS1B WRKYG1166-T1241 shown in yellow and AvrRps4c. 
The structures of RRS1-R and RRS1B WRKY domain were predicted with 100% confidence using 
Phyre2164 using the template of the crustal structure of WRKY1 (PDB ID:c2aydA71). AvrRps4c (PDB 
ID:4B6X166) is shown in cyan. The sequence identity between RRS1 WRKY and RRS1B WRKY and the 
template WRKY1 is 41% and 48% respectively.  The solid molecular surface of each complex is 
presented on the left whilst the secondary structure ribbons are shown on the right. Amino acids 
predicted at the interface are shown as sticks, with lysine (K1 and K2) residues of RRS1-R or RRS1B 
WRKY motif highlighted in green, and glutamic acid residues (E187 and E175) of AvrRps4 highlighted 
in purple. Modelling was conducted by Dr Lennart Wirthmueller and Dr Yan Ma, Figure adapted from 
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5.2.3 Quantitative binding analysis of RRS1 WRKY Dom6S and AvrRps4c in 
vitro 
 
To further investigate the interaction between RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c, 
and to gain quantitative insights on this binding event, I used surface plasmon resonance 
(SPR). This technique allows for quantitative analysis of biomolecular interactions, e.g. 
protein-protein240. SPR measures changes in the refractive index on the surface of a sensor 
chip upon which one binding partner has been immobilized, referred to as the ligand, when 
the second binding partner flows over the chip surface in the analyte. Should the two 
binding partners interact, the mass bound to the surface of the chip increases and changes 
the refractive index of a polarised light beam directed towards the sensor chip surface. In 
this way you can gain quantitative real-time information on a protein-protein binding 
event240.  
 
For the purposes of this study, AvrRps4c was used as the ligand immobilised on the surface 
of the sensor chip. This was enabled by expressing AvrRps4c with a non-cleavable C-
terminal Hisx6 tag (from the pOPINE vector) allowing the protein to bind to a Ni-NTA sensor 
chip surface. Alongside wild-type AvrRps4c, single mutant AvrRps4c E187A and double 
mutant E187A/E175A were also used as negative binding controls. After immobilizing 
AvrRps4c to the surface of the sensor chip, RRS1 WRKY Dom6SE1195-C1290 protein was injected 
over the chip surface as the analyte. In SPR, refractive differences caused by binding 
between the analyte and ligand is shown in a change of response units (RU). The maximum 
binding capacity of analyte to the ligand chip, assuming all ligand is active and binding sites 
are available, is referred to as the Rmax. The theoretical Rmax can be calculated using the 
formula below and reflects the theoretical maximum amount of analyte bound to a given 
amount of immobilized ligand on a chip surface. The Rmax is dependent on the molecular 
weight (MW) of the analyte and ligand, the amount of ligand immobilized on the surface of 





Once the theoretical Rmax has been calculated for a given interaction it can be compared 
with the experimental data RU for binding between the ligand and analyte which is then 
expressed as a percentage of the theoretical Rmax value (% Rmax). This value provides 
quantitative data on the binding affinity of the ligand and analyte.  
Rmax = 
 
MW of analyte (RRS1 WRKY) 
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Initial SPR experiments with RRS1 WRKY Dom6SE1195-C1290 showed issues with non-specific 
binding of RRS1 WRKY Dom6SE1195-C1290 to the surface of the chip. Extensive optimisation 
work required varying both the temperature at which the SPR analysis was conducted from 
4-250C, the concentration of NaCl in the SPR running buffer conditions, as well as the flow 
rate of analyte before conditions were identified which were suitable for conducting the 
binding experiments. It was observed that conducting the experiment at lower 
temperatures (40c) slowed the dissociation rate of the RRS1 WRKY Dom6SE1195-C1290 – 
AvrRps4c complex improving the quality of data collected, Figure 5.8. The final conditions 
included conducting the analysis at 80C in running buffer containing 860 mM NaCl and an 
analyte flow rate of 30 µl/min for 120 seconds contact time and 60 seconds dissociation 
time. These conditions were used for all subsequent SPR work with these proteins.  
 
 
Figure 5.8 Lower temperature slowed dissociation of RRS1 WRKY Dom6SE1195-C1290 and 
AvrRps4c. SPR experiment conducted at (A) 250C and (B) 40C. Slow rates of dissociation observed at 
lower experimental condition when all other factors were kept constant AvrRps4c concentrations 
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To determine the best concentrations of analyte to collect Rmax data with, I conducted an 
initial experiment with a large range of RRS1 WRKY Dom6SE1195-C1290 concentrations from 
50-3000 nM, Figure 5.9A. From this data I decided to conduct Rmax experiments at 
concentrations of 500 nM and 3000 nM RRS1 WRKY Dom6SE1195-C1290, as the %Rmax values for 
these analyte concentrations fell in the desired ranges of ~80% and ~20% respectively. Rmax 
experiments were then carried out at each of these concentrations with three binding level 
replicates taken for each analyte concentration with each AvrRps4c effector. The 
experiment was repeated twice with results from the two data sets combined to produce 
the %Rmax data shown in Figure 5.9B. The %Rmax plot showed a clear increased affinity of 
RRS1 WRKY Dom6SE1195-C1290 for wildtype AvrRps4c compared to E187A and E187A/E175A 
mutants, indicating the importance of these glutamic acid residues in binding RRS1.  
 
In addition to representing ligand and analyte binding as % Rmax, SPR can also give steady 
state affinity information on a binding event. One such parameter is the equilibrium 
dissociation constant, KD, which reflects the point at which the rate of complex dissociation 
equals the rate of association. This is calculated using a titration of analyte concentrations 
and fitting the experimental data responses to a steady-state affinity model. I looked to 
gain steady state kinetic information on the RRS1 WRKY Dom6SE1195-C1290 -AvrRps4c binding 
event. However, I was unable to determine KD values for this interaction as, despite 
optimisation work, the data failed quality tests used by the Biacore software when fitting to 
steady-state affinity models. The issues leading to this failure were predominantly a high 
bulk effect and a very fast-on fast-off binding event, which seems to occur between RRRS1 




































Figure 5.9 AvrRps4c residues E187 and E175 play important role in RRS1 WRKY Dom6SE1195-C1290 
binding of AvrRps4c (A) To identify RRS1 WRKY Dom6SE1195-C1290 concentrations to conduct %Rmax 
analysis at, initial binding of RRS1 WRKY Dom6SE1195-C1290 at concentrations from 0-3000 nM to 
AvrRps4c WT, E187A and E187A/E175A was investigated. (B) %Rmax of RRS1 WRKY Dom6SE1195-C1290 
bound to wildtype and mutant AvrRps4c assuming a 1:1 binding model for RS1 WRKY Dom6S: 
AvrRps4. The left and right panel were conducted with 500 nM and 3000 nM RRS1 WRKY Dom6SE1195-
C1290 respectively. The median is represented in the centre line of the box, and the upper and lower 
quartile by the box limits. Whiskers extend from smallest value in Q1 - 1.5x interquartile range (IQR) 
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are represented by a black square or circle, repeats are seen to cluster with values from alike 
repeats. This is likely due to differences in concentration of AvrRps4 protein used in each repeat as 
due to a lack of aromatic residues AvrRps4 protein concentration is hard to measure. Alternatively, 
the clustering might reflect differences in loading of RRS1 WRKY protein on chip between repeats 
which though kept in a set range did differ between repeats. Plots were produced using the ggplot2 
package171 in R. 
 
5.2.4 Purifying/understanding the structural basis of RRS1 WRKY Dom6S-
AvrRps4c complex 
 
In addition to gaining biochemical insights into the association between RRS1 WRKY Dom6S 
and AvrRps4c, a key development in understanding this interaction would be in attaining an 
atomic structure of this protein complex. Understanding the structural basis of NLR-effector 
interactions is a key goal in the field of NLR biology, and presents a major bottleneck in 
efforts towards engineering NLRs with expanded pathogen recognition capabilities. To 
understand the structural basis of RRS1 WRKY Dom6S recognition of AvrRps4, a diverse 
range of crystallisation screens were setup with purified RRS1 WRKY Dom6SE1195-C1290 -
AvrRps4c complex.  
 
RRS1 WRKY Dom6SE1195-C1290 -AvrRps4c protein complex was produced using purification 
‘method 2’ described in 2.6.3. This was due to the fact that the growth of cultures 
expressing RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c required different induction levels of 
IPTG induction for high yielding protein expression, 0.4 mM and 1 mM respectively. As such 
cultures expressing RRS1 WRKY Dom6SE1195-C1290 in pOPINS3C and cultures expressing 
untagged AvrRps4c in pOPINA were grown separately, pelleted and resuspended in lysis 
buffer. Following thawing, the lysate of the two cultures were mixed prior to sonication. 
The rationale for this strategy is that during IMAC purification the His-SUMO tagged RRS1 
WRKY Dom6SE1195-C1290 would interact and co-elute with untagged-AvrRps4c if the proteins 
were forming a complex. Following IMAC purification and gel filtration, the Hisx6-SUMO tag 
was cleaved from the RRS1 WRKY Dom6SE1195-C1290 protein using 3C protease and removed 
by IMAC purification. The protein complex then underwent a final round of purification by 
gel filtration, an example trace of which can be seen in Figure 5.10A.  The presence of both 
proteins in the peak trace was confirmed by SDS-PAGE. Following concentration of protein 
and prior to crystallisation screen setup, the presence and integrity of RRS1 WRKY 
Dom6SE1195-C1290 and AvrRps4c was confirmed by mass spectrometry analysis, Figure 5. 10 B, 
where the predicted molecular weights for each protein, 11137.65 Da and 9929.0 Da 
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respectively, were observed to match the mass spectrometry spectra peaks of 11137.75 Da 
and 9929.20 Da indicating the proteins had not degraded during purification.  
 
 RRS1 WRKY Dom6SE1195-C1290-AvrRps4c complex was then used in a large range of 
crystallisation screens designed to test diverse regions of crystallisation space to identify 
conditions which may support crystal formation. 96-well commercial screens were setup in 
sitting-drop diffusion experiments with two wells setup for each buffer condition with X 























































Figure 5.10 Purification of RRS1 WRKY Dom6S (E1195-C1290) and AvrRps4c (G134-Q221) complex. 
(A) Gel filtration trace of RRS1 WRKY Dom6SE1196-C1290 –AvRps4c complex eluting from a Superdex 75 
26/600 gel filtration column peaking at 162 ml following 3C protease cleavage of RRS1 WRKY 
Dom6SE1196-C1290 Hisx6-SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from 
peak highlighted in blue. (B) Intact mass spectrometry analysis of purified RRS1 WRKY Dom6S –
AvRps4c complex. Spectra show different species identified by peaks in intact mass spectrometry 
analysis, peak of interest for RRS1 WRKY Dom6SE1196-C1290 (11137.7549 Da) and AvrRps4c is circled 
(9929.2012 Da), exact mass (in Daltons) is labelled above each peak. Experiments, except for mass 
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Screens with RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c complex were setup at ~12 mg/ml 
and 6 mg/ml with protein concentrations measured prior to each screen. Screens were 
setup at 200C in six commercial screens; JCSG-plus™, Morpheus®, MIDAS™, ProPlex™, PACT 
premier™ and Structure (all Molecular-Dimensions). Additionally, the complex was also 
screened in a custom screen designed by Clare Stevenson and Dave Lawson at JIC 
crystallography platform known as the KISS screen. However, none of these screens 
highlighted any conditions in which crystal formation of the complex was supported.  
There are many parameters which can affect the nucleation and growth of protein crystals, 
such as the composition and pH of buffer reservoir solution, protein concentration and 
temperature. The parameters in which protein crystallisation will occur are not predictable. 
As such, in addition to using multiple sparse matrix crystallization screens, which vary in 
their buffer composition, precipitant mix and pH, I wanted to investigate the effect of 
temperature on crystalizing this complex. As SPR Rmax experiments suggested that the RRS1 
WRKY Dom6SE1195-C1290 -AvrRps4 complex appeared to be more stable at lower 
temperatures of 4-80C, I hypothesised that lower temperatures may aid crystallisation of 
the complex. Therefore, I setup several commercial 96-well sitting drop screens at 40C to 
see if this would support crystallization. Screens setup at this temperature were at a 
protein complex concentration of 12 mg/ml and 6 mg/ml. The screens trialled at 40C were 
JCSG-plus™, Morpheus®, PACT premier™ and ProPlex™. At 40C protein crystals were 
observed in well C5 of JCSG-plus™ using protein at a measured concentration of 12 mg/ml, 
Figure 5.11. The conditions for this well were 0.8 M Sodium phosphate monobasic 
monohydrate, 0.8 M Potassium phosphate monobasic, 0.1 M Sodium HEPES, pH 7.5 with 
no Precipitant. Whilst these crystals were not of a high enough quality to collect X-ray 
diffraction data, work is ongoing to optimise these conditions to obtain crystals suitable for 










Gaining biochemical and structural insights into AvrRps4 recognition by RRS1 
 168 
 
I hypothesised that issues with co-crystallising the RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c 
complex may be due to dissociation of the complex during crystallisation, as observed with 
RRS1 WRKYE1195-T1273 and AvrRps4c in Figure 5.16. To aid the stability of the RRS1 WRKY 
Dom6SE1195-C1290 -AvrRps4c complex, I decided to try expressing a construct of RRS1 WRKY 
Dom6S which was linked with a short peptide linker to AvrRps4c. Similar methods have 
been previously employed in gaining structures of protein complexes, for example the RRS1 
TIR-RPS4 TIR complex structure in which the two TIR domains were linked with a 5 residue 
‘GSGGS’ linker. Co-crystallising proteins using a linker comes with the caveat that linking 
the two proteins may impose artificial interactions or steric hinderance between the two 
proteins. In order to minimise such artificial interactions, I made use of the 6 amino acid 
residue ‘NAAIRS’ linker sequence. This sequence is described as having a neutral structure 
and can adopt both β-strand and α-helical secondary structures241, therefore minimising 
the formation of any forced secondary structure between two proteins. The protein-protein 
interaction model in Figure 5.7 was used to choose which protein termini to link, choosing 
the two termini which, in the model, were the closest. For the purposes of this study, I 
decided to link the C-terminal end of RRS1 WRKY Dom6SS1184-C1290, a construct used in the 
lab prior to the switch to RRS1 WRKY Dom6SE1195-C1290, to the N-terminal end of AvrRps4c 
using a ‘GSNAAIRSNAAIRSGS’ sequence. Using PCR primers with extensions to introduce 
the NAAIRS linker sequence, a Golden Gate Level 0 pICSL01005 construct with RRS1 WRKY 
Dom6SS1184-C1290 -GSNAAIRSNAAIRSGS- AvrRps4c was generated. This was then used as a PCR 
template to clone RRS1 WRKY Dom6SS1184-C1290 -GSNAAIRSNAAIRSGS- AvrRps4c into pOPINE 
Figure 5.11 Images of crystals seen during RRS1 WRKY Dom6SE1195-C1290 -AvrRps4c trials. 
Crystals observed in well C5 of JCSG-plus™ screen with 12 mg/ml protein at 40C, buffer 
conditions 0.8 M Sodium phosphate monobasic monohydrate, 0.8 M Potassium phosphate 
monobasic, 0.1 M Sodium HEPES, pH 7.5 with no Precipitant. Left image shows crystals in 
brightfield light and right in polarised light.  
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with a 3C protease cleavage site added to the C-terminus of the construct as a primer 
extension, Figure 5.12. This construct was expression tested in Rosetta™ 2 (DE3), BL21(DE3) 
and SHuffle® T7 cell lines but proved insoluble expression in all lines.  
 
5.3 RRS1 WRKY directly interacts with AvrRps4c in vitro 
 
I hypothesised that the lack of success in crystallising RRS1 WRKY Dom6SE1195-C1290 and 
AvrRps4c complex may be due in part to the predicted unstructured secondary structure of 
RRS1’s Dom6S (secondary structure and disorder prediction conducted using Phyre2164 
 and RONN software162) which can impede crystallization of a protein. As such, I looked to 
expand my work to focus on AvRps4 interaction with the RRS1 WRKY domain without 
Dom6. As pervious in planta work has shown Dom6S of RRS1 is not required for recognition 
of AvrRps4152, all functionally important interactions between AvRps4 and RRS1 WRKY must 
be facilitated without Dom6S. Therefore, information on RRS1 WRKY-AvrRps4 interaction is 
highly relevant for informing mechanistic studies of this NLR. 
 
5.3.1 Purifying RRS1 WRKY and AvrRps4c 
 
To examine the  interaction of RRS1 WRKY with AvrRps4, I used a construct with the same 
boundaries utilised by Zhang et al, 201771 which expressed RRS1-R E1195-T1273. Having 
established this construct expressed well in pOPINS3C in Rosetta™ 2 (DE3) cells, Figure 
5.3B, purification was scaled up to 6-8 L cultures. Following cleavage of 6xHis-SUMO affinity 
tag with 3C protease, Figure 5.13B, RRS1 WRKYE1195-T1273 protein was reloaded on a 
Superdex™ 75 16/600 column for a final round of gel filtration purification. The presence 
and purity of the protein in each peak fraction following gel filtration was confirmed by 
SDS-PAGE, Figure 5.13A. The presence, and integrity, of final concentrated protein was 
confirmed by mass spectrometry analysis prior to downstream experiments which found 
the predicted molecular weight for this protein, 9344.62 Da matched the mass 
spectrometry spectra peak of 9344.79 Da. AvrRps4c protein used in interaction studies with 
RRS1 WRKYE1195-T1273 was produced as described in 5.2.1.  
RRS1 WRKY Dom6S AvrRps4cGSNAAIRSNAAIRSGS
Linker
S1184 C1290 G134 Q221
3C-6His
Figure 5.12 Linked construct of RRS1 WRKY Dom6S and AvrRps4. Protein has a C-terminal 3C 
protease cleavable 6xHis tag. Amino acid residue number are shown above protein. 
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The complex of RRS1 WRKYE1195-T1273 and AvrRps4c for crystallisation trials was produced 
using ‘method 2’ described in 2.6.3 and 5.2.4. Due to differences in IPTG induction 
concentration required for these two proteins to produce high yields, 0.4 mM and 1 mM 
respectively, cultures growing 6xHis-SUMO tagged RRS1 WRKYE1195-T1273 expressed in 
pOPINS3C and untagged AvrRps4c expressed in pOPINA were grown separately with cell 
lysates mixed prior to sonication. Untagged AvrRps4c in complex with RRS1 WRKYE1195-T1273, 
co-eluted with 6xHis-SUMO tagged RRS1 WRKYE1195-T1273 during IMAC purification. Following 
gel filtration, 6xHis-SUMO tag was cleaved from RRS1 WRKY and removed by IMAC 
purification, Figure 5.14. The RRS1 WRKYE1195-T1273 -AvrRps4c complex then underwent a 
second gel filtration down a Superdex™ 75 16/600 column. The presence of both proteins 
under the gel filtration trace peak was confirmed by SDS-PAGE, Figure 5.14.  
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CL-crude lysate, soluble fraction, El1 -Concentrated protein following IMAC purification and first gel 
filtration, +3C-Post overnight 3C protease cleavage, FT-Flow through after second IMAC purification, 
El2 -Elution from second IMAC, P- Purified protein after second Gel filtration. (C) Intact mass  
Figure 5.13 Purification of RRS1 WRKY (E1195-T1273) in pOPINS3C. (A) Gel filtration trace of RRS1 
WRKYE1195-T1273 eluting from a Superdex 75 26/600 gel filtration column peaking at 95 ml following 3C 
protease cleavage of Hisx6-SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from 
peak highlighted in blue. (B) SDS-PAGE gel showing samples taken throughout the purification of RRS1 
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(cont) spectrometry analysis of purified RRS1 WRKY, spectra showing different species identified by 
peaks in intact mass spectrometry analysis, peak of interest for RRS1 WRKYE1195-T1273 is circled 
(9344.7930 Da), exact mass (in Daltons) is labelled above each peak. Experiments, except for mass 





Figure 5.14 Purification of RRS1 WRKYE1195-T1273 and AvrRps4c G134-Q221 complex. (A) Gel filtration 
trace of RRS1 WRKYE1195-T1273 –AvRps4c complex eluting from a Superdex 75 16/600 gel filtration 
column peaking at 79 ml following 3C protease cleavage of RRS1 WRKYE1195-T1273 Hisx6-SUMO tag, 
accompanying SDS-PAGE gel above trace shows fractions from peak highlighted in blue. (B) SDS-
PAGE gel of RRS1 WRKYE1195-T1273 + Hisx6-SUMO tag and AvrRps4c after first IMAC purification and 
gel filtration (El1) and after 3C protease cleavage of RRS1 WRKYE1195-T1273 Hisx6-SUMO tag (+3C). 
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5.3.2 RRS1 WRKY and AvrRps4c form a complex in vitro 
 
As with RRS1 WRKY Dom6S, I wanted to confirm RRS1 WRKY alone could interact with 
AvrRps4c in vitro. I looked to first confirm this using the qualitative method of analytical gel 
filtration. As descried in 5.2.2, RRS1 WRKYE1195-T1273 and AvrRps4c were first run as single 
proteins on a Superdex™ 75 10/300 GL column analytical gel filtration column. As single 
proteins RRS1 WRKYE1195-C1290 and AvrRps4c eluted at 15.2 ml and 13.0 ml respectively, 
Figure 5.15. However, when the two proteins were mixed in a molar ratio of 1:1 and left to 
incubate on ice for one hour before being run on a Superdex™ 75 10/300 GL column, the 
two proteins eluted in a single peak together at 12.6 ml indicating that a complex had been 
formed. Conversely when RRS1 WRKYE1195-C1290 was incubated with double mutant AvrRps4c 
E187A/E175A, no peak shift was observed, and the two proteins eluted as separate peaks 
at 13.4 ml and 15.1 ml indicating no complex was being formed, Figure 5.15. SDS-PAGE 
analysis confirmed the presence of the relevant proteins under the gel filtration peaks, 
Figure 5.15B.  
 
Having confirmed the ability of RRS1 WRKY to directly bind AvrRps4 qualitatively, I aimed to 
gain a quantitative insight on this binding event using SPR. As described in 5.3.2, SPR Rmax 
experiments were setup with AvrRps4c, wild type and negative control mutants E187A and 
E187A/E175A, used as the ligand bound to the surface of the Ni-NTA sensor chip, and RRS1 
WRKYE1195-T1273 as the analyte. Similar to RRS1 WRKY Dom6SE1195-C1290, I found that RRS1 
WRKYE1195-T1273 was prone to bind non-specifically to the surface of the sensor chip. I 
conducted extensive optimisation experiments to identify suitable conditions for 
conducting Rmax analysis including varying the temperature of the experiment from 4-250C, 
concentration of NaCl in the SPR running buffer, and the flow rate at which the analyte 
RRS1 WRKY was applied to sensor chip. The optimal conditions identified through these 
approaches were to use 80C, with 500 mM NaCl in the SPR running buffer, and an analyte 
flow rate of 30µl/min for 120 seconds contact time and 60 seconds dissociation time. Rmax 
data was collected for the interaction between RRS1 WRKYE1195-T1273 and AvrRps4c at the 
analyte concentrations of 500 nM and 3000 nM. Two biological repeats were conducted 
each containing three technical repeats of each investigated interaction. The data from the 
two biological replicates was combined to give %Rmax Figures for RRS1 WRKYE1195-T1273 
interaction with wild-type, E187A and E187A/E175A AvrRps4c, Figure 5.16.  
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Despite the extensive optimisation work described above, I was unable to generate 
equilibrium dissociation constant (KD) values for RRS1 WRKYE1195-T1273 and AvrRps4c binding. 
This was because the data failed the quality tests used by the Biacore software when 
attempting to fit the data to a steady-state affinity model, largely due to high bulk effects.  
 
Figure 5.15 RRS1 WRKYE1195-T1273 and AvrRps4c form a complex in vitro (A) Analytical gel filtration 
traces showing elution volume of AvrRps4c (blue), RRS1 WRKYE1195-T1273 (red), RRS1 WRKYE1195-T1273 
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(B) SDS-PAGE analysis shows the fractions taken from volumes on trace indicated by coloured 
triangles. Peak volumes shown indicate elution volume. Baselines corrected to zero. The peak 
observed in all traces at ~17 ml is caused by the presence of the reducing agent TCEP in the sample 


















5.3.3 Crystalizing RRS1 WRKY and AvrRps4c complex 
 
To identify conditions for crystallization of the RRS1 WRKYE1195-T1273-AvrRps4c complex, 
commercial 96-well sitting drop vapour diffusion screens were setup. Initially, sparse-matrix 
screens used protein concentrations of 11.2 mg/ml and 5.6 mg/ml in JCSG-plus™ and 
MIDAS™ (Molecular Dimensions). At these concentrations I observed a high level of 
precipitation in wells containing the higher 11.2 mg/ml of protein but not 5.6 mg/ml. As 
such, I decided to lower the protein concertation to 6.3 mg/ml and ~3.15 mg/ml for future 
Figure 5.16 AvrRps4c residues E187 and E175 play important role in RRS1 WRKYE1195-T1273 binding of 
AvrRps4c . %Rmax of RRS1 WRKYE1195-T1273 bound to wild type and mutant AvrRps4c assuming a 1:1 
binding model for RS1 WRKY Dom6S: AvrRps4. The left and right panel were conducted with 500 nM 
and 3000 nM RRS1 WRKYE1195-T1273 respectively. The median is represented in the centre line of the 
box, and the upper and lower quartile by the box limits. Whiskers extend from smallest value in Q1 - 
1.5x interquartile range (IQR) and the largest value within Q3 + 1.5x IQR. Individual data points from 
each biological repeat are represented by a black square or circle. Plots were produced using the 
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screening. Based on these concentrations, the KISS, Morpheus® and ProPlex™ 
crystallisation screens were setup at 250C (ProPlex™ is a crystallisation screen especially 
formulated for the crystallisation of protein complexes). Two conditions in these screens 
supported the growth of crystals, Figure 5.17. Firstly, in well A1 of the KISS screen setup 
with 6.3 mg/ml of protein complex with well conditions of 0.1M sodium acetate trihydrate, 
10% PEG 3350, pH 4, 0.2M ammonium sulfate. Secondly, in well C2 of the ProPlex™ screen 
also setup with 6.3 mg/ml of protein complex with buffer conditions 0.1M Sodium citrate, 
pH 4.5 and 20% PEG4000. However, both these crystals were hypothesised to comprise 
only AvrRps4c as they did not fluoresce in UV light, Figure 5.17, which is characteristic of 
AvrRps4c protein which has a very low extinction coefficient at 280 nM due to a lack of 
aromatic residues. If these crystals contained RRS1 WRKYE1195-T1273 they would be expected 
to glow in UV light as RRS1 WRKYE1195-T1273 has a high extinction coefficient. The conditions 
above were also very similar to those in which AvrRps4c was originally crystallized166, 14–
16% vol/vol 2-methyl-2, 4-pentandiol buffered with 0.1 M sodium acetate, pH 5.1–5.3. 
Therefore, these crystals were not taken further for analysis by X-ray diffraction. 
 
Having observed the increased stability of the RRS1 WRKYE1195-T1273-AvrRps4c complex at 
lower temperatures of 4-80C in analytical gel filtration and SPR experiments, Figure 5.8, I 
setup crystallisation trials at 40C to investigate whether a lower temperature would help 
crystallization. I setup the following 96-well sparse matrix commercial crystallisation 
screens at 6.1 mg/ml and 3 mg/ml; Structure, JCSG-plus™, PGA™ and PACT premier™ 
(Molecular Dimensions) but no crystal formation was observed.  
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Figure 5.17 Images of crystals seen during RRS1 WRKYE1195-!273 -AvrRps4c crystallization trials 
predicted to be AvrRps4c only. Images on left are brightfield view images on right taken in UV light. 
(cont) (A) Crystals found well A1 of KISS screen with buffer conditions 0.1M sodium acetate, pH 4.0, 
0.2M ammonium sulfate, 10% PEG 3350. (B) Crystals found in well C2 of commercial screen 
ProPlex™, buffer conditions 0.1M, sodium citrate, pH 4.5, 20% PEG4000. Crystals in both wells were 
found not to glow in UV light and were therefore predicted to be AvrRps4c only.   
 
5.4 Investigating interactions of RRS1B WRKY and AvrRps4c 
 
In addition to gaining biochemical and structural insights into the binding event between 
RRS1 WRKY and AvrRps4, I also expanded the study to examine the interaction of the 
RRS1B WRKY with AvrRps4. This was based on the rationale that should a structure of this 
interface be obtained, it would provide an excellent opportunity to compare how a single 
effector, AvrRps4, is recognised by different NLRs when compared to a structure for RRS1 
WRKY-AvrRps4. Given the sequence similarity of only 56% across the WRKY domain 
between RRS1 and RRS1B, understanding this interface at the structural level could provide 
interesting insights into the requirements and flexibilities of this NLR-effector interaction. 
 
To generate an expression construct of RRS1B WRKY with similar boundaries to RRS1 
WRKYE1195-T1273, the WRKY domain sequences of RRS1-R and RRS1B were aligned using 
Clustal Omega242. This identified RRS1B residues N1163-H1237 as the equivalent construct, 
Figure 5.18A. RRS1B WRKYN1163-H1237 was cloned into pOPINS3C as for the RRS1 WRKY 
construct. Small-scale expression tests of RRS1B WRKYN1163-H1237 in pOPINS3C were 
A 
B 
0.1 M sodium acetate 
trihydrate, pH 4,0.2 M 
ammonium sulfate,  
10% PEG 3350 
0.1 M Sodium citrate,  
pH 4.5, 20% PEG4000 
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conducted in Rosetta™ 2 (DE3), BL21(DE3), SHuffle® T7 and Lemo21(DE3) cell lines, with 
expression levels judged by SDS-PAGE of the soluble fraction of the total cell lysate, Figure 
5.18B. The expression tests found that similar to RRS1 WRKY, RRS1B WRKY showed greatest 
yields of soluble expression in Rosetta™ 2 (DE3) grown in LB media with 0.4 mM IPTG 
induction.  
 
Having optimised conditions for soluble expression of RRS1B WRKYN1163-H1237, expression 
was scaled up to 6-8 L of culture, followed by protein purification. Following IMAC 
purification and gel filtration, the 6xHis-SUMO tag was cleaved from RRS1B WRKYN1163-H1237 
with 3C protease, and the protein subjected to a final round of gel filtration purification on 
a Superdex™ 75 26/600 column. The presence of protein was confirmed by SDS-PAGE of 
the fractions comprising the peak, Figure 5.19. 
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To investigate AvrRps4 recognition by RRS1B I produced complex of RRS1B WRKYN1163-H1237 -
AvrRps4c utilising method 3, described in 2.6.3. In this method, AvrRps4c in pOPINF, and 
RRS1B WRKYN1163-H1237 in pOPINS3C were grown and purified by IMAC and gel filtration 
separately. Both proteins then underwent overnight cleavage of 6xHis and 6xHis-SUMO 
tags respectively with 3C protease. Following protease cleavage, cleaved affinity tag and 
tagged protein was removed by IMAC purification. During this second IMAC purification 

















































































Figure 5.18  Expression trialling of RRS1B WRKYN1163-H1237 (A) Sequence alignment of RRS1-R WRKY 
and RRS1B WRKY amino acid sequence, alignment constructed using Clustal Omega242, construct 
used for expression testing is highlighted in orange with core ‘WRKYGQK’ motif highlighted in blue, 
and amino acid number listed on the right of the sequence. (B) Small-scale expression trial results for 
expressing RRS1B WRKYN1163-H1237 in pOPINS3C in a variety of cell lines listed below each gel. 16% 
SDS-PAGE were stained with Coomassie dye to visualise protein. RRS1B WRKY protein bands of 
interest are highlighted with an arrow to the right of gel. CL: crude lysate, SF: Soluble fraction. 
 
Figure 5.5.19  Expression trialling of RRS1B WRKYN1163-H1237 (A) Sequence alignment of RRS1-R WRKY 
and RRS1B WRKY amino acid sequence, alignment constructed using Clustal Omega242, construct 
used for expression testing is highlighted in orange with core ‘WRKYGQK’ motif highlighted in blue, 
and amino acid number listed on the right of the sequence. (B) Small-scale expression tri l results for 
ex ressing RRS1B WRKYN1163-H1237 in pOPINS3C in a variety of cell lines listed below each gel. 16% 
SDS-PAGE were stained with Coomassie dye to visualise protein. RRS1B WRKY protein bands of 
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were eluted into the same vessel. The untagged proteins were incubated on ice for an hour 
to allow the proteins to interact and form a complex, as previously demonstrated in 
analytical gel filtration studies. The proteins then underwent a final round of gel filtration 
purification on a Superdex™ 75 16/600. During this step, the proteins eluted in a single 
peak form the column, and the presence of both proteins was confirmed by SDS-PAGE, 
indicating that RRS1B WRKYN1163-H1237 and AvrRps4c could form a complex in vitro, Figure 
5.20. I found that yields of RRS1B WRKYN1163-H1237-AvrRps4c complex were higher when the 
proteins were produced by this method rather than mixing the cell lysates of cultures of 
AvrRps4c and RRS1B WRKYN1163-H1237 as was used for RRS1 WRKYE1195-T1273-AvrRps4c complex 






























Figure 5.21 Purification of RRS1B WRKY (N1163-H1237) in pOPINS3C. Gel filtration trace of RRS1B 
WRKY eluting from a Superdex 75 26/600 gel filtration column peaking at 251 ml following 3C 
protease cleavage of SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from 
peak highlighted in blue. The trace blip peak at ~257 ml was caused by a changeover in the AKTA 
fraction collection plate. Experiment repeated 3 times with similar results found across repeats. 
 
Figure 5.22 Purification of RRS1B WRKY (N1163-H1237) and AvrRps4c(G134-Q221) complex. Gel 
filtration trace of RRS1B WRKYN1163-H1237 –AvRps4c complex eluting from a Superdex 75 16/600 gel 
filtration column peaking at 72 ml following 3C protease cleavage of RRS1 RRS1B WRKYN1163-H1237 
Hisx6-SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from peak highlighted 
in blue.Figure 5.23 Purification of RRS1B WRKY (N1163-H1237) in pOPINS3C. Gel filtration trace 
of RRS1B WRKY eluting from a Superdex 75 26/600 gel filtration column peaking at 251 ml 
following 3C protease cleavage of SUMO tag, accompanying SDS-PAGE gel above trace shows 
fractions from peak highlighted in blue. The trace blip peak at ~257 ml was caused by a 





In addition to direct purification of the complex, I investigated whether RRS1B WRKYN1163-
H1237 and AvrRps4c could form a complex by mixing the separately purified components 
followed by analytical gel filtration. For this, RRS1B WRKYN1163-H1237 and AvrRps4c were 
separately purified and run individually to monitor their elution volumes. Subsequent to 
this, the two proteins were mixed together in a 1:1 molar ratio and left to incubate on ice 
for four hours. However, unlike RRS1 WRKYE1195-T1273, RRS1B WRKYN1163-H1237 did not form a 
complex with AvrRps4c under these conditions, as no peak shift was observed Figure 5.21. 
Why RRS1B WRKYN1163-H1237 and AvrRps4c did not form a complex when mixed but did when 
co-purified is not fully understood and further work will be needed to identify binding 






























Figure 5.24 Purification of RRS1B WRKY (N1163-H1237) and AvrRps4c(G134-Q221) complex. Gel 
filtration trace of RRS1B WRKYN1163-H1237 –AvRps4c complex eluting from a Superdex 75 16/600 gel 
filtration column peaking at 72 ml following 3C protease cleavage of RRS1 RRS1B WRKYN1163-H1237 
Hisx6-SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from peak highlighted in 
blue. Experiment repeated 3 times with similar results found across repeats. 
 
 
Figure 5.25 Qualitative binding analysis of RRS1B WRKY and AvrRps4c. (A) Analytical gel filtration 
traces showing elu ion volume of AvrRps4c (blue), RRS1B WRKY (red), mixi g of R S1B WRKY and 
AvrRps4c (yellow) and mixing of RRS1B WRKYN1163-H1237 and AvrRps4c E187A/E175A (gr en). (B) SDS-
PAGE analysis shows the fractions taken from volumes on trace indicated by coloured triangles. 
Peak volumes shown indicate elution volume. Baselines corrected to zero. The peak observed in all 
traces at ~17 ml is caused by the presence of the reducing agent TCEP in the sample buffer.Figure 
5.26 Purification of RRS1B WRKY (N1163-H1237) and AvrRps4c(G134-Q221) complex. Gel 
filtration trace of RRS1B WRKYN1163-H1237 –AvRps4c complex eluting from a Superdex 75 16/600 gel 
filtration column peaking at 72 ml following 3C protease cleavage of RRS1 RRS1B WRKYN1163-H1237 
Hisx6-SUMO tag, accompanying SDS-PAGE gel above trace shows fractions from peak highlighted in 
blue. 
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Figure 5.27 Qualitative binding analysis of RRS1B WRKY and AvrRps4c. (A) Analytical gel filtration 
traces showing elution volume of AvrRps4c (blue), RRS1B WRKY (red), mixing of RRS1B WRKY and 
AvrRps4c (yellow) and mixing of RRS1B WRKYN1163-H1237 and AvrRps4c E187A/E175A (green). (B) SDS-
PAGE analysis shows the fractions taken from volumes on trace indicated by coloured triangles. 
Peak volumes shown indicate elution volume. Baselines corrected to zero. The peak observed in all 
traces at ~17 ml is caused by the presence of the reducing agent TCEP in the sample buffer. 
Experiment repeated twice with similar results found across repeats. 
 
 
Figure 5.28 Purification of RRS1 TIR (K6-G153) in pMCSG7. Gel filtration trace of RRS1 TIR eluting 
from a Superdex 75 26/600 gel filtration column peaking at 199 ml following 3C protease cleavage 
of tag, accompanying SDS-PAGE gel above trace shows fractions from peak highlighted in 
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5.5 Non-WRKY domain RRS1-AvrRps4 interactions 
 
There is some evidence in the literature for effectors interacting with integrated domain 
NLRs outside of an NLR’s integrated domain. For example the Magnaporthe oryzae effector 
AVR-Pia has been observed to interact with Oryza sativa NLR RGA5 at sites outside of 
RGA5’s integrated HMA/RATX1 domain72. Following from this observation, unpublished in 
planta co-immunoprecipitation from Dr Sung Huh and Dr Yan Ma in the Jones laboratory 
suggested that the TIR domain of RRS1 may also interact with AvrRps4 and RRS1 WRKY 
Dom6S. The data showed the ability of RRS1’S TIR domain to interact constitutively with 
RRS1 WRKY Dom6S and that this interaction was enhanced in the presence of AvrRps4, but 
not PopP2. To test if this interaction could be recapitulated in vitro, and allow for further 
biochemical study of this interaction, I conducted a qualitative binding experiment by 
analytical gel filtration.  
 
RRS1 TIR protein was produced using the construct and conditions developed by Williams 
et al, 2014114 which expressed RRS1 K6-Y153 in pMCSG7 with a TEV protease cleavable 
6xHis tag in Rosetta™ 2 (DE3) cells. RRS1 TIRK6-G153 protein was expressed and purified by 
IMAC purification before gel filtration. The 6xHis tag was cleaved by overnight incubation 
with TEV protease before un cleaved protein and cleaved tag was removed by IMAC. The 
protein then underwent a final round of purification by gel filtration on a Superdex™ 75 
26/600 column and the presence of RRS1 TIRK6-G153 was confirmed within the gel filtration 



































Figure 5.30 Purification of RRS1 TIR (K6-G153) in pMCSG7. Gel filtration trace of RRS1 TIR eluting 
from a Superdex 75 26/600 gel filtration column peaking at 199 ml following 3C protease cleavage 
of tag, accompanying SDS-PAGE gel above trace shows fractions from peak highlighted in blue. 
 
Figure 5.31 Qualitative binding analysis of RRS1 WRKY Dom6S, RRS1 TIR and AvrRps4c. Analytical 
gel filtration traces showing elution volume of AvrRps4c (blue), RRS1 WRKY Dom6SE1195-C1290 (red), 
RRS1 TIRK6-G153 (green), RRS1 WRKY Dom6SE1195-C1290 /AvrRps4c complex (yellow) and mixing of RRS1 
WRKY Dom6SE1195-C1290, RRS1 TIRK6-G153, AvrRps4c (grey). SDS-PAGE analysis shows the fractions 
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To investigate the binding of RRS1 TIRK6-G153, RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c 
qualitative analytical gel filtration analysis was conducted. The proteins were first run 
separately on a Superdex™ 75 10/300 GL column, eluting at 12.8 ml 14.1 ml and 12.7 ml 
respectively, Figure 5.23. As RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c had previously been 
observed to interact, a complex of RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c was also run 
to enable comparison of peak shifts in the presence of RRS1 TIR, Figure 5.23. The RRS1 
TIRK6-G153, RRS1 WRKY Dom6SE1195-C1290 and AvrRps4c were then mixed in a molar ration of 
1:1:1 and incubated on ice overnight. The protein mixture was then run on the analytical 
gel filtration column. However, no shift in trace peak, indicative of complex formation, was 
observed. Only peaks for RRS1 TIRK6-G153, and a peak for complex of RRS1 WRKY Dom6SE1195-
C1290 and AvrRps4c, were seen at 11.9 ml and 13.1 ml, Figure 5.23. The lack of interaction 
between RRS1 TIR-RRS1 WRKY and AvrRps4c in vitro is not fully understood. A hypothesis 
could be that this interaction in facilitated by another interaction partner present in the in 
planta coimmunoprecipitation assays, but not when the proteins are mixed in isolation. 
Alternatively, the binding conditions provided in this in vitro assay could be inappropriate 
for supporting this binding event. It has been previously observed for example certain 
protein complexes are better supported in in vivo environments such as through co-
expression in the same cell strain than in vitro. Conversely, the observed in planta RRS1 TIR, 
RRS1 WRKY and AvrRps4c interaction could be an artefact potentially due to protein 
overexpression levels. Should this interaction be proved true in future work, it could 
provide an interesting avenue of investigation for future work into understanding this NLR-
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Figure 5.33 Qualitative binding analysis of RRS1 WRKY Dom6S, RRS1 TIR and AvrRps4c. Analytical 
gel filtration traces showing elution volume of AvrRps4c (blue), RRS1 WRKY Dom6SE1195-C1290 (red), 
RRS1 TIRK6-G153 (green), RRS1 WRKY Dom6SE1195-C1290 /AvrRps4c complex (yellow) and mixing of RRS1 
WRKY Dom6SE1195-C1290, RRS1 TIRK6-G153, AvrRps4c (grey). SDS-PAGE analysis shows the fractions taken 
from volumes on trace indicated by coloured triangles. Peak volumes shown indicate elution 
volume. Baselines corrected to zero. The peak observed in all traces at ~17 ml is caused by the 
presence of the reducing agent TCEP in the sample buffer. Experiment repeated twice with similar 
results found across repeats. 
 
 
Figure 5.34 Qualitative binding analysis of RRS1 WRKY Dom6S, RRS1 TIR and AvrRps4c. Analytical 
gel filtration traces showing elution volume of AvrRps4c (blue), RRS1 WRKY Dom6SE1195-C1290 (red), 
RRS1 TIRK6-G153 (green), RRS1 WRKY Dom6SE1195-C1290 /AvrRps4c complex (yellow) and mixing of RRS1 
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5.6 Exploring RRS1 WRKY interactions with W-box DNA 
 
In addition to understanding the structural basis of AvrRps4 recognition by RRS1/RRSB 
WRKY, I wanted to examine the effect AvrRps4c has on the ability of the RRS1 WRKY 
domain to bind to W-box DNA. For this I used a specialised SPR technique called ReDCaT 
(Re-usable DNA Capture Technique), specialised for examining protein-DNA interactions172. 
As a negative control for wild type W-box DNA sequence (TTGACCG)243 I trialled the use 
three W-box mutant variants. These were: Mutant 1 which was the W-box mutant 
sequence used in previous EMSA (electrophoretic mobility shift assay) studies with RRS165, 
Mutant 2 which was generated through combining W-box mutations used by other non-
RRS1 publications174,175 and Mutant 3 which was generated by scrambling the wild-type W-
box using an online scrambling tool from GenScript. Nucleotide deviations of these mutants 
from the wild type W-box sequence are highlighted in Figure 5.25. The wild-type and 
mutant sequences of W-box DNA were trialled as both single and triple repeats of the 
sequence, the details are shown in Table 2.8.  
 
The SPR ReDCaT technique involves immobilizing biotinylated single stranded ReDCaT linker 
DNA sequences to a streptavidin coated SPR sensor chip. The DNA sequences for binding 
testing are then generated as two separate oligonucleotides, forward and reverse. The first 
strand contains only the forward sequence of the DNA sequence to be tested (W-box), 
whilst the second strand contains the reverse sequence of your testing DNA sequence and 
the complementary sequence to the ReDCaT linker sequence. These two oligonucleotides 
are annealed by heating and injected over the ReDCaT linker immobilized chip. The 
annealed oligonucleotides bind to the ReDCaT chip. A pictorial representation of this 
experimental setup is shown in Figure 2.2. This allows you to generate a SPR sensor chip 
displaying your DNA sequence of choice to proteins which are then flowed over as analyte. 
 
Initial experiments used a construct of RRS1 WRKY Dom6S generated prior to switching to 
the RRS1 WRKY Dom6SE1195-C1290 described in 5.2. This construct expressed RRS1 residues 
S1183-C1290 in pOPINF in SHuffle® T7 cell grown in LB media. Following 3C protease 
cleavage on 6xHis tag the protein underwent a final round of purification by gel filtration in 
which protein presence in trace peak was confirmed by SDS-PAGE, see Figure 5.24. 
 
These early experiments showed that the RRS1 WRKY Dom6S protein was interacting non-
specifically with the ReDCaT chip. Subsequent trialling of this system varying NaCl 
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concentration in the SPR buffer and analyte flow rate established conditions in which this 
non-specific interaction was reduced. These optimised conditions used a buffer containing 
300 mM NaCl, and an analyte concentration of 500 nM and analyte flow rate of 30 µl/min 
with 60 seconds contact time and 60 seconds dissociation time.  
 
Under these conditions RRS1 WRKY Dom6SS1184-C1290 showed a clear increased affinity for 
wild type W-box DNA over mutant 1, 2, or 3 W-box DNA. This increased affinity of RRS1 
WRKY Dom6SS1184-C1290 for wild type W-box DNA was observed for both single and triple 
DNA sequence repeats, Figure 5.18B.  
 
Having established that RRS1 WRKY Dom6SS1184-C1290 was capable of binding W-box DNA in 
the SPR ReDCaT experiment, I investigated whether AvrRps4 could disrupt this interaction. 
The experimental plan was to conduct both displacement and competition assays. In the 
displacement setup, W-box DNA would first be immobilized to the ReDCaT chip. Following 
this, RRS1 WRKY would then be flowed over the chip as the analyte and bind the W-box 
DNA. Next, AvrRps4c would then be flowed over the RRS1 WRKY bound W-box DNA chip 




















Figure 5.35 Purification of RRS1 WRKY Dom6S (S1184-C1290) in pOPINF. Gel filtration trace of 
RRS1 WRKY Dom6SS1184-C1290 eluting from a Superdex 75 26/600 gel filtration column peaking at 
182 ml following 3C protease cleavage of Hisx6 tag, accompanying SDS-PAGE gel above trace 
shows fractions from peak highlighted in blue. Experiment repeated 3 times with similar results 
found across repeats. 
 
 
Figure 5.36 Purification of RRS1 WRKY Dom6S (S1184-C1290) in pOPINF. Gel filtration trace of 
RRS1 WRKY Dom6SS1184-C1290 eluting from a Superdex 75 26/600 gel filtration column peaking at 
182 ml following 3C protease cleavage of Hisx6 tag, accompanying SDS-PAGE gel above trace 
shows fractions from peak highlighted in blue  
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RRS1 WRKY would be mixed with AvrRps4c prior to flowing over the W-box DNA 







 I setup this experiment using the RRS1 WRKYE1195-T1273 construct described in 5.3.1 to 
complement structural work with this construct. However, I was unable to collect this data 
due to issues with non-specific binding of RRS1 WRKYE1195-T1273 to the surface of the sensor 
chip. Conditions were setup as for the RRS1 WRKY Dom6SS1184-C1290 using SPR buffer 
containing 300 mM NaCl and a flow rate of 30 µl/min (60 seconds contact time, 60 seconds 
dissociation time). Various optimization experiments were tried to reduce the non-specific 
binding effect, including varying the RRS1 WRKYE1195-T1273 analyte concentration from 10-500 
nM and decreasing the analysis temperature to 80C, as had worked for Rmax studies, but no 
Wild Type W-box T T G A C C G 
Mutant 1 (EMSA) T A G A C G G 
Mutant 2 (Literature) T T G C A C G 
















WT Mutant 1 Mutant 2 Mutant 3



















































Figure 5.39 RRS1 WRKY Dom6SS1184-C1290 binds WT but not mutant W-box DNA in vitro. (A) W-box 
DNA sequences used in SPR ReDCaT chip experiment. 3 different W-box DNA mutants were 
co pared to wild type, Mutant 1 is the sequence previously used in RRS1 WRKY EMSA study65 
(EMSA mutant), Mutant 2 is based on sequences used in the literature and Mutant 3 was generated 
by scrambling the wild-type W-box sequence using a GenScript online scrambling tool. Nucleotide 
deviations from wild type sequence are highlighted in orange. (B) %Rmax plots of RRS1 WRKY 
Dom6SS1184-C1290 binding to WT and mutant W-box DNA immobilised on a ReDCaT SPR chip. RRS1 
WRKY Dom6SS1184-C1290 binding was tested against single and 3 repeats of each DNA sequence.   
 
Figure 5.40 RRS1 WRKY Dom6SS1184-C1290 binds WT but not mutant W-box DNA in vitro. (A) W-box 
DNA sequences used in SPR ReDCaT chip experiment. 3 different W-box DNA mutants were 
compared to wild type, Mutant 1 is the sequence previously used in RRS1 WRKY EMSA study65 
(EMSA mutant), Mutant 2 is based on sequences used in the literature and Mutant 3 was generated 
by scrambling the wild-type W-box sequence using a GenScript online scrambling tool. Nucleotide 
deviations from wild type sequence are highlighted in orange. (B) %Rmax plots of RRS1 WRKY 
Dom6SS1184-C1290 binding to WT and mutant W-box DNA immobilised on a ReDCaT SPR chip. RRS1 
WRKY Dom6SS1184-C1290 binding was tested against single and 3 repeats of each DNA sequence.   
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conditions rescued the non-specific binding issues sufficiently. I also tested various SPR 
running buffers. This included increasing the NaCl concentration in the SPR buffer to 860 
mM and increasing the surfactant Tween20 from 0.05% to 0.1%, but again no significant 
reduction in RRS1 WRKYE1195-T1273 non-specific binding was achieved. This experiment was 
repeated with RRS1B WRKYN1163-H1237, but similar to RRS1 WRKYE1195-T1273, issues with non-
specific binding to the sensor chip prevented data being collected.  Work is now ongoing to 
optimise conditions for completing the analysis of how AvrRps4c might affect the ability of 




The objective of this chapter was to use structural biology and biochemical techniques to 
explore the molecular and structural basis of AvrRps4 recognition by RRS1. Using a range of 
allelic variants of RRS1, and the paralogous RRS1B, I investigated whether inherent 
flexibilities of the RRS1 system enable this NLR to recognise multiple effectors, Table 5.1. It 
was hoped that through gaining structural information on the RRS1 WRKY-AvrRps4 
interface we could complement previous in planta work to further dissect the mechanism 
of RRS1/RPS4 activation. Through gaining the structure of RRS1 WRKY-AvrRps4, the aim 
was to compare this with the published structure of RRS1 WRKY-PopP271 and investigate 
how a single NLR can bind structurally and mechanistically distinct effectors. Should a 
structure of RRS1B WRKY-AvrRps4c also be achieved, this would then provide interesting 
insights into how a single effector, AvrRps4, binds two NLR WRKY domains which only share 
56% sequence identity141.  
 
Initial expression trials identified conditions in which I could express RRS1 WRKY Dom6S 
(E1195-C1290) and WRKY (E1195-T1273). Despite trials in multiple cell strains I was unbale 
to produce soluble RRS1 WRKY Dom6RE1195-Y1373. As described in chapter 3, additional 
trialling to identify soluble constructs of RRS1 WRKY Dom6R, which looked at a variety of N-
terminal expression boundaries (RRS1-R S1184, R1194, E1195 and E1209) and expression in 
multiple expression vectors with various soluble tags (pOPINF, pOPINS3C and pOPINM) also 
failed to identified conditions for soluble expression of this protein in E. coli. I hypothesise 
this may be due to the inherent predicted disorder of the Dom6R extension, which may 
hinder expression of this protein in E. coli. The constructs I carried forward for quantitative 
and qualitative binding experiments mirrored the N-terminus of the construct used by 
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Zhang et al, 201771, such that direct comparison could be conducted in the future should a 
structure of RRS1 WRKYE1195-T1273-AvrRps4 be achieved.  
 
 
Having identified conditions for the soluble expression of RRS1 WRKYE1195-T1273 and WRKY 
Dom6SE1195-C1290 I confirmed these proteins could both directly bind AvrRps4c in vitro by 
analytical gel filtration, Table 5.1. Previous in planta work had shown that AvrRps4 E187A 
/E175A mutants were incapable of activating RRS1/RPS4 dependent HR. These glutamic 
acid residues are located in a patch of negative surface charge on AvrRps4c which ClusPro 
2.0 protein-protein interaction modelling predicts interact with key lysine residue (K2) in 
RRS1’s ‘WRKYGQK’ motif, Figure 5.7. To help validate this model, I investigated whether the 
inability of AvrRps4 E187A /E175A to induce HR was due to a loss/reduction in binding 
affinity with RRS1 WRKY domain. Using analytical gel filtration, I showed that both AvrRps4c 
E187A and E187A /E175A were unable to bind RRS1 WRKY or WRKY Dom6S protein. This 
observation supports the hypothesis that these residues form important interactions in this 
 
 
Protein  Amino acid Expression conditions Experiment update 
RRS1 WRKY  E1195-T1273 pOPINS3C, Rosetta™ 2 (DE3) 
 E. coli 
Interacts with AvrRps4c by analytical 
gel filtration and SPR. AvrRps4 
residues E187 and E175 important 
for facilitating this interaction. RRS1 WRKY 
Dom6S 




N1163- H1237 pOPINS3C, Rosetta™ 2 (DE3)  
E. coli 
Only interacts with AvrRps4c 
immediately following SUMO tag 
cleavage cell lysate stage of 
purification. 







Cultures of RRS1 WRKY and 
AvrRps4 grown separately and 
cell lysates mixed after thawing 
Crystallisation efforts continue. Only 








Cultures of RRS1 WRKY Dom6S 
and AvrRps4 grown separately 
and cell lysates mixed after 
thawing 









RRS1B WRKY only interacts with 
AvrRps4c immediately following 
SUMO tag cleavage cell lysate 
stage of purification 
Shown proteins interact via 
analytical gel filtration. 
Crystallisation efforts continue. 
 
Table 5.1 Summary of successful expression of RRS1 WRKY variations and AvrRps4c with experimental 
update.  
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NLR-effector interface, and that loss of this interaction prevents AvrRps4 from binding RRS1 
WRKY domain and activating the RRS1/RPS4 complex.  
 
SPR Rmax analysis showed that whilst wild type AvrRps4c could bind RRS1 WRKYE1195-T1273 or 
WRKY Dom6SE1195-C1290, the binding of single mutant AvrRps4c E187A and double mutant 
E187A/E175A was significantly reduced. Interestingly, AvrRps4c E187A/E175A showed 
lower affinity for RRS1 WRKYE1995-T1273 than single mutant E187A in Rmax experiments. This 
mirrors in planta coimmunoprecipitation data which showed a reduced and abolished 
ability of the E187A and E187A/E175A mutants, receptively, to disrupt RRS1 Dom4 and 
WRKY Dom6R interactions153. The quantitative Rmax data from this study therefore supports 
the previously proposed model that binding of AvrRps4 to the WRKY domain of RRS1 
disrupts interactions between RRS1 Dom4 and WRKY Dom6R. The data therefore supports 
that the inability of AvrRps4 E187A/E175A to activate RRS1/RPS4 caused by a failure to 
interact with the RRS1 WRKY domain and disrupt interaction between the WRKY and Dom4 
region of RRS1. 
 
Unfortunately, due to issues with data quality I was unable to attain KD values for the 
interactions between RRS1 WRKYE1195-T1273 /WRKY Dom6SE1195-C1290 and AvrRps4c. The fast 
on-off interaction between RRS1 WRKYE1195-T1273 /WRKY Dom6SE1195-C1290 protein and 
AvrRps4c was intriguing, and not expected given the stability of the complex as observed by 
analytical gel filtration. This difference is likely due to the setup of these two experimental 
assays. The protein complex is formed for analytical gel filtration analysis by incubating the 
proteins together for an extended period of time on ice, compared to SPR where the 
contact time is only seconds as the analyte is flowed over the ligand chip. Additionally, the 
buffer conditions in which the SPR and analytical gel filtration experiments for RRS1 WRKY 
Dom6SE1195-C1290 interactions were conducted differ due to issues with non-specific binding. 
SPR experiments were conducted in a higher salt buffer containing 860 mM NaCl whilst 
analytical gel filtration buffer contained 500 mM NaCl. NaCl concentration for RRS1 
WRKYE1195-T1273 studies however was 500 mM NaCl in both SPR and analytical gel filtration 
studies. It is therefore likely that the observed differences in RRS1 WRKY-AvrRps4 complex 
stability are due to innate differences between the SPR and analytical gel filtration 
techniques. 
 
The virulence mechanism of AvrRps4 in A. thaliana is not fully understood. Given the lack of 
apparent enzymatic activity of AvrRps4 it is hypothesised the effector may act as a 
Gaining biochemical and structural insights into AvrRps4 recognition by RRS1 
 192 
structural block in WRKY transcription factor DNA binding. Given the observation of RRS1 
WRKY inability to bind AvrRps4’s E187A or E187A/E175A it will be interesting for future 
work to understand if these glutamic acid residues play a role in the virulence AvrRps4 
virulence function, for example in disrupting the ability of WRKY transcription factors to 
bind W-box DNA. I started to investigate this using ReDCaT SPR analysis. ReDCaT SPR allows 
you to gain quantitative binding data on a protein-DNA interaction. The aim of using this 
technique was to investigate the ability of AvrRps4 to disrupt RRS1 WRKY interactions with 
W-box DNA. Previous EMSA data suggested that AvrRps4 did not affect the ability of RRS1 
to bind W-box DNA, but the requirement of the RRS1-R K1221 residue for both binding 
AvrRps4 and W-box DNA called this in to question. I hypothesised that the qualitative EMSA 
study may not have been sensitive enough to monitor transient or weaker changes AvrRps4 
may have on the binding of DNA by RRS1. The work in this chapter has now identified 
conditions in which this assay may now be conducted. It will be interesting to see in future 
work if this assay does reveal DNA binding disruption abilities of AvrRps4, and how this is 
affected in E187A/E175A mutants. 
 
The ultimate goal for the work in this chapter was to gain an atomic structure of the 
complex of RRS1 WRKY and AvrRps4c to allow further dissection of the structural basis of 
effector recognition. To this end, extensive crystallisation trials were setup with RRS1 WRKY 
Dom6SE1195-C1290 and AvrRps4c complex at 250C. The screens trialled were largely of the 
“sparse matrix” variety, to cover a large area of crystallisation space244, and included 
screens such as ProPlex™, which have been specially formulated for crystallisation of 
protein complexes. However, these screens did not yield conditions in which crystals 
formed. As I had observed an increased stability in RRS1 WRKY Dom6SE1195-C1290 and AvrRps4 
complex formation during SPR experiments at lower temperatures, I decided to setup 
further crystallisation screens at 40C. From these lower temperature trials, I identified 
conditions in which small fine bundle like crystals formed. As these crystals were unsuitable 
for the collection of X-ray diffraction data, work is ongoing to optimise these conditions to 
produce larger crystals. As the Dom6S region of RRS1 is predicted to contain large regions 
of disordered structure, I hypothesised that removing these potentially destabilising 
regions to express RRS1 WRKY alone may improve our ability to gain a structure of the RRS1 
WRKY-AvrRps4 interface. Further to this, in planta data has shown the Dom6S is not 
required for AvrRps4 binding and RRS1/RPS4 induction of ETI, so all functionally important 
interactions between AvrRps4 and the C-terminal region of RRS1 must be contained in the 
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WRKY domain alone. However, despite setting up multiple screens at both 250C and 40C, 
the RRS1 WRKYE1195-T1273-AvrRps4c complex proved recalcitrant to crystallisation. 
 
One hypothesis to explain why we have been unable to get crystals of the complex is that 
crystallisation conditions may be leading to dissociation of the complex. For example, as 
seen in RRS1 WRKYE1195-T1273 -AvrRps4c complex screens where crystals of AvrRps4c were 
observed to be forming. One way to prevent this complex dissociation during crystallisation 
is to express the two interactors linked with a flexible peptide sequence as one protein 
construct. This technique was used to obtain structures of the RRS1 TIR-RPS4 TIR 
complex87. Based on this, I expressed a construct in which WRKY Dom6SS1184-C1290 and 
AvrRps4c were linked using a flexible ‘NAAIRS’ sequence241. Unfortunately, despite trialling 
in multiple cell lines, soluble expression of this construct was not observed. Producing 
linked RRS1 WRKY and AvrRps4 still provides a promising avenue for future work to gain a 
complex of this NLR-effector interface, although it may require further extensive trialling 
with multiple solubility tags or linkers to identify suitable conditions.  
 
In addition to trialling linked constructs of RRS1 WRKY and AvrRps4, further work could be 
done to identify suitable crystallisation conditions for this complex. For example, a thermal 
shift assay could be conducted with these proteins to identify buffer conditions which 
increase the stability of this NLR-effector complex. It has been shown that raising the 
melting point of a protein through the addition of buffer components which stabilise 
proteins increase the likelihood of protein crystal formation245,246. Using assay screens such 
as differential scanning fluorimetry for RRS1 WRKY and AvrRps4c protein could therefore 
identify buffer conditions to improve the stability of the complex and increase the 
likelihood of crystallisation. Alternatively, other methods of crystallisation could be also 
conducted such as hanging drop, microbatch or microdialysis, which may provide more 
suitable conditions for crystallizing this complex247. Beyond crystallography, small angle X-
ray scattering (SAXS) analysis could be conducted with RRS1 WRKY-AvrRps4 complex. This 
would provide a molecular envelope for the complex in to which the published crystal 
structures of RRS1 WRKY71 and AvrRps4c166 could be docked. This would allow us to gain 
structural information on this binding event without the need for crystallisation.  
 
Given that more than 70% of WRKY transcription factors are implicated in defence61,62, this 
family of proteins represents a likely target hub for effectors looking to manipulate host 
responses to pathogens. As such, understanding how different WRKY integrated domain 
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NLRs bind and activate upon effector recognition could provide vital insights for future 
engineering of synthetic NLRs which bind previously unrecognized WRKY targeting 
effectors. Previous in planta work suggests that RRS1 and RRS1B may activate their 
respective NLR immune receptor complexes by distinct mechanisms. Domain switching of 
WRKY domains between the RRS1 and RRS1B results in RPS4/B dependent autoactivity 
demonstrating the WRKY domains of these NLRs are not interchangeable. In addition, 
AvrRps4 recognition by RRS1B requires the WRKY and C-terminal Dom6B whilst RRS1 only 
requires the WRKY domain. Furthermore, truncation of both the WRKY and Dom6 region of 
RRS1 results in an RPS4 dependent autoactivity in the case of RRS1, but not RRS1B153 (and 
unpublished data from Dr Yan Ma). These observations suggest that the two NLRs are 
undergoing different inter- and intra-molecular interaction changes upon binding AvrRps4. 
Therefore, should we be able to gain a structure of RRS1 WRKY and RRS1B WRKY in 
complex with AvrRps4c we could begin to look at the conserved features and, indeed 
differences, which enable these RRS1/B WRKY domains to perceive AvrRps4 despite only 
sharing 56% sequence identity. Structural information of these binding events would also 
aid our mechanistic understanding of how different integrated WRKY domain NLRs are 
activated and could help inform the future generation of synthetic NLRs. Having established 
a pipeline for purifying RRS1B WRKYN1163-H1237 singularly and in complex with AvrRps4c, we 
are now in a position to start working towards attaining these structures either through 
crystallography of SAXS.  
 
It is important to have a thorough understanding of all the interaction surfaces between a 
given NLR and an effector to support and guide future engineering of synthetic NLRs with 
expanded effector recognition. Previous in planta work had observed that AvrRps4 could 
associate with protein from exons 1-5 of RRS1 (M1-K1189) which did not contain WRKY 
Dom6, though this interaction was significantly weaker than with the WRKY Dom6 region of 
RRS165. This suggested that AvrRps4 could interact with RRS1 outside of the integrated 
WRKY domain. Follow up work suggested that the TIR domain of RRS1 could interact with 
RRS1 WRKY Dom6S, and that binding of AvrRps4 enhanced this interaction. However, the 
biological function of this interaction is still not understood (unpublished work of Dr Yan 
Ma and Dr Sung Huh). This observation is similar to work in the literature demonstrating 
the ability of AvrPia to bind to the O. sativa NLR RGA5 at sites additional to the integrated 
HMA/RATX1 domain. This led me to investigate whether I could recapitulate the binding 
event between RRS1 WRKY Dom6S, TIR and AvrRps4c in vitro such that this potential RRS1-
AvrRps4 interaction surface could be further explored biochemically. However, I was not 
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able to recapitulate this binding event by mixing and incubating the proteins on ice, with 
AvrRps4c only observed to bind RRS1 WRKY Dom6SE1195-C1290. As discussed in 5.5, the reason 
for the inability to recapitulate this binding event is not known understood. Hypothesis 
include a lack of an interaction partner either another domain of RRS1/RPS4 or external 
protein found in partner or that the conditions in the experimental setup were not 
appropriate for supporting binding. Future work to optimise binding conditions may lead to 
the ability to produce and study this multi domain complex in vitro and provide insights on 
a role for this interaction surface in RRS1/RPS4 activation. The observation that effectors 
may bind NLRs at multiple locations is also interesting from an evolutionary stand point and 
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6 General discussion & future perspectives 
 
Crop losses from pest and disease pose a major threat to our global food security.  With 
pressures on global agricultural outputs likely to rise due to climatic change and increasing 
demands of a growing population, plant pathogen-derived yield losses are 
unsustainable248,249. Only through understanding the complex interplay between plants and 
their pathogens can we learn to manipulate the interactions between these systems, and 
help tip the evolutionary balance towards crops. 
 
The apparent convergent downstream signalling of NLRs across plant species highlight 
these receptors as a prime candidate for use in transgenic crops250. The power NLRs have to 
elevate disease resistance in transgenic crops is exemplified by the deployment of Rpi-vnt1 
from the wild relative of potato Solanum venturii in potato (Solanum tuberosum). Rpi-vnt1 
in transgenic lines conferred resistance to the oomycete pathogen P. infestans, the causal 
agent of late-blight disease, through recognition of the effector Avr-vnt1251. In addition to 
interfamily transfer of existing cloned NLRs252,253, in principle there is huge potential for 
improving crop disease resistance through engineering synthetic NLRs capable of perceiving 
previously unrecognised pathogen effectors.  
 
Integrated domain-containing NLRs are a prime candidate scaffold for engineering efforts. 
Using the design structure of integrated domain NLRs, receptors could be engineered to 
recognise pathogen effectors based on effector host targets. This strategy could confer 
recognition to pathogens which currently evade molecular detection by the plant immune 
system. However, such engineering strategies will not be as straightforward as simply 
swapping the integrated domains of NLRs for known effector targets. This is demonstrated 
by the autoactive phenotype when the WRKY domain of RRS1 is switched to other WRKY 
transcription factor domains152. Moreover, extensive understanding of the structural basis 
of NLR recognition of effectors and the NLR intra- and inter-molecular interactions which 
subsequently activate ETI will be needed to engineer NLRs successfully. In this manner we 
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understanding and ability to translate laboratory results into agricultural outputs will likely 
rely on gaining structural insights into the functioning of NLRs.  
 
6.1 Investigating expression systems for NLR protein production 
 
Until recently, available structures of plant NLRs were limited to singular domains, primarily 
of the N-terminal CC or TIR domains and integrated domains, with prediction of full-length 
NLRs relying on inference from mammalian NLR structures. With the publishing of the CNL 
ZAR1 structure, we now have for the first time an atomic-level model for a full-length plant 
NLR. Whilst this structure provides significant insights into the activation and autoinhibition 
mechanism of NLRs, discussed in 1.4.1, ZAR1 only represents one method of effector 
perception, utilising an indirect-decoy effector recognition strategy. There is therefore a 
great incentive in the field for gaining structures of TNLs and CNLs which utilise various 
methods of effector detection.  
 
A major bottleneck in attaining the structure of plant NLRs is the associated difficulties with 
expressing full-length NLR protein to yields appropriate for structural studies. This barrier 
has plagued both the animal and plant NLR field for decades. This study therefore set out to 
evaluate a diverse array of expression systems for the production of the NLRs RRS1 and 
RPS4, in order to identify conditions which supported soluble full-length expression of 
these plant NLRs. I evaluated various heterologous host species including prokaryotic E. 
coli, eukaryotic Sf9 insect cells as well as various plant-based expression systems including 
transgenic A. thaliana and agroinfiltrated N. benthamiana. In addition to trialling in vivo 
expression systems, cell-free wheat germ extract was also investigated for RRS1 expression 
capabilities.  A comprehensive list of soluble expression results from the trials in this study 
can be found in Appendix 5. 
 
These trials demonstrated that soluble expression of multidomain RRS1/RPS4 protein was 
reliant upon a plant-based folding environment. The exact capabilities which make plant-
based expression systems suitable for soluble RRS1 expression but not other eukaryotes 
such as insect cells is not fully understood. Soluble expression conceivably requires a 
chaperone repertoire found only in plants or post-translational modifications which are 
specifically supported in plant systems. Interestingly unlike RRS1, expression of full-length 
ZAR1 was supported in Sf21 insect cells108,109. This suggests that different NLRs may have 
distinct folding requirements given the expression of NLRs varies between expressions 
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systems with varying protein folding capacities e.g. insect cell v plant expression systems. 
This result is particularly interesting in the case of RRS1 and ZAR1 given both these NLRs are 
found in A. thaliana. The differences in folding requirements might reflect the evolution of 
the two NLRs. It could be hypothesised that more ancient NLRs might require simplified 
folding machinery compared to more recently evolved NLRs. The basis of this hypothesis is 
that ancient NLRs will have been maintained in the genome through a longer period of 
evolution, which may select for less reliance on chaperones for proper protein folding. A 
criterion for identifying potential ancient NLRs is the presence of NLR orthologs across 
multiple genera. ZAR1 for example is one of the few Arabidopsis NLRs where a N. 
benthamiana orthologue has been defined suggesting it is one of the more ancient NLRs in 
the Arabidopsis NLR repertoire254. This hypothesis might therefore explain the ability to 
express soluble ZAR1 in insect cells but not RRS1.  
 
Whilst expression of full-length RRS1 was observed in wheat germ cell-free extract and 
agroinfiltrated N. benthamiana leaves, the trials in this study highlighted transgenic A. 
thaliana plants as the most viable source of NLR protein in terms of scalability and cost. 
Using A. thaliana plants, I was able to purify RRS1 to quantities suitable for analytical gel 
filtration analysis, Figure 6.1 & Figure 4.10. This is a major breakthrough in purifying RRS1 
protein and signifies that with further scale up, quantities of RRS1 could be purified suitable 
for structural studies and other quantitative biochemical techniques such as SPR. 
 
Current success rates for crystallography structure determination are still low with 
structural genomics projects estimating that less than 4% of expression targets result in a 
defined structure255,256. Given this low success rate and the high protein concentrations 
required for crystallography, successful structure determination of RRS1, and plant NLRs is 
general, is more likely to come from utilising techniques such as SAXS and cryo-electron 
microscopy. A crystalline sample is not required for SAXS analysis and provides the 
molecular envelope of a protein into which structures can then be docked. Using the known 
structures of RRS1’s WRKY71 and TIR domain114 and modelling from ZAR1, a structure of 
RRS1 should be attainable in this manner. Cryo-electron microscopy has been utilised to 
solve the structure of the mammalian NLR NLRC4-NAIP inflammasome and recently ZAR1. 
Similarly to SAXS, by not relying on a crystalline sample cryo-electron microscopy 
overcomes a major hurdle in structure determination by traditional X-ray crystallography. 
Historically, cryo-electron microscopy use was restricted to macromolecules with a 
molecular weight in excess of 500 kDa and a resolution limit of ∼5 Å. However, in recent 
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years the size limit of single-particle cryo-electron microscopy has been significantly 
lowered to ~65 kDa with a resolution of ∼3 Å through the application of technologies which 
can enhance the image contrast for small protein complexes257. Given that 155 kDa RRS1 
has been observed in this study and others to form a multimeric complex218,233, 
determination of the structure of RRS1 should therefore be technically feasible using this 
method.  
 
Whilst this study tested a diverse array of expression systems for RRS1 and RPS4 protein 
production, a number of alternatives still remain untested. In addition to plant cell cultures 
discussed in 4.5.1, other heterologous systems which could be investigated include 
prokaryotes such as Bacillus subtilis258 and Ralstonia eutropha259, and eukaryotic systems 
such as yeast260, micro-algae261 and mammalian cells262. Given that the results in this study 
suggest that multi-domain expression of RRS1 and RPS4 is not well supported in 
prokaryotes, future work would benefit from focussing on eukaryotic systems. In particular 
use of algae expression systems such as micro-algae Chlamydomonas reinhardtii hold 
strong potential for plant NLR production. As a plant-based system, although significantly 
more distantly related to A. thaliana than wheat or N. benthamiana, it could be 
hypothesised that micro-algae possess the appropriate chaperones and cellular machinery 
for plant NLR production. Micro-algae also offer several benefits over transgenic plants 
including a faster transformation to scale up production timeline, and the ability to grow 
the cells in a bioreactor261. As a single cell type, micro-algae also offers less variation in 
recombinant protein production compared to transgenic plants which could benefit 
downstream processing uniformity261. Similarly, as discussed in 4.5.1, plant cell cultures  
such as N. tabacum BY-2 or NT-1 cells226 would offer similar benefits of batch consistency 
and control of protein production pipelines and would be worth exploring further for NLR 
protein production.  
 
The insights presented in this extensive multi-system expression screen study should 
provide a strong foundation for future studies looking to express plant NLRs, Figure 6.1 and 
Appendix 5. This study highlights the importance of protein folding environment for plant 
NLRs. The results in this study suggest that whilst some NLRs may be correctly folded in 
insect cells108,109 , others may strictly require a plant-based system for multi-domain 
expression. Transgenic plants were particularly highlighted as the most viable source of NLR 
protein for the case of RRS1 and RPS4 and likely other NLRs given the scalability, relative 
low costs and folding capabilities this system provides. However, what future studies are 
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likely to highlight is there is no single ‘silver bullet’ for expression of these receptors given 
the difficulties the field has faced in gaining structures of NLRs in recent decades. 
Nonetheless, with improvements in high-throughput expression testing strategies a 
technical advancement in structure resolution techniques such as cryo-electron 
microscopy, barriers to the determination of full-length NLR structures continue to fall.  
RPS4 TIR NB-ARC CTDLRR









Non-plant based Heterologous expression systems
Plant based Heterologous expression systems
• Expression of full 
length RRS1
• Good expression of full 
length RRS1 and RPS4
• Expression of full length 
RRS1 and RPS4 and 
RRS1B and RPS4B. 
Excellent affinity tag 
trailing capabilities
• Good expression of truncations 
focused on RRS1 WRKY and TIR 
domains
• Low-Medium expression of RRS1 
and RPS4 truncations of domains 
of interest e.g. RPS4 CTD
• Low to no expression outside 
of RRS1 WRKY. No soluble 
multidomain constructs.
• Low to no soluble expression of 
multidomain constructs. Difficult 
scale up setup. 
• Very low protein 
yields. High costs. 
Requires cDNA.
• Inefficient purification 
with anti-FLAG beads. 
Long plant generation 
pipeline for new lines.











Figure 6.1 Summary of protein expression screening of RRS1 and RPS4 in this study. Figure outlines 
the main positives and negative outcomes of a range of heterologous and plant-based expression 
systems trialled for expression of RRS1 and RPS4 in this study 
 
Figure 6.2 Summary of protein expression screening of RRS1 and RPS4 in this study. Figure outlines 
the main positives and negative outcomes of a range of heterologous and plant-based expression 
systems trialled for expression of RRS1 and RPS4 in this study 
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6.2 Understanding the structural basis of effector recognition by 
integrated domain NLRs 
 
Whilst full-length structures are an important ultimate goal for the field of NLR biology, 
great value is still held in gaining the structure of NLR subdomains and particularly in 
understanding NLR-effector interfaces. Understanding the structural basis of NLR-effector 
binding events is key to deciphering the mechanism through which NLRs are activated and 
regulate plant defences. Such insights will provide crucial information for deciphering plant-
pathogen interactions and help guide future engineering efforts to generate NLRs with 
expanded recognition capabilities.  
 
The power structural biology brings to engineering integrated domain containing NLRs with 
expanded pathogen recognition capacity, has recently been demonstrated in a proof-of-
concept study263. The study focussed on the recognition of M. oryzae AVR-Pik effector 
variants by the HMA integrated domain containing O. sativa NLR Pikp-1 and Pikm-1 alleles. 
Whilst the allele Pikm-1 confers recognition in its NLR pair to AVR-PikD/E/A variants, Pikp-1 
only confers resistance to AVR-PikD. Through gaining the structure of Pikp-1 HMA domain 
complexed with AVR-PikD, and Pikm-1 HMA with AVR-PikD/E/A, the authors were able to 
highlight two key residues in Pikm-1 which facilitated recognition of AVR-PikE and AVR-
PikA70,181,263. Mutation of these residues in Pikp-1 to match those found in Pikm-1, 
conferred Pikp-1 extended recognition of AVR-PikE and Avr-PikA263. This is a key proof-of-
concept example of how structure-guided engineering can extend the effector recognition 
profile of an NLR. 
 
The Pik/AVR-Pik systems provides insights into understanding the structural basis of NLR 
recognition of multiple allelic variations of a single effector. Effector recognition by RRS1 
expands on this concept by providing a system to investigate how a single NLR binds 
structurally and mechanistically distinct effectors. To enable this investigation, a structure 
of RRS1 WRKY complexed with AvrRps4 is required to conduct comparative studies with the 
RRS1 WRKY-PopP2 complex71. The work presented in this study has now developed the 
tools to gain such a structure. In this project I have developed pipelines for the production 
of both RRS1 WRKY Dom6SE1195-C1290 and RRS1 WRKYE1195-T1273 protein. These proteins have 
now been shown to directly interact in vitro with AvrRps4c, both qualitatively by analytical 
gel filtration analysis and in quantitative SPR studies. Through these binding investigations, 
I have begun to validate a protein-protein interaction model for the complex of RRS1 WRKY 
and AvrRps4c which highlighted two AvrRps4 residues, E175 and E187, as playing an 
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important role in facilitating recognition by the RRS1 WRKY domain. Future work continuing 
crystallisation trials or conducting SAXS analysis with these protein complexes will hopefully 
lead to the structural resolution of this NLR-effector interface.  
 
Attaining a RRS1 WRKY-AvrRps4c structure would enable interesting comparative work with 
the RRS1 WRKY-PopP2 structure71. Given the apparent differences in the virulence 
mechanism of AvrRps4 and PopP2, it will be interesting to see what are the conserved and 
distinct interfaces these effectors establish with the RRS1 WRKY domain. From an 
evolutionary viewpoint, comparisons of the two different interfaces will provide insights 
into how the emergence of new plant NLR effector perception specificities arise. In addition 
to comparative work with PopP2, understanding the structural basis of AvrRps4 binding to 
RRS1 may shed light on questions arising from in planta work. For example, why does the 
mutant AvrRps4KRVY/AAAA retain the ability to bind RRS1 but not activate RRS1/RPS4 defence. 
As the KRVY motif region of AvrRps4 (K135-Y138) is not in the electron dense region of the 
AvrRps4c structure, we are unable to predict the interactions involved in this region150. 
However, when complexed with the RRS1 WRKY domain, this region of AvrRps4 may be 
stabilised and allow us to observe the intricacies of the interaction involving this motif.  
 
Whilst the structure of RRS1 WRKYE1195-T1273 in complex with PopP2 highlights a number of 
key binding interfaces71, in planta work has shown that in the context of full-length RRS1, 
Dom6R is required to translate PopP2 binding into RRS1/RPS4 complex activation. It is vital 
therefore that we understand the interactions involving Dom6R with PopP2 and other 
domains within the RRS1/RPS4 complex. This will allow us to investigate how multiple 
pathogen effector recognition is facilitated by RRS1-R. As RRS1 Dom6R shows little 
homology to any other known protein domain, we are unable to conduct accurate protein-
protein interaction modelling studies with RRS1 WRKY Dom6R. Therefore, work to 
understand the intricacies of interactions with Dom6R will require attaining a structure of 
this protein domain. Identification in this study of a construct and condition in which RRS1 
WRKY Dom6RE1209-Y1373 protein can be produced in insect cells, therefore opens an exciting 
new branch of RRS1-effector interaction investigations. Given the mechanistic importance 
of Dom6R in PopP2 activation of the RRS1/RPS4 complex, attaining structural information 
of the C-terminal extension could provide key insights into the mechanism which 
transduces PopP2 binding in to RPS4 dependent defence activation of RRS1-R but not RRS1-
S. Understanding how different activation mechanisms are coordinated and maintained in 
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an NLR would provide invaluable understanding as to how we could synthetically design 
NLRs with multiple recognition specificities in the future. 
 
Whilst comparing the structures of RRS1 WRKY with AvrRps4c and PopP2 enables 
investigation into how a single NLR binds distinct effectors, comparing the RRS1 and RRS1B 
WRKY interface with AvrRps4c allows us to question how a single effector is recognised by 
different NLRs. RRS1 and RRS1B share only 56% and 58% sequence identity across their 
WRKY and Dom6 regions respectively141. Attaining a structure of both RRS1 and RRS1B 
WRKY bound to AvrRps4 would therefore enable a comparison of how these distinct WRKY 
domains bind AvrRps4. Moreover, given that the AvrRps4 induced activation mechanisms 
of RRS1 and RRS1B appear to differ significantly152, it will be interesting to see in future 
work if these differences are reflected in distinct interactions with AvrRps4. In this manner, 
comparison of these two systems would enable the investigation of how evolution has 
driven the emergence of distinct activation strategies for the same effector. Work in this 
study has developed the tools to start investigating these questions with the identification 
of soluble expression conditions of RRS1B WRKYN1163-H1237. I have shown in this study that 
RRS1B WRKYN1163-H1237 can directly interact with AvrRps4c in vitro and identified a pipeline 
for the production of RRS1B WRKYN1163-H1273 -AvrRps4c complex for use in structural studies.  
With such tools in place, investigations can continue to understand AvrRps4c recognition by 
RRS1B at the atomic level.  
 
WRKY transcription factors are widely involved in host immune responses61,62. 
Consequently, they represent a likely target for pathogen effectors to attenuate host 
defences. AvrRps4 and PopP2 are currently the only effectors identified to target WRKY 
transcription factors. However, the observation that WRKY domains are one of the mostly 
commonly found integrated domains in NLRs, implies there is a strong selection force 
driving integration of WRKY domains into NLRs. This is likely the result of effector 
manipulation of WRKY transcription factors. Should further WRKY transcription factor-
targeting effectors be identified, attaining structural information of these effectors’ 
interactions with WRKY transcription factors should be prioritised. Through such structures, 
we may be able to utilise structure-guided engineering strategies to expand the recognition 
profile of WRKY integrated domain containing NLRs such as RRS1. In doing so this work 
could be used to confer resistance to previously unrecognised pathogens.  
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The work in this study has developed key tools to begin to understand fundamental 
questions of NLR effector perception, namely how a single NLR can recognise multiple 
distinct effectors, and how a single effector is recognised by different NLRs. This work will 
contribute to a growing body of research into effector perception by NLRs which aims to 
utilise molecular understanding of plant-pathogen interactions to strengthen food security.  
  
6.3 Summary and outlook 
 
The work presented in this thesis aimed to develop tools and insights into the structural 
functioning of NLRs. Through extensive expression trials, pipelines have been identified for 
the production of RRS1 protein suitable for structural and biochemical studies. These trials 
additionally provide a valuable foundation for future studies looking to purify plant NLRs, 
Figure 6.1 and Appendix 5. Furthermore, strategies have also been developed for the 
production of RRS1 WRKY, WRKY Dom6S and WRKY Dom6R as well as paralogous RRS1B 
WRKY domain protein, Table 5.1. As demonstrated in this study, this material has already 
begun to shed light on our understanding of effector perception by integrated domain 
containing NLRs. Future work is now in a position to utilise these tools to further tease 
apart the intricacies of multiple effector recognition by RRS1.  
 
Whilst our models for plant NLR activation are constantly developing, key questions still 
remain; what are the intra- and inter-molecular interactions involved in NLR auto-
regulation? How does effector binding relieve NLR autoinhibition? What role does 
nucleotide hydrolysis play in NLR activation? What is the significance of NLR 
oligomerisation in instigation of ETI, and how does this differ between the NLR N-terminal 
domain classes? Our ability to engineer synthetic NLRs to target previously unrecognized 
effectors, relies on gaining an in-depth understanding of molecular intricacies of NLR 
activity and deciphering the black boxes in our current thinking. Of course, whilst scientific 
generation of transgenic crops with an expanded NLR repertoire is scientifically possible, 
deployment of such plants for agricultural purposes still faces significant political and social 
hurdles. Therefore, until public opinion and government legislation towards the use of 
genetically engineered crops changes, the potential of utilising our understanding of NLRs 
will be significantly constrained.  
 
It will be exciting to see how our understanding of NLRs evolves through future structural 
and biochemical studies. In gaining such knowledge we will take significant steps forward in  
General discussion & future perspectives 
 205 




Appendix 1: List of primers used in this study 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pOPINF: Carbenicillin- Cleavable His6 tag 
 
pOPINF: Carbenicillin- Cleavable His6 tag 
pOPINM: Carbenicillin- Cleavable His6-MBP 
tag 
 









pOPINS3C: Carbenicillin- Cleavable His6-SUMO tag 
 
pOPINS3C: Carbenicillin- Cleavable His6-SUMO tag 
pOPINA: Kanamycin- Untagged (reliant on plasmid digestion) 
 

















pOPINE: Carbenicillin- Non-cleavable His6 tag 
 
pOPINE: Carbenicillin- Non-cleavable His6 tag 
pEU-E01: Carbenicillin- Wheat Germ expression vector 
 







pMCSG7:  Carbenicillin- E. coli expression vector TEV cleavable His6 tag expression 
vector 
 
pMCSG7:  Carbenicillin- E. coli expression vector TEV cleavable His6 tag expression 
vector 
RRS1-HF cDNA pICSL86977: Kanamycin- plant expression vector 
 
















pGreenII-0229:  Kanamycin- plant expression vector, used for 35S::RPS4-HS 





































Calibration curve: HiLoad Superdex 75 26/60
logMW= (-1.241 x Ve)/110.7 + 6.3908



















Molecular Weight Calibration curve: HiLoad Superdex 75 26/60 
 
 
Molecular Weight Calibration curve: Superose™ 6 Increase column 
 
Curve generated by Dr John Steele. Protein run were: Vitamin B12 (1.4 kDa), Aprotinin 
(6.5 kDa), Cytochrome C (12.4 kDa), RNAse A (13.7 kDa), Myoglobin (17.6 kDa), 
Carbonic anhydrase (29 kDa), HPLF+7 monomer (56.9 kDa) , BSA (66 kDa), Alcohol 
dehydrogenases (150 kDa)  
 
 
Curve generated by Dr John Steele. Protein run were: Vitamin B12, Aprotinin, 
Cytochrome C, RNAse A, Myoglobin, Carbonic anhydrase, HPLF+7 monomer, BSA, 
Alcohol dehydrogenases  
 
Curve generated by Dr Abbas Maqbool. Protein run were: Ovalbumin (42.7 kDa), 
Aldolase (156.8 kDa) and Thyroglobulin (660 kDa) 
 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 5: Results of protein expression trials 
 Table lists succesfulf soluble expresion attempts of RRS1 and RPS4 protein in all expression 
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